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Summary 
 NSP4, encoded by rotavirus genome segment 10 has been shown to be a 
transmembrane, endoplasmic reticulum (ER) specific N-linked glycoprotein. 
Consistent with its localization to the ER membrane, NSP4 was first shown to have a 
role in the morphogenesis of the infectious virion. The protein has also been reported 
to have cytotoxic activity when applied extracellularly to cells. Consequently it has 
been earmarked as an enterotoxin being secreted from virus-infected cells to cause 
early cellular pathology in the gut. 
The effect of expressing the NSP4 protein of group A rotaviruses in cells has 
been studied. It led to the rapid appearance of long cytoplasmic extrusions. 
Site-directed mutagenesis was used to block N-linked glycosylation at both of the 
known glycosylation sites near the amino terminus of NSP4. This revealed that the 
NSP4 induced formation of the cytoplasmic extrusions was dependent on the 
protein’s ability to become fully glycosylated. The cytoplasmic extrusions seen in 
cells expressing glycosylated NSP4 were also evident in virus-infected cells. 
Using real-time confocal microscopy a dynamic elongation of the cytoplasmic 
extrusions with a growth speed of 2 µm/min was observed in virus-infected cells. 
The cytoplasmic extrusions were found to contain β-tubulin and F-actin. Inhibiting 
their polymerization prevented the formation of the extrusions from virus-infected 
cells. Functional studies using Cell Tracker dyes showed that the cytoplasmic 
extrusions could disseminate vesicles from virus-infected cells onto the plasma 
membrane surface of uninfected cells. The vesicles were then found in the interior of 
the uninfected cells. Mono-specific antibody to NSP4 revealed the presence of the 
protein in the vesicles suggesting that the cytoplasmic extrusions facilitated the direct 
cell-cell spread of NSP4. 
The effect of NSP4 expression on the microtubular network of cells was 
analysed. It was found that NSP4 de-polymerized the microtubular network from the 
centre of cells and promoted the assembly of microtubules at the periphery of the 
cells in a glycosylation independent manner. Similar de-polymerization and 
re-assembly of the microtubules was observed in the virus-infected cells. 
Interestingly in the presence of nocodazole, tubular structures containing tubulin and 
viral proteins excluding NSP4 were found in virus-infected cells. 
A YFP-PCA assay was established to screen for cellular partners of NSP4. The 
functionality and the sensitivity of the assay were examined, but only two false 
positive colonies were isolated in the first screening. 
In conclusion, the function of glycosylated and unglycosylated NSP4 was 
examined with the former possessing the ability to promote the formation of the 
cytoplasmic extrusions from cells and both being capable of disrupting the 
microtubular network indicating that two forms of NSP4 play different roles in NSP4 
function. The cytoplasmic extrusions seen in our studies may be relevant to rotavirus 
infection and pathogenesis. 
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Chapter 1 
Introduction 
 2 
Rotaviruses are the predominant etiological agents of acute viral gastroenteritis in the 
young of a wide range of mammalian and avian species including human infants 
(Flewett, 1978; Kapikian, 2001; Pedley et al., 1983). As such they are globally 
important medical and veterinary pathogens that constitute a major cause of 
morbidity and mortality among the young. Therefore they assume a special 
importance worldwide. 
The first recognition of human rotavirus was in 1973 by direct visualization using 
electron microscopy of patient faeces. The 70-nm viral particle identified using EM 
was subsequently designated rotavirus. Shortly afterwards, it became apparent that 
rotaviruses were an important etiologic agent of diarrhoea in infantile and young 
children accounting for approximately 35 to 50% of hospitalizations due to 
gastroenteritis during the first 2 years of life (Kapikian, 2001). Following their initial 
detection rotaviruses have been reported from many countries leading to their being 
established as a major viral etiologic agent in both the developed and developing 
world (Kapikian, 2001). 
In 1980, following treatment of clinical isolates with trypsin, the successful 
cultivation of human rotaviruses in African green monkey kidney cells was reported 
facilitating extensive investigations at the molecular level (Wyatt et al., 1980). The 
development of monoclonal antibodies and recombinant DNA technologies during 
the 1980s and 1990s and the later application of GFP and RNAi based technologies, 
contributed to considerable understanding of the rotavirus replication cycle, their 
epidemiology, pathogenesis, and the nature of host resistance to rotavirus disease. 
The increasing concern about both the medical and social burdens of rotavirus 
disease lead to the development of the first rotavirus vaccine in 1998. The removal of 
this vaccine from the market in 1999, seemed to be a setback for efforts to control 
 3 
rotaviruses (Centers for Disease Control and Prevention, 1999). However renewed 
efforts have been made and two new vaccines were released in 2006. Clinical trials 
of these vaccines carried out on a large scale in both developed and developing 
countries have resulted in the WHO recommending the use of a rotavirus vaccine 
worldwide in June 2009 (Nelson et al., 2009). 
 
1.1 Rotavirus 
1.1.1 Classification 
Rotaviruses make up one genus within the family Reoviridae, with seven distinct 
virus groups having been recognized (Estes, 2001; Pedley et al., 1983; Pedley et al., 
1986). Rotaviruses falling into each of the seven groups (A-G) share the same 
cross-reacting so-called group antigen measurable by a number of serologic tests 
(immunofluorescence, ELISA and immuno-electron microscopy) (Estes, 2001; 
Pedley et al., 1983; Pedley et al., 1986). Among these seven groups, group A 
rotaviruses have been recognized as the predominant etiological agents of acute viral 
gastroenteritis in infants and young children (Estes, 2001). Thus this thesis will focus 
exclusively on group A rotaviruses. 
The salient characteristics of group A rotaviruses are as follows: 
(1) The mature virions are approximately 100 nm in diameter and possess a triple 
layered icosahedral protein capsid with an outer layer, an inner layer and a core. 
(2) 60 spikes protrude from surface of the outer layer of the virus particle. 
(3) The viral genome is composed of 11 segments of double-stranded RNA (dsRNA) 
capable of genetic reassortment within isolates from each virus group. 
(4) Virus particles are capable of making capped RNA transcripts using virion 
associated RNA-dependent RNA polymerase and RNA capping enzymes. 
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(5) Viral cultivation in vitro is facilitated by treatment of mature virus with 
proteolytic enzymes that enhances infectivity by cleavage of the external spike 
protein (VP4). 
(6) Viral replication occurs in the cytoplasm of infected cells. 
(7) Rotaviruses exhibit a unique morphogenic pathway. 
Group A rotaviruses have been divided into a number of serotypes based on the 
reactivity of viruses in plaque reduction (or fluorescent foci reduction) neutralization 
assays using hyperimmune serum prepared in antibody negative animals. Through 
the use of such assays, 14 G serotypes (G for glycoprotein VP7) have been 
recognized to date. Among these G serotypes, G1-4 and G9 are the most common 
human strains world-wide (Centers for Disease Control and Prevention, 2008). 
Genotying of VP7 using sequence and hybridization assays has demonstrated a clear 
correlation with the serotypes defined by neutralization assays (Kapikian, 2001). The 
sero-genotypic correlation has not been as clearly defined in VP4 typing (Kapikian, 
2001). Consequently VP4 typing (P) has focused on using sequence analysis and 
hybridization assays to establish in excess of 20 VP4 genotypes whereas only 13 
VP4 serotypes have been recognized to date (Banyai et al., 2010; Hoshino and 
Kapikian, 1996; Kapikian, 2001). To integrate the VP4 serotype and genotype 
designation, an open Arabic number following P is used to denote serotype, with an 
Arabic number in brackets designating genotype. For example, the human Wa strain 
is designated P1A[8] (Kapikian, 2001). 
 
1.1.2 Physicochemical Properties of the Virus Particle 
Mature infectious rotavirus virions are nonenveloped icosahedral, triple-layered and 
about 100 nm in diameter. They resembled a wheel with short spokes and a 
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well-defined smooth outer rim when observed using standard negative staining by 
electron microscopy (Flewett et al., 1974) and it is from this wheel like morphology 
that they derive their name. The composition of virions includes VP1, VP2 and VP3 
as the inner-most layer, VP6 as the mid-layer, with VP4 and VP7 forming the 
outermost shell which is required for virus infectivity. 
Using cryo-electron microscopy (cryoEM) and improved image processing 
techniques the current understanding of virions has been enhanced reaching a 
resolution of about 9.5-Å (Fig 1.1) (Li et al., 2009). All three viral layers show 
icosahedral organization (Li et al., 2009). Starting from the inside of the virion, the 
major architecture of the inner layer surrounding the viral genome possesses 120 
molecules of VP2 arranged as 60 dimers (Li et al., 2009). Beneath of this VP2 lattice 
there are 12 copies of VP1 and VP3 per virion. The intermediate shell surrounding 
the inner core is made up of 780 molecules of VP6 arranged as 260 trimers (Li et al., 
2009). This VP6 shell may provide structural integrity to the rotavirus capsid by 
enhancing the morphologic homogeneity and long-term stability of the particle (Zeng 
et al., 1996). The outermost layer consists of 780 molecules of VP7 and 120 
molecules of VP4. The VP7 interacts with the tips of the VP6 trimers to form the 
outer most shell. Meanwhile VP4 which forms 60 spikes protruding 120Å from the 
surface of the outer shell interacts with both VP6 and VP7 (Li et al., 2009). A 
distinctive feature of the viral capsids is the 132 aqueous channels that penetrate the 
virion to link the inner core with the outer surface. These channels are thought to 
import the metabolites required for RNA transcription and export the nascent RNA 
transcripts for subsequent viral replication (Lawton et al., 1997). 
All three forms of the virus particle (triple-layered, double-layered and core) can be 
found in stool samples and tissue culture supernatants. However only triple-layered 
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particles are fully infectious under normal conditions (Bridger and Woode, 1976). In 
order to maintain the stability of the triple-layered particle calcium is necessary, 
apparently acting to stabilize the outer capsid glycoprotein VP7, with the crucial 
concentration of calcium required varying for different viral strains (Estes, 2001). 
Consequently the treatment of particles with calcium chelators (EDTA and EGTA) 
removes the outer capsid leading to a loss of virus infectivity. However the double 
shelled particles or DLPs produced by such treatment are capable of viral RNA 
transcription (Cohen et al., 1979; Estes et al., 1979). Reconstitution of TLPs from 
DLPs can be achieved by presenting VP4 and VP7 at the proper concentration of 
calcium (Chen and Ramig, 1993a). Viral cores can be produced from DLPs by 
treating them with chaotropic agents such as sodium thiocyanate or high 
concentrations of calcium chloride (Chen and Ramig, 1993b). 
The three types of viral particle have distinct densities in cesium chloride (CsCl) and 
sedimentation values in sucrose which are as follows: 
(1) TLPs have a density of 1.36g/cm3 in CsCl and sediment at 520-530S in 
sucrose. 
(2) DLPs have a density of 1.38g/cm3 in CsCl and sediment at 380-400S in 
sucrose. 
(3) Cores have a density of 1.44g/cm3 in CsCl and sediment at 280S in sucrose. 
Thus the different viral particles can be separated by density equilibrium 
centrifugation on CsCl gradients. Additionally agarose gel electrophoresis has been 
shown to allow separation of the three types of particle (Estes, 2001). 
TLPs are relatively stable under normally environmental conditions. They are 
resistant to fluorocarbon extraction, and treatment with ether, chloroform or nonionic 
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Figure 1.1: Structure of reconstruction of rotavirus particle at 9.5-Å resolution. 
Picture adapted from Li et al (Li et al., 2009). From the outermost layer, VP4 spikes are in red, VP7 
layer is in yellow, VP6 layer is in blue, VP2 layer is in green, the internal density (RNA and 
polymerase complex) is in orange. 
 
detergents which probably reflects the lack of a lipid envelope on mature particles 
(Estes et al., 1979). Infectivity of TLPs is stable within the pH range of 3 to 9. 
However VP4 is selectively lost at high pH and the particle can be broken down by 
exposure to very low pH (Anthony et al., 1991; Weiss and Clark, 1985). In the 
presence of 1.5 mM CaCl2 TLPs remain infectious for at least a month at room 
temperature but there is a loss of infectivity after repeated freezing and thawing 
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(Narang and Codd, 1983). Despite their stability, there are several potent 
disinfectants effective against rotaviruses including SDS, 95% ethanol, phenols, 
formalin and chlorine (Narang and Codd, 1983). Among these, 95% ethanol is the 
most potent disinfectant which works by removing the outer capsid shell (Narang 
and Codd, 1983). 
 
1.1.3 Viral Genome 
The viral genome is composed of 11 segments of double-stranded RNA (dsRNA). 
Deproteinized rotavirus dsRNAs are not infectious indicating the need for the viral 
RNA-dependent RNA polymerase to transcribe mRNA. The general features shared 
by all 11 dsRNA are as follows: 
(1) The +RNA of dsRNA contains a 5’ m7G cap but lacks a 3’ poly-A tail (Imai et al., 
1983; McCrae and McCorquodale, 1983). 
(2) The open reading frame of each segment is flanked by 5’ and 3’ untranslated 
regions (UTRs) that are of variable length. The open reading frame typically encodes 
a single protein except for gene 11 that encodes two proteins (NSP5 and NSP6) in 
some strains of rotavirus (Mattion et al., 1991; Rainsford and McCrae, 2007). 
(3) All segments share very little sequence identity except for very short consensus 
sequences at the termini (McCrae and McCorquodale, 1983; Mitchell and Both, 
1990a). The 3’ consensus sequence of the plus sense RNA strand has the conserved 
sequence 5’-UGUGACC-3’ as the minimal essential promoter for dsRNA synthesis 
(Wentz et al., 1996). 
(4) The rotavirus segments are completely base paired and the gene sequences are 
A+U rich (58% to 67%) (Kapikian, 2001). 
Analysis of the viral genome using polyacrylamide gel electrophoresis (PAGE) is 
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relatively easy and popular for detecting virus and monitoring viral outbreaks and 
transmission. Thus the electrophoretic pattern of group A rotavirus is composed of 
four high-molecular-weight dsRNAs (gene 1-4), two middle-size segments (gene 5 
and 6), a distinctive triplet of segments (gene 7-9), and the two smallest segments 
(gene 10 and 11) (Kapikian, 2001). 
 
1.1.4 Genome-Protein Coding Assignment 
The coding assignments and many functions of the viral proteins have been 
determined using in vitro translation of viral RNA (McCrae and McCorquodale, 
1983), immunological studies with specific antibodies, expression of viral proteins 
via recombinant DNA and analysis of reassortant viruses (Both et al., 1983; 
Greenberg et al., 1983b; Kantharidis et al., 1983; Mason et al., 1983). Figure 1.2 
shows the eleven gene segments and the corresponding viral proteins. Both the 
genome segments and viral proteins are numbered based on their migration order on 
PAGE from the slowest to the fastest. But the absolute migration order of cognate 
genes does vary among viral strains. The identification of cognate genes is made on 
the basis of hybridization with gene-specific probes or direct sequencing. 
 
1.1.5 Functions of Viral Structural and Nonstructural Proteins 
1.1.5.1 Structural Proteins (VPs) 
The 11 genome segments encode six structural proteins found in virions (Fig 1.3) 
and six non-structural proteins, although some viral strains have been reported as 
lacking the NSP6 open reading frame (Rainsford and McCrae, 2007). The structural 
proteins are VP1, VP2, VP3, VP4, VP6 and VP7, with VP5* and VP8* being 
 10 
generated by proteolytic cleavage of VP4. The core particle is composed of VP1, 
VP2 and VP3 which together act as the virus transcriptional unit. VP4, VP6 and VP7 
are the major structural proteins and make up the largest proportion of the virion. 
 
1.1.5.1.1 VP1 
VP1 have been detected inside the VP2 core (Patton, 1996). VP1 appears to be the 
viral RNA polymerase functioning as both the viral replicase and transcriptase 
(Patton, 1996). Amongst the core proteins only VP1 shows a specific viral RNA 
binding property (Patton, 1996). Although VP1 is the candidate as the viral 
polymerase, VP2 has been shown to be required for its replicase activity (Patton et 
al., 1997). 
 
1.1.5.1.2 VP2 
Studies have shown that VP2 forms the basic architecture of the core and is capable 
of forming core-like particles spontaneously when expressed in the insect 
baculovirus system (Labbe et al., 1991). VP2 also binds RNA non-specifically which 
is thought to facilitate its role in viral replication and encapsidation (Labbe et al., 
1994). 
 
1.1.5.1.3 VP3 
VP3 has been detected inside the VP2 core (Patton, 1996) and acts as a 
multifunctional capping enzyme possessing the viral guanylyltransferase and 
methyltransferase activities during virus replication (Chen et al., 1999; Liu et al., 
1992; Pizarro et al., 1991). 
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Figure 1.2: Polyacrylamide gel analysis of viral genes and corresponding proteins. 
The viral genome RNA segments and proteins shown are for the UKtc strain of bovine rotavirus 
analyzed by SDS-PAGE. All gene segments are mono-cistronic except for gene 11 which encodes a 
second out of phase reading frame. The genome segments were from virus-infected cells pulse-labeled 
at 5-6 hours post infection. The viral proteins were from virus-infected cells pulse-labeled at 6 hours 
post infection. SDS-PAGE pictures adapted from McCrae (McCrae and Faulkner-Valle, 1981). 
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Figure 1.3: Schematic representation of gene-protein coding assignment and location of 
structural proteins in the virion. 
Left: Rotavirus dsRNA genome (UKtc strain) and the proteins encoded in each gene segments. Right: 
CryoEM reconstruction of the rotavirus particle demonstrating the position of the viral structural 
proteins in the particle (Prasad et al., 1988; Yeager et al., 1990). The outermost layer (VP4 and VP7) 
is in yellow, the VP6 layer is in blue, the inner core (VP1, VP2 and VP3) is in red. 
 
1.1.5.1.4 VP4 
The viral spike protein VP4 is the viral haemagglutinin, which is surprising given its 
lack of glycosylation, and appears to be a very important virulence factor in mice and 
piglets (Kalica et al., 1983; Offit et al., 1986). It also determines host range and cell 
tropisms (Estes, 2001). The penetration, but not the binding of virus to cells can be 
greatly enhanced by proteolytic cleavage of VP4 to produce VP5* and VP8*, and 
this also leads to some increase in virus infectivity (Kaljot et al., 1988). Protective 
immunity in children and animals can be effectively induced by VP4 via the 
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generation of VP4-specific neutralizing antibody (Estes, 2001). 
1.1.5.1.5 VP6 
VP6 which forms the middle shell of the virion accounts for about 50% of the total 
virion protein. It is a hydrophobic protein and very stable after spontaneous 
trimerization (Gorziglia et al., 1985). It is highly immunogenic leading to it being the 
primary antigen detected in routine diagnosis of rotavirus disease (Estes et al., 1987). 
Surprisingly in vivo protection has been observed when two immunoglobulin A 
antibodies against VP6, which lack virus neutralization activity, are administrated to 
the luminal side of the intestinal tract (Burns et al., 1996). In common with several 
other major structural proteins of members of the Reoviridae (Lopez et al., 2005a; 
Plascencia-Villa et al., 2009), VP6 is capable of assembling nano-tubular structures 
spontaneously in virus-infected cells or when expressed individually in the insect 
baculovirus system (Lopez et al., 2005a; Plascencia-Villa et al., 2009). Although the 
potential role of these structures in infection is currently unknown they have been 
exploited in the production of a novel nanobiomaterial (Lopez et al., 2005a; 
Plascencia-Villa et al., 2009). 
 
1.1.5.1.6 VP7 
The N-linked glycoprotein VP7 forms the smooth surface of the outer capsid and 
accounts for 30% of the total virion protein. It is the G serotype determinant of 
rotavirus (Greenberg et al., 1983a). This fact has stimulated intense investigations of 
its structure, biosynthesis and function. VP7 is co-translationally glycosylated as it is 
inserted into the ER membrane (Ericson et al., 1983; Kabcenell and Atkinson, 1985). 
The glycosylation of VP7 involves addition of high mannose oligosaccharides that 
are processed by trimming. Although VP7 has up to three glycosylation sites, only 
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two of them are apparently used in different viral strains (Kouvelos et al., 1984a; 
Kouvelos et al., 1984b). Studies attempting to understand the ER retention property 
of VP7 showed that it is an integral membrane protein with a luminal orientation 
(Kabcenell and Atkinson, 1985). VP7 has also been shown to be the dominant target 
for cytotoxic T-lymphocyte (CTL) activity in mice indicating its important role in the 
immune response against rotavirus (Heath et al., 1997; Offit et al., 1994). 
 
1.1.5.2 Nonstructural proteins (NSPs) 
During viral infection, rotaviruses also encode at least five non-structural proteins 
(NSPs). Although they are not present in viral particle they play very important roles 
in viral replication, morphogenesis and pathogenesis. 
 
1.1.5.2.1 NSP1 
NSP1 (segment 5) is the least conserved protein encoded by rotaviruses (Mitchell 
and Both, 1990b) and has received considerable attention recently following 
recognition of its role as an antagonist of the interferon (IFN) signaling pathway (Sen 
et al., 2009). Following viral infection recognition by the host of expressed viral 
proteins and nucleic acids causes activation of IFN regulatory factors (IRFs) that lead 
in turn to expression of type I IFNs (IFN-α and IFN-β). NSP1 was first shown to 
interact with the IFN regulatory factor 3 (IRF3, mediates expression of IFN-α and 
IFN-β)) in a yeast two hybrid screen (Graff et al., 2002). This interaction was 
subsequently shown to promote proteasome-dependent degradation of IRF3 (Barro 
and Patton, 2005). In addition NSP1 has also been reported to mediate proteasome 
dependent degradation of IRF5 and IRF7 (Barro and Patton, 2007). IRF5 functions to 
up-regulate IFN expression and IRF7 serves as a master regulator of type I IFN 
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(IFN-α and IFN-β) expression (Honda et al., 2005). Role of NSP1 in degrading of 
IRF5 suggests that it functions to down-regulate expression of IFNs whereas its role 
in stimulating the turnover of IRF7 suggests that it also functions to suppress the IFN 
signalling pathway (Barro and Patton, 2007). The NSP1 from the Wa strain has also 
been showed to prevent nuclear accumulation of the signal transducer and activator 
of transcription 1 (STAT1) and STAT2 (Holloway et al., 2009). This inhibits 
activation of the expression of many IFN-stimulated genes (ISG) with antiviral 
properties whose expression in surrounding uninfected cells would normally result in 
establishment of anti-viral state in the cell population (Holloway et al., 2009). 
Studies have also shown that NF-kB, which plays a key role in anti-viral defenses, is 
affected by NSP1 through prevention of its activation and nuclear accumulation 
(Graff et al., 2009; Holloway et al., 2009). Specifically NSP1 from the porcine OSU 
strain induces proteasome-dependent degradation of β-transducin repeat containing 
protein (β-TrCP) (Graff et al., 2009). β-TrCP stimulates the degradation of NF-kB 
inhibitor (IkBα). Therefore increased degradation of β-TrCP leads to a preservation 
of IkBα which in turn prevents activation of NF-kB (Graff et al., 2009). As the 
molecular mechanism of NSP1 has been investigated in great detail the actual 
functionality of NSP1 in infected host has been called into question by the 
observations that bovine UK strain of rotavirus is able to degrade IRF3 in simian 
COS7 cells but not in mouse fibroblasts and murine NIH 3T3 cells (Sen et al., 2009). 
By contrast mouse EW strain and simian RRV strain of rotaviruses have shown their 
ability to degrade IRF3 in all of these three cell lines mentioned above (Sen et al., 
2009). This finding suggests that the phenotype of IRF3 degradation of viral strains 
is cell line dependent. 
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1.1.5.2.2 NSP2 
A distinct feature of rotavirus infected cells is the formation of cytoplasmic inclusion 
bodies called viroplasms where viral replication occurs. NSP2 has been shown to be 
an important component in forming viroplasms by interacting with NSP5 (Eichwald 
et al., 2004; Fabbretti et al., 1999). This interaction of NSP2-NSP5 is able to drive 
formation of viroplasm-like structures without the presence of other viral proteins 
(Eichwald et al., 2004; Fabbretti et al., 1999). However when NSP2 is transiently 
expressed alone it distributes diffusely in the cytoplasm (Eichwald et al., 2004; 
Fabbretti et al., 1999). Furthermore NSP2 has been shown to have high affinity to 
microtubules and this has been proposed to cause the association of viroplasms to the 
microtubular network and also virus induced microtubule de-polymerization 
(Cabral-Romero and Padilla-Noriega, 2006; Martin et al., 2010). Enzymatic studies 
have revealed that NSP2 possesses nucleoside triphosphatase (NTPase), RNA 
triphosphatase (RTPase) and helix-destabilizing activity (Taraporewala et al., 1999; 
Taraporewala and Patton, 2001; Vasquez-Del Carpio et al., 2006). These activities 
indicate that NSP2 also acts as a multi-functional protein involved in genome 
replication and packaging. 
 
1.1.5.2.3 NSP3 
NSP3 was initially reported to function primarily in the shut-off cellular protein 
expression following viral infection (Padilla-Noriega et al., 2002). In eukaryote 
protein translation, eukaryotic initiation factor 4E (elF4E) first binds to the of 5’-cap 
structure of mRNA. At the same time the poly A tail at the 3’ end of mRNA is 
recognized by poly A binding protein (PABP). This is followed by the scaffold 
protein elF4G, bringing elF4E and PABP together through its interaction with them. 
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This latter interaction causes circularisation of mRNA which is required for efficient 
initiation of translation (Imataka et al., 1998; Preiss and Hentze, 1998; Tarun and 
Sachs, 1995). To interrupt this process NSP3 is first thought to recognize a minimal 
consensus sequence GACC at the 3’ end of rotavirus mRNAs (Poncet et al., 1994). 
At the same time NSP3 also interacts with elF4G taking the position of PABP so that 
the PABP and its associated mRNA are evicted from the cellular translation complex 
resulting in the shut off of cellular protein synthesis (Piron et al., 1998). The 
simultaneous interaction of NSP3 with elF4G and the 3’ end of viral mRNA has also 
been reported as being required for efficient translation of viral mRNA (Vende et al., 
2000). However this straightforward role for NSP3 has been called into question by 
studies using RNAi technology to knock down NSP3 expression which had little 
effect on viral gene expression (Montero et al., 2006). Based on these observations 
the function of NSP3 in promoting the translation of viral proteins requires further 
investigation. In a separate study, a novel cellular protein, RoXaN associated with 
NSP3 (Vitour et al., 2004). This interaction does not appear to impair the interaction 
between NSP3 and elF4G and protein complexes of NSP3, elF4G and RoXaN can be 
found in virus infected cells suggesting the participation of RoXaN in regulation of 
viral protein expression (Harb et al., 2008; Vitour et al., 2004). 
 
1.1.5.2.4 NSP4 
The most studied NSP is perhaps NSP4 which is encoded by segment 10. This viral 
protein is both cotranslationally and post-translationally glycosylated. It is ER 
resident and has been shown to function like a receptor capable of mediating the 
budding of DLPs through the ER membrane (Au et al., 1989; Au et al., 1993; Taylor 
et al., 1993). NSP4 has also been shown to be a viral enterotoxin secreted in a 
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paracrine fashion (Ball et al., 1996; Zhang et al., 2000). A more detailed discussion 
of NSP4 will be presented later in this chapter. 
 
1.1.5.2.5 NSP5 
NSP5 is one of the two proteins encoded by segment 11. It is both O-glycosylated 
and phosphorylated post translationally (Afrikanova et al., 1996). Protein 
modification studies have shown that NSP5 possesses auto-kinase activity which 
leads to its hyper-phosphorylation independent of other viral proteins (Sen et al., 
2006; Sotelo et al., 2010). Interactions of NSP5 with NSP2 and VP2 have been 
reported to be able to produce the viroplasm-like structures in a calcium dependent 
manner (Contin et al., 2010; Fabbretti et al., 1999; Sen et al., 2007). Recently the 
NPS5-NSP2 and NSP5-VP2 interactions have been shown to recruit all the other 
viral proteins found in viroplasms (Contin et al., 2010). These results have been 
interpreted as indicating that NSP5 plays a key role in the assembly of viroplasms 
and in recruitment of viroplasmic proteins (Contin et al., 2010). The overall role of 
NSP5 in the viral replication cycle has also been studied by knocking down its 
expression using RNAi technology (Campagna et al., 2005; Lopez et al., 2005b). 
This lead to a reduction in the number and size of viroplasms, an altered intracellular 
distribution of the other viroplasm-associated proteins, a decreased production of the 
other structural and non-structural proteins, of genomic dsRNAs, and of infectious 
viral particles (Campagna et al., 2005; Lopez et al., 2005b). These observations 
pinpoint NSP5 as not only functioning to assembly viroplasms but as also being 
involved in the regulation of viral replication. 
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1.1.5.2.6 NSP6 
Gene segment 11, the smallest genomic RNA segment not only encodes NSP5 but 
also has an alternative open reading frame, encoding NSP6 in most viral strains. 
NSP6 is encoded in a +1 alternate reading frame in gene 11 that is positioned 
completely within the ORF of NSP5. Expression studies of NSP6 showed that it 
appears to be expressed at a low level, with a high turnover rate also having been 
detected in a pulse-chase analysis (Mattion et al., 1991; Rainsford and McCrae, 
2007). Interaction of NSP6 with NSP5 has been demonstrated by using 
co-immunoprecipitation from cells co-transfected with ORFs of NSP5 and NSP6 and 
in yeast two hybrid assays; however this interaction could not be confirmed in virus 
infected cells (Torres-Vega et al., 2000). The C-terminal region of NSP5 has been 
mapped as interacting with NSP6, with this region of NSP5 also having been shown 
to be involved in both dimerization and its hyper-phosphorylation (Torres-Vega et al., 
2000). Studies have shown that NSP6 is co-localized with NSP5 to viroplasms in 
virus-infected cells (Rainsford and McCrae, 2007; Torres-Vega et al., 2000). The 
absence of the start codon of NSP6 in two human strains (Mc323 and 512-C) 
(Kojima et al., 1996; Wu et al., 1998), and truncated NSP6 found in both the 
Alabama strain of lapine virus (Gorziglia et al., 1989) and the porcine OSU strain 
(Gonzalez and Burrone, 1989) has led to the suggestion that NSP6 may play 
non-essential role in regulation during the viral replication cycle (Rainsford and 
McCrae, 2007). 
 
1.1.6 Viral Replication Cycle 
1.1.6.1 Attachment and Entry 
The initial stage in a rotaviral infection is targeting of the virus to tissue and cells. 
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This virus-tissue/cell interaction that determines both the tissue and cell tropism and 
host range requires two factors, viral capsid proteins and cell surface molecules 
(cellular receptors). Investigations focusing on these interactions have primarily been 
conducted using either the monkey kidney epithelial cell line MA104 and/or the 
polarized human colon carcinoma cell line Caco-2. Both of these cell lines are highly 
permissive for rotavirus infection and in the case of Caco-2 cells are thought to 
reflect the in vivo situation. The outermost layer of TLPs made up of VP4 and VP7 
as expected has been shown to be involved in the initial binding of the virus to the 
host cell (Lopez and Arias, 2004). A variety of potential cellular receptors have been 
reported as being involved in this binding including N-acetylneuraminic acid (sialic 
acid), several integrins (α2β1, αvβ3, α4β1 and αxβ2) and a heat shock cognate 
(hsc70) (Lopez and Arias, 2004). Turning to the viral molecules involved, studies 
have shown that the proteolytic cleavage of the VP4 and the glycosylation of VP7 
are not essential for this binding (Fukuhara et al., 1988; Petrie et al., 1983). 
Amongst the various potential cellular receptors identified sialic acid has been 
generally considered to mediate the initial viral attachment to susceptible cells based 
on the observation that treatment of cells with neuraminidase (NA) or pre-incubation 
of virus with sialic acid containing compounds both reduced the infectivity of some 
viral strains (Isa et al., 2006; Lopez and Arias, 2004). Viral strains affected by such 
treatments are classified as NA-sensitive strains and include the simian rotaviruses 
SA11 and RRV, and the bovine strain NCDV (Isa et al., 2006; Lopez and Arias, 
2004). By contrast a number of animal virus isolates and most strains isolated from 
humans are not affected by prior neuraminidase treatment of cells and consequently 
are classified as NA-resistant strains and these include the human strains Wa and 
DS-1 (Isa et al., 2006; Lopez and Arias, 2004). However this division does not mean 
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that NA-resistant strains do not use sialic acid for cell attachment but rather that they 
may use sialic acid located in the internal regions of oligosaccharide structures, like 
ganglioside GM1. This internal sialic acid is less sensitive or completely insensitive 
to NA treatment (Lopez and Arias, 2004). Recent studies using NMR spectroscopy, 
molecular modelling and infectivity competition assays have provided evidence that 
the sub-terminal sialic acid of ganglioside GM1 was a key determinant for cell-virus 
recognition of the NA-resistant human strain Wa (Haselhorst et al., 2009). This 
suggests that sialic acid also plays a role in the cell attachment of NA-resistant 
strains. 
There is some evidence that integrins are the subsequent components that virus bind 
specifically to after initial attachment to cells. To date a number of integrins 
including α2β1, αxβ2, α4β1 and αvβ3 have been identified as having a role at the 
post-attachment level (Lopez and Arias, 2004). Expression of integrin α2β1 (VLA-2) 
in Chinese hamster ovary (CHO) cells allowed virus to enter and replicate 2-10 fold 
more productively than in parental CHO cells (Ciarlet et al., 2002). However VLA-2 
alone was not responsible for viral cell attachment and entry (Ciarlet et al., 2002). 
Additional studies have shown that VP4 from a number of rotavirus strains including 
those from humans, monkeys, and cattle was the viral protein interacting with 
VLA-2 in vitro (Graham et al., 2003). This VLA-2-VP4 interaction has been 
supported by experiments showing that antibodies against different domains of VP4 
and anti-peptide against the VP4 interaction domain of VLA-2 both inhibited viral 
binding to cells expressing VLA-2 (Fleming et al., 2007; Graham et al., 2004). The 
relevance of VLA-2 to viral infection in vivo has also been investigated in newborn 
mice infected with RRV. This showed that the expression of VLA-2 in biliary 
epithelial cells (cholangiocytes) but not in hepatocytes made cholangiocytes rather 
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than hepatocytes susceptibility to RRV infection. The use of monoclonal antibodies 
against the α2 unit of VLA-2 has also been shown to reduce the ability of RRV to 
cause biliary atresia in mice (Jafri et al., 2008). 
The αvβ3 integrin has also been examined in some detail. Transfection of αvβ3 
genes into CHO cells significantly increased their susceptibility to the rotavirus 
strains RRV, nar3 and Wa (Guerrero et al., 2000). The viral protein responsible for 
αvβ3 binding was identified as VP7 rather than VP4 (Graham et al., 2003; Zarate et 
al., 2004). 
A recent study using RNA interference based silencing of α2 and β3 in MA104 cells 
showed a reduction in infectious virus yield of strains RRV and Wa but not UK and 
TFR-41, providing further support for the α2 and β3 subunits of integrins 
involvement in viral entry of some viral strains (Isa et al., 2009). 
Additional members of the integrin family, such as α4β1 and αxβ2 have also been 
reported to promote viral post-attachment binding (Fleming et al., 2007; Graham et 
al., 2005; Graham et al., 2003; Graham et al., 2004). α4β1 has been shown to 
interact with VP4 (Graham et al., 2005), and its interaction with VP7 has also been 
suggested by the fact that antibodies directed against VP7 reduced viral binding to 
α4β1 (Fleming et al., 2007). Studies on αxβ2 have shown that it interacts with the 
amino acid motif GPR in VP7 (Graham et al., 2003). Furthermore synthetic peptides 
containing amino acids GPR have been shown to block the infectivity of virus 
(Graham et al., 2004). Finally heat shock cognate 70 (Hsc70) has been identified as 
promoting viral entry at a post-attachment step (Guerrero et al., 2002). The studies 
on Hsc70 have shown that it interacts with VP4 and VP6, probably through the 
peptide binding and ATPase domains of hsc70 (Gualtero et al., 2007; Zarate et al., 
2003) (Perez-Vargas et al., 2006). 
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Thus, to date the study of rotavirus entry has revealed the participation of sialic acid, 
integrins and hsc70 as cellular receptors and has also suggested that the molecules 
required for viral entry are viral strain and cell line dependent. It is also possible that 
there are other cell surface proteins playing indispensable roles in the entry process. 
Consequently it appears that the molecular mechanism of rotavirus entry is a 
complex and multistep process demanding the correct organization and interaction 
between both of the viral surface antigens (VP4 and VP7) and various cell surface 
receptors. 
 
1.1.6.2 Internalization 
Following attachment to the cell surface virus initiates the internalization of the viral 
particle. Studies using electron microscopy have shown that the viral particles are 
associated with coated pits and sequestered in a variety of coated vesicles suggestive 
of receptor-mediated endocytosis being employed for internalization (Ludert et al., 
1987; Quan and Doane, 1983). Alternatively, using the same experimental technique, 
it has been proposed that direct plasma membrane penetration is employed by trypsin 
pre-treated infectious virus particles. By contrast, in these studies untreated 
noninfectious viral particles were removed from the plasma membrane by 
endocytosis resulting in a non-productive infection (Suzuki et al., 1985). Studies 
using biochemical approaches have demonstrated that the use of lysosomotropic 
agents, such as NH4Cl, chloroquine, methylamine, and amantadine, and of drugs that 
block the intracellular traffic of endosomes, such as cytochalasin D, dansylcadaverin 
and bafilomycin A1, have no effect on the viral entry (Bass et al., 1995; Cuadras et 
al., 1997; Fukuhara et al., 1987; Kaljot et al., 1988; Ludert et al., 1987). The failure 
of these treatments argues against endocytosis being the primary route used by virus 
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to enter the cells. Consequently, direct plasma membrane based entry is perhaps now 
more favoured as the internalization mechanism of rotaviruses (Sanchez-San Martin 
et al., 2004). Using a combination of biochemical and genetic (over-expression of 
dominant-negative mutants of the target gene) approaches one study has 
demonstrated that the entry of virus is not through a well-defined clathrin or 
caveolin-dependent endocytosis but is rather dependent on functional dynamin in a 
cholesterol sensitive pathway (Sanchez-San Martin et al., 2004). Recently in a 
comparison of four different strains of rotaviruses, which included the simian strain 
RRV used in the above studies, hsc70, dynamin, and cholesterol were required for 
entry of all of the strains. However the human strain Wa, porcine strain TFR-41, and 
bovine strain UK all appear to enter the cells through clathrin-mediated endocytosis 
as their infectivity is blocked by the treatment inhibiting this pathway. These three 
strains of rotaviruses are also consistently sensitive to changes in the endosomal pH 
(Gutierrez et al., 2010). These studies emphasizes the possibility that different viral 
strains appear to utilize diverse mechanisms (i.e. direct plasma membrane 
penetration and/or endocytosis) for their internalization, and that the exact 
mechanism of each pathway still remains unclear. 
 
1.1.6.3 Uncoating 
The uncoating process of rotaviruses involves removing the outermost shell made up 
of VP4 and VP7. This process can be achieved in vitro by the use of EDTA or EGTA 
as chelating agents (Cohen et al., 1979). In vivo, it is thought that the low levels of 
calcium concentration in the cells is important to activate this event; the inhibition of 
uncoating of the porcine strain OSU on MA104 cells by the calcium ionophore 
A23187 being the experimental basis for this conclusion (Ludert et al., 1987). It has 
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also been reported that the uncoating of the RRV and SA11 strains for virus are not 
affected by the use of compounds such as the calcium ionophores A23187 and 
ionomycin or of the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin 
which increases intracellular calcium levels (Cuadras et al., 1997). These different 
observations being made concerning the importance of calcium levels for viral entry 
may be accounted for by the different viral strains used in the various studies 
(Cuadras et al., 1997; Ludert et al., 1987). 
 
1.1.6.4 Transcription 
The product of uncoating associated with virus entry is the double-shelled (DS) 
particle that is transcription-competent. The transcriptional ability of DLPs has been 
demonstrated in vitro by using treatment with EGTA or EDTA to uncoat the TLP 
(Cohen et al., 1979; Mason et al., 1980). To initiate transcription the viral RNA 
dependent RNA polymerase believed to be VP1 utilizes viral dsRNA to synthesize 
positive sense single stranded mRNA (Lawton et al., 2001). The nascent RNA 
transcripts are capped at their 5’ end by the virion associated guanylyl and 
methyltransferase activities residing in the virion core protein VP3 to produce 
mRNAs with a m7GpppG(m) cap at their 5’ end (Lawton et al., 2001). As the 
elongation process proceeds, the growing mRNA protrudes from DLPs through 
channels that penetrate the VP2 and VP6 capsid layers (Lawton et al., 2001). On 
completion mRNA molecules are released into the cytoplasm of the infected cell and 
a new cycle of transcription begins using the same viral RNA template and enzymes 
(Lawton et al., 2001). Transcript of the 11 segments dsRNA in the DLP involves 12 
copies of VP1 and VP3 and is a distinct feature of segmented viruses (Prasad et al., 
1996). In an early study done using the bovine UKtc strain of rotavirus, the 
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transcriptional regulation of viral genes has been shown to occur at two levels 
(Johnson and McCrae, 1989). The first is temporal control, with the genes divided 
into three categories, the first being genes 1, 2, 6, 8 and 11 whose transcription 
proceeds at a more or less linear rate throughout the infection cycle (Johnson and 
McCrae, 1989). The second category includes only gene 7 which accumulates 
rapidly early in the infection cycle and reaches a plateau at which it is maintained for 
the rest of the infection cycle (Johnson and McCrae, 1989). The third and final 
category involves genes 3, 4, 5, 9 and 10 which have low rates of transcription at 
early times post infection, but the rate increases later in the infection cycle (Johnson 
and McCrae, 1989). The second level of transcriptional control is a quantitative one, 
with the greatest accumulation being seen for genes 2 and 7 at 73,000 to 94,000 
molecules per cell; a medium level seen in gene 3 at 45,000 molecules per cell and 
genes 1, 5, 8, 9 and 11 at 30,000 to 36,000; with the lowest levels being seen for 
genes 4, 6 and 10 at 14,000 to 21,000 molecules per cell (Johnson and McCrae, 
1989). 
 
1.1.6.5 Translation 
To translate the capped viral mRNA released from DLPs the virus hijacks the 
translational machinery of the cell, with cellular ribosomes being recruited for 
synthesis of all 12 of the viral proteins (Patton et al., 2006). To regulate viral protein 
translation NSP3 has been shown to be important in shutting off cellular protein 
synthesis and enhancing viral protein synthesis by interacting with eIF4G (eukaryotic 
initiation factor 4G) and RoXaN (rotavirus X protein associated with NSP3) (Harb et 
al., 2008; Padilla-Noriega et al., 2002; Piron et al., 1999; Piron et al., 1998; Vende et 
al., 2000; Vitour et al., 2004). However the interaction between NSP3 and eIF4G 
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only appears to shut off cellular protein synthesis and not contribute to efficient viral 
protein translation as indicated in NSP3 knock down experiments using RNAi 
(Montero et al., 2006). A study attempting to understand the translational regulation 
used by bovine strain UKtc rotavirus clearly showed that viral proteins are neither 
synthesized in equal amounts nor are the amounts similar to that of their 
corresponding gene transcripts (Johnson and McCrae, 1989). This study showed that 
VP6 and NSP4 were synthesized in the largest quantities compared to the nine other 
viral proteins with NSP5 and NSP6 being the least synthesized proteins (Johnson and 
McCrae, 1989; Rainsford and McCrae, 2007). 
 
1.1.6.6 Genome Replication 
Following translation of the viral proteins NSP2 and NSP5 they assemble to form 
electron-dense cytoplasmic inclusions (viroplasms). These structures are the sites for 
viral (-)RNA synthesis and the formation of DLPs (Altenburg et al., 1980; Fabbretti 
et al., 1999; Petrie et al., 1984). It has been proposed that the initial plus sense RNA 
transcripts made by infecting DLPs translocates to either polysomes for protein 
translation or viroplasms for negative strand RNA synthesis i.e. genome replication 
(Patton et al., 2006). Further synthesis of viral plus sense RNA for replication has 
been reported to occur exclusively in viroplasms from newly formed DLPs (Silvestri 
et al., 2004). Packaging of plus sense transcripts into cores and its replication to form 
dsRNA occur in succession such that no naked dsRNA is formed in the cytoplasm of 
infected cells (Patton et al., 2006). 
 
1.1.6.7 Particle Assembly and Maturation 
In virus infected cells DLP particles (VP1, VP2, VP3 and VP6) are formed in 
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viroplasms and released into the cytoplasm, the NSP4-driven translocation of DLPs 
across the ER membrane to the ER is followed by their maturation to become 
infectious TLPs. The viral core (VP1, VP2 and VP3) has been shown to accumulate 
in viroplasms using electron microscopy (Korolev et al., 1981; Suzuki et al., 1981). 
Following expression of viral proteins, recruitment of VP1 and VP2 from the 
cytoplasm has been reported to depend both on their high affinity to single-stranded 
RNA and their interactions with NSP2 and NSP5 (Arnoldi et al., 2007; Colomina et 
al., 1998; Patton et al., 2006). The enriched VP2 forms the structural basis for the 
viral core and its simultaneous association with VP1 and VP3 leads to the formation 
of a functional viral core (Zeng et al., 1998). The formation of DLPs is achieved by 
adding VP6 to the viral core. Co-expression of VP2 and VP6 in insect cells results in 
the formation of DLPs, which is indicative of the intrinsic ability of VP6 to associate 
with the viral core (Zeng et al., 1996). During DLP formation in infected mammalian 
cells VP6 has been observed in the exterior region of viroplasms (Lopez et al., 
2005a). This would allow VP6 to associate with newly assembled and translocated 
cores to form DLPs as they move toward the periphery of viroplasms. NSP4 has 
been shown to regulate VP6 localization around viroplasms probably by its 
interaction with VP6, with silencing NSP4 by specific siRNA resulting in the 
formation of large filamentous arrays of VP6 in the cytoplasm (Au et al., 1989; 
Lopez et al., 2005a). The association of VP6-encapsidated DLPs and NSP4 allows 
the former to bud across the ER into the lumen of the ER, with the DLPs acquiring a 
lipid envelope during this translocation step (Lopez et al., 2005a). The heterotrimeric 
complex containing NSP4 and the ER lumen resident VP7 and VP4 proteins 
eventually results in the maturation of DLPs by disassociation of NSP4 and the lipid 
envelope and the addition of VP7 and VP4 (Lopez et al., 2005a). Research 
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addressing the role of VP7 and VP4 in the process of TLP maturation has been done 
using specific siRNA knockdown. Silencing VP7 resulted in the accumulation of 
DLPs in the ER but had no effect on DLP formation. This suggests that VP7 is 
involved in removing the lipid envelope (Lopez et al., 2005a). Knock down of VP4 
lead to the appearance of TLPs lacking VP4 spikes suggesting that VP4 is not 
involved in the budding of DLP into the ER or the removal of the lipid envelope. 
Thus it appears that VP4 only plays a role in the final step of TLP maturation by 
forming spikes on the surface of TLP (Arias et al., 2004; Dector et al., 2002). The 
silencing of both VP7 and VP4 did not prevent DLPs from entering the ER lumen 
suggesting that NSP4 alone was sufficient to drive DLPs into the ER lumen. 
 
1.1.6.8 Release of Virions 
The mechanism of progeny virion release from cells differs in undifferentiated 
(MA104) and differentiated (Caco-2) cell lines. In MA104 cells, an undifferentiated 
cell line, release of virions has been reported to be through cytolysis at the end of the 
viral replication cycle (Musalem and Espejo, 1985; Perez et al., 1998). By contrast in 
differentiated Caco-2 cells, virions have been shown to be released preferentially 
from the apical surface of the cell through a vesicular transport process that bypasses 
the Golgi apparatus (Gardet et al., 2007; Jourdan et al., 1997). The apical release has 
been reported to involve actin and lipid rafts (Gardet et al., 2007; Sapin et al., 2002). 
However disruption of the cellular skeleton particularly the actin network has been 
reported in Caco-2 cells at later times in the viral replication cycle (Brunet et al., 
2000a). Furthermore endogenously expressed or exogenously added NSP4 have also 
been shown to alter the actin network (Berkova et al., 2007). Taken together, these 
observations in differentiated enterocytes suggest that the release of progeny virions 
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may be blocked late in the infection cycle because of disruption of the actin network 
by viral replication in the infected cells. In addition disruption of the actin network in 
bystander uninfected cells by secreted NSP4 may set a barrier in these cells that will 
not support progeny virions released following infection. 
 
1.1.7 Rotavirus Disease 
1.1.7.1 Symptoms and Clinic Features 
Rotavirus infection normally leads to diarrhoea varying from subclinical through 
mild to severe and finally a lethal dehydrating infection. Rotavirus patients usually 
have a temperature of 37.9 °C or above (Kapikian, 2001). Vomiting and dehydration 
often occur with a mean duration of 2.6 days for vomiting. Diarrhoea follows the 
vomiting where it occurs and lasts for a mean duration of 5 days. In some severe 
infections, illness progresses to death within 1 to 3 days of the onset of symptoms. It 
is believed that dehydration, electrolyte imbalance and aspiration of vomit are the 
main factors accounting for death (Kapikian, 2001). In immunodeficient children a 
chronic infection with serious symptoms can be established. In such children viral 
antigen was seen in sections of the liver and kidney and noticeable alterations in the 
viral genome were found after death of those patients (Kapikian, 2001). 
 
1.1.7.2 Diagnosis and Treatment 
The disease symptoms of rotavirus infection are not sufficiently specific to be 
diagnostic and consequently the identification of viral antigen or genomic RNA is 
required for diagnosis. To date a number of sensitive and viral strain specific 
methods have been developed (Kapikian, 2001). The distinctive morphology of the 
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rotavirus particle means that electron microscopy can be applied for direct detection 
in 80% to 90% of rotavirus-positive specimens (Kapikian, 2001). Currently the most 
widely used and promising diagnostic method is RT-PCR. It has allowed detection of 
virus and gene-typing from 4 to 57 days after the onset of diarrhoea (Richardson et 
al., 1998; Xu et al., 1990). Confirmatory ELISA and flow cytometry applied for 
rotavirus detection have also been reported to have excellent sensitivity (Barardi et 
al., 1999; Eiden et al., 1991; Ellens and de Leeuw, 1977). Other routinely used 
methods such as dot hybridization, counterimmuno-electro-osmophoresis, gel 
electrophoresis of rotavirus RNA, reverse passive hemagglutination assay (RPHA) 
and latex agglutination have also been developed in some labs and are the basis for 
some of the commercial kits available for diagnosing rotavirus infection. 
In most cases of rotavirus mediated diarrhoea the patient will normally be 
recommended to take oral rehydration therapy (ORT) to increase fluid uptake in 
order to prevent the dehydration associated with vomiting and diarrhoea. If after 
ORT treatment severe dehydration still persistents then intravenous fluids must be 
given immediately (Kapikian, 2001). 
 
1.1.7.3 Epidemiology 
Although rotaviruses infect people of all ages, infants and young children are those 
primarily affected by this infection. Infants younger than 6 months are generally 
protected by maternal derived immunity (Haffejee, 1995). However, when this 
wanes a high incidence of symptomatic infection occurs covering the 6 to 24 month 
age group. By 3 years of age more than 90% of children are positive for antibodies 
against rotaviruses (Huilan et al., 1991). In the United States, about 2.7 million 
episodes of diarrhoea are estimated annually to be associated with rotavirus infection 
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(Kapikian, 2001). This results in 410,000 visits to a physician, 160,000 emergency 
room visits, 50,000 hospitalization, and 20 deaths (Kapikian, 2001). Economically 
this results in over $264 million in medical costs and over $1 billion in social costs 
(Kapikian, 2001). In developing countries, there are estimated to be approximately 
130 million episodes of rotavirus illness with 18 million severe cases and 873,000 
deaths (Kapikian, 2001), making rotaviruses globally the most important agent of 
life-threatening diarrhoea in infants and young children. In adults, infection is 
common but normally produces minimal or no symptoms due to the high level of 
immunity from previous infections (Kapikian, 2001). 
The faecal-oral route of transmission is the major one seen in rotaviruses. A 
respiratory route of transmission is suggested by the temporal pattern of disease in 
temperate zones, with a distinct winter peak of incidence (Brandt et al., 1983; Ward 
et al., 1986). Additionally in tropical countries the seasonal pattern does not display 
uniformity throughout the year but rather shows a peak incidence in the rainy season 
(Cook et al., 1990). Studies have shown that the most efficient way to eliminate virus 
is treatment with alcohol (70%) with or without savlon which removes over 99% of 
the virus (Ansari et al., 1989). This study also found that routine sanitation methods 
such as tap water alone or with soap, even savlon in water (1:200) only remove about 
80% of the virus (Ansari et al., 1989). The remaining 20% of infectious virions after 
routine washes are sufficient to produce clinical disease as it has been shown that as 
little as 1 infectious viral particle is capable of causing disease (Graham et al., 1987). 
Therefore, transmission of virus is common and difficult to prevent even in countries 
with good hygiene practices. 
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1.1.8 Pathogenesis 
In vivo, rotaviruses initialize pathogenesis by infecting mainly mature enterocytes in 
the mid and upper section of the villi of the small intestine (Kapikian, 2001). Direct 
observations of the gastrointestinal tract demonstrated subsequent viral replication 
resulted in lesions in the jejunal mucosa of hospitalized infants and young children 
(Kapikian, 2001). These lesions include shortening and atrophy of the villi, 
mononuclear cell infiltration in the lamina propria, irregular microvilli and 
denudation of microvilli (Kapikian, 2001). 
Studies of viral pathogenesis in experimentally infected animals have revealed more 
details. In calves and piglets showing clinical signs of disease, histopathological 
studies have revealed thinning of the epithelium cell wall, villous atrophy, shortened 
villi and conversion of epithelium from columnar to cuboidal (Carpio et al., 1981; 
Collins et al., 1989). However the histological change in the intestine could not 
wholly explain the mechanism of fluid loss and malabsorption as watery diarrhoea 
was seen in piglets before the detection of extensive intestinal damage (McAdaragh 
et al., 1980). Moreover, infected rabbits showed normal histology with significant 
alteration in glucose and leucine uptake (Lundgren and Svensson, 2001). Thus the 
involvement of viral molecules and cellular factors has been extensively investigated. 
Recently it has become clear that watery diarrhoea is a consequence of disturbances 
at the cellular and molecular level. Four hypotheses have been put forward to explain 
the intestinal secretion of fluids and electrolytes: 
(A) Diminished absorptive capacity of the intestinal epithelium. 
(B) Villi ischemia due to disrupted intestinal microcirculation. 
(C) Involvement of the Enteric Nervous System (ENS) 
(D) Rotavirus enterotoxin (NSP4) 
 34 
These four hypotheses have been comprehensively reviewed (Lundgren and 
Svensson, 2001) and only the last of them will be discussed in detail in this thesis. 
 
1.1.9 Rotavirus Vaccines 
In 1998 the first licensed rotavirus vaccine (RotaShield, by Wyeth) was approved by 
the FDA in the United States. It was a live attenuated vaccine, able to prevent 
80-100% of group A rotavirus induced severe diarrhoea, with no statistically 
significant serious adverse effects having been detected in the clinical trials. 
However after little more than a year, the vaccine was withdrawn after the discovery 
of a potential link between intussusception and the first dose of vaccine (Centers for 
Disease Control and Prevention, 1999). 
Despite the disappointment engendered by the withdrawal of Rotashield from the 
market, there was new hope in 2006 with the announcement of two rotavirus 
vaccines. Rotarix developed and marketed by GlaxoSmithKline (GSK) is a single 
serotype, live attenuated human rotavirus vaccine administrated orally. It was shown 
to prevent G1 and non-G1 (G3, G4 and G9) rotavirus gastroenteritis (McCormack 
and Keam, 2009; Vesikari, 2008). The other oral vaccine, RotaTeq developed and 
marketed by Merck, is a live pentavalent vaccine. It contains five rotaviruses 
generated by reassortment and prevents G1, G2, G3, G4 and P1A induced 
gastroenteritis and severe disease at 74% and 98% efficacy respectively (Chandran 
and Santosham, 2008). To date ongoing evaluations of cost-effectiveness and 
vaccination programs globally show great reductions in clinical and economic 
burden for both of these vaccines (O'Ryan et al., 2009; Weycker et al., 2009). 
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1.2 Non-Structural Protein 4 of the UKtc Bovine Strain (NSP4) 
1.2.1 NSP4 Structure and Modification 
NSP4, encoded by genome segment 10, is a glycoprotein of 175 amino acids that has 
been found as an integral protein in the ER membrane. The primary translation 
product of NSP4 is 20 KDa but it becomes 28 KDa after co-translational and post 
translational glycosylation and oligosaccharide processing (Kabcenell and Atkinson, 
1985). There are three hydrophobic domains (H1-H3) near to the N-terminus of 
NSP4 with two N-linked high mannose glycosylation sites being in the first of these 
domains (aa7 to 21). A predicted amphipathic α-helix and a folded coiled coil region 
are in the middle of the protein. The C terminus that is hydrophilic forms an 
extended cytoplasmic domain. The H2 transmembrane domain (aa28 to 47) which 
traverses the ER membrane enables NSP4 to anchor on the ER. The H3 domain 
(aa67 to 85) appears to lie on the cytoplasmic side of the ER membrane and is 
associated with DLP binding (Jagannath et al., 2006). Glycosylation studies indicate 
that carbohydrate moieties remain sensitive to endoglycosidase H digestion, and 
oligosaccharide processing of the Man9GlcNAc carbohydrate added to NSP4 stops 
at Man8GlcNAc, with the mannose-9 species predominating, indicating that no 
further trimming occurs in the Golgi (Estes, 2001). 
 
1.2.2 Sequence Conservation 
NSP4 is highly conserved across the group A rotaviruses that infect mammals. 
Detailed computational analysis of NSP4 sequences in GenBank has allowed the 
recognition of at least four genetic groups of NSP4, with 14 amino acids being 
absolutely conserved among all group A NSP4 protein. Of the conserved amino 
acids, two are glycosylation sites, one is in the middle of the transmembrane segment, 
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seven cross the VP4 binding domain, and five span in the middle of the toxic peptide 
domain, indicating the functional importance of the conservations (Lin and Tian, 
2003). A more recent study detecting adaptive evolution of NSP4 has shown that 
NSP4 has suffered strong purifying selection across species (Song and Hao, 2009). 
The requirement for functionally important domains and host adaptive selection of 
NSP4 may explain the reason for its conservation in different species. In addition, 
analysis using sequences of human group B rotavirus has shown that despite the 
absence of primary sequence conservation between group A and B NSP4’s, the 
predicted secondary structural features of the two proteins are highly conserved 
(Guzman and McCrae, 2005). 
 
1.2.3 Immunogenicity 
Immunization with NSP4 has been shown to be able to induce immunity that protects 
animals and children from viral challenge (Hou et al., 2008; Iosef et al., 2002; Malik 
et al., 2008). This protection has been seen in experimental animals including 
neonatal mice and gnotobiotic pig models. In the latter model moderate titres of 
serum IgM, IgG and IgA antibodies to NSP4 have been detected (Ball et al., 1996; 
Iosef et al., 2002). Furthermore anti-NSP4 antibodies have also been reported to be 
sufficient to block rotavirus-induced diarrhoea in mice (Hou et al., 2008). More 
importantly in children it has been demonstrated that NSP4 induces IgG, IgA and 
significant IFN-gamma during natural infection (Malik et al., 2008; Ray et al., 2003; 
Vizzi et al., 2005). 
 
1.2.4 NSP4 Functions 
NSP4 possesses pleiotropic properties in both viral morphogenesis and 
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pathogenesis. On the one hand, it locates to the endoplasmic reticulum (ER) 
membrane and serves as a receptor for the introduction of viral double-layer 
particles (DLP) to enter the ER lumen where they can assemble with VP4 and VP7 
to produce infectious triple-layer particles (TLP). On the other hand, NSP4 appears 
to be secreted from infected cells before the release of virus to act in a paracrine 
fashion as a viral enterotoxin. The sequence elements and functional domains of 
NSP4 described in the following sections are summarized in figure 1.4. 
 
1.2.5 Morphogenesis 
NSP4 plays a crucial role in viral assembly facilitating the budding of viral DLPs 
into the ER lumen where they form infectious TLPs by the addition of the outer 
shell proteins (VP4 and VP7). When the budding starts, the C terminal half of 
NSP4 alone is responsible and sufficient for binding with DLPs (Estes, 2001).The 
20 amino acids at the C terminus of NSP4 are involved in binding DLPs and the 
terminal methionine is essential for binding activity (Taylor, 1992; Taylor et al., 
1993). As the budding progresses, an enveloped DLP will be generated. To remove 
this envelope glycosylated NSP4 and VP7 are required (Estes, 2001; Lopez et al., 
2005a). Subsequent addition of VP4 and VP7 is facilitated by the fact that NSP4 
binds VP4 and forms heterooligomers of NSP4, VP4 and VP7 in enveloped DLPs 
which recruits sufficient VP4 and VP7 to the maturation site of TLP in the ER (Au 
et al., 1993; Estes, 2001). The assembly of the VP7 layer and VP4 spikes has been 
shown to occur spontaneously at certain concentrations of calcium when these 
proteins are co-expressed with VP2 and VP6 in insect cells using baculovirus 
system (Crawford et al., 1994). During this process amino acids 73 to 85 and the C 
terminal (CT) both appear to be important for the oligomerization of NSP4 
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(Jagannath et al., 2006). Studies blocking the synthesis of NSP4 in virus infected 
cells using RNAi technology have demonstrated that the absence of NSP4 not only 
leads to disruption of the intracellular accumulation and sub-cellular distribution of 
several viral proteins and viroplasms but also results in little or no virus particles 
(neither DLPs nor TLPs) being assembled (Lopez et al., 2005a; Silvestri et al., 
2005). This suggests that NSP4 is functioning in the whole process of viral 
replication to guarantee the final viral morphogenesis rather than just in the final 
budding of DLPs and TLP maturation events. 
 
1.2.6 Pathogenesis 
The second function of NSP4 that appears to require the protein to be secreted 
from virus infected cells is its role in viral pathogenesis. NSP4 contributes to the 
process of diarrhoea directly. It has been characterized as the first and to date the 
only viral enterotoxin, that can cause diarrhoea in a neonatal mouse model without 
other components of the virus (Ball et al., 1996; Horie et al., 1999). Furthermore, 
the influence of NSP4 in inducing diarrhoea is specific and the alteration in vital 
amino acids yields an avirulent form of NSP4 that does not induce diarrhoea in 
newborn mice (Zhang et al., 1998). Moreover, amino acids between 112 and 175 
of NSP4 have been identified as the key region of the protein involved in the 
pathogenesis (Zhang et al., 2000). The purified peptide (aa112-175) can trigger all 
the toxic events seen with the intact NSP4 protein (Zhang et al., 2000). In infected 
non-differentiated MA104 cells a peptide cleavage product of NSP4 encompassing 
this region has been reported as being secreted by the microtubule and actin 
filament network trafficking pathway rather than the ER-Golgi vesicle-mediated 
secretion pathway inhibited by brefeldin A (Zhang et al., 2000). Further analysis of 
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possible NSP4 secretion has been done in the polarized epithelial cell line Caco-2 
which is thought to more closely mimic the in vivo situation. Secretion of NSP4 
was detected mainly from the apical surface of this cell line and its secretion was 
sensitive to treatment of brefeldin A and monensin indicating involvement of the 
Golgi apparatus during secretion. The form of secreted NSP4 in this second study 
was full length and fully glycosylated (Bugarcic and Taylor, 2006). These 
observations are contradictory but they may reflect different strategies of secreting 
NSP4 in different cell types. Furthermore neither of these studies could exclude 
NSP4 being in the vesicles disseminated from virus-infected cells described in 
chapter 5 of the thesis. 
The mechanism by which secreted NSP4 destroys epithelial cells through what is 
currently believed to be a paracrine like pathway has been the focus of much 
attention. As the release of glycosylated NSP4 occurs before lysis of the infected 
cell, the secreted NSP4 has been shown to interact with cellular integrins α1β1 and 
α2β1 of bystander cells (Seo et al., 2008). These interactions activate a 
phospholipase C-inositol 1,4,5-triphosphate (PLC-IP3) cascade that stimulates the 
release of Ca2+ from the ER (Dong et al., 1997). Calcium imported into the 
cytoplasm causes an intracellular Ca2+concentration increase due either to Ca2+ 
release from intracellular pools (ER) by IP3 or Ca2+ import across plasma 
membrane via various Ca2+channels (Ruiz et al., 2005). Cytoplasmic 
Ca2+concentrations play an extremely important role in live cells and disrupting 
them results in dysfunction of crucial cellular molecules and eventually death of 
the bystander epithelia (Ruiz et al., 2005). 
Consistent with this role for NSP4, alterations of cellular Ca2+ homeostasis can be 
observed in either rotavirus infected cells or following transfection of an NSP4 
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expressing plasmid alone (Berkova et al., 2003a). However in both cases NSP4 
appears to activate an undefined cascade rather than using the PLC-IP3 pathway 
(Berkova et al., 2003b; Dong et al., 1997; Michelangeli et al., 1991). The 
expression of NSP4 alone was sufficient to mimic the Ca2+ homeostasis changes 
induced by rotavirus infection in cultured cells (Diaz et al., 2008). Silencing of 
NSP4 in virus infected cells using RNAi technology leads to a reduction in Ca2+ 
levels to those seen in mock-infected cells which has further validated the 
influence of NSP4 on intracellular calcium homeostasis (Zambrano et al., 2008). 
Mutational analysis using NSP4 expressing cells has demonstrated that the 
essential domain required for triggering the Ca2+ permeability increase may be 
located in either residues 55 to 69 or the overlapping domain of residues 66 to 83, 
deletions of which lead to dramatic reductions in cytotoxic activity. However, 
deletion of residues 1 to 60 including the two glycosylation sites only reduced 51Cr 
release from cells by approximately 30% and deletion of the region from amino 
acids 110 to 119 had no affect (Newton et al., 1997). It must be recognized 
however that these deletions in NSP4 may also affect its secondary or tertiary 
structure or alter its intracellular trafficking pathway. Consequently they need to be 
interpreted with caution in terms of their ability to reveal the functional region of 
NSP4 involved in triggering changes in Ca2+ permeability. Although the detailed 
mechanism by which NSP4 regulates intracellular calcium levels has not been 
completely defined it is clear that NSP4 is the main protein responsible for 
alteration of calcium levels that facilitates viral replication and participates in viral 
pathogenesis. 
In addition to the pathogenic mechanism that relies on disrupting intracellular 
calcium levels, other potentially pathogenic strategies have also been proposed. 
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First, if NSP4 is incubated with polarized epithelium, paracellular leakage mainly 
through tight-junction-associated protein disruption is observed. Surprisingly, if 
NSP4 is then removed the original integrity of the epithelium is regained and 
electrical resistance recovers (Tafazoli et al., 2001). Secondly NSP4 appears to act 
through the enteric nervous system (ENS) to induce Cl- secretion and hence signal 
an increase in intracellular calcium concentration (Lundgren et al., 2000). This 
indicates that in vivo ENS related cellular components are also involved in the 
NSP4 pathway (Lundgren et al., 2000). Thirdly NSP4 has been reported to 
up-regulate inducible nitric oxide synthase (iNO) that is responsible for nitric oxide 
(NO) production in infected mice (Borghan et al., 2007). The production of NO 
has been implicated in affecting both intestinal motility (Hoffman et al., 1997) and 
mucosal permeability (Kubes, 1992) and also acting as a modulator of intestinal 
ion transport via either its activation of the ENS (Izzo et al., 1998) or its direct 
action on the intestinal epithelium (Borghan et al., 2007; Resta-Lenert and Barrett, 
2002). Finally supernatants containing secreted NSP4 can induce a Ca2+-dependent 
microvillar F-actin alteration in uninfected Caco-2 cells (Brunet et al., 2000a). 
Endogenous expression of NSP4 has also been consistently shown to lead to 
alteration of the actin network organization through the actin remodeling protein 
cofilin that is also regulated by intracellular calcium levels (Berkova et al., 2007). 
All of these observations may have a role to play in the final symptoms of rotavirus 
disease and undoubtedly NSP4 has multiple roles in the development of such 
symptoms. 
 
1.2.7 Intracellular Localization and Interactions with Cellular Proteins 
The intracellular localization of NSP4 following both viral infection and transient  
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Figure 1.4: Linear schematic of NSP4 and its sequence elements and functional domains. 
H1-H3, hydrophobic domains 1 (aa7-21), 2 (aa29-47) and 3 (aa65-85). G, glycosylation sites at aa8 
and 18. Amphipathic α-helical region at aa55-72. α-helical homotetrameric coiled coil region at 
aa95-134 or 137. Secreted toxic peptide at aa112-175 (Zhang et al., 2000). Domain at aa83-123 is 
important for ER retention (Estes, 2001). Multimerization requires aa73-85 (Jagannath et al., 2006). 
Domain 114-135 damages the liposomal membrane but not the cytoplasmic membrane, induces 
diarrhoea, possesses membrane destabilizing activity (Estes, 2001). Three domains in red (aa1-60, 
aa55-59 and aa66-83) if deleted resulted in reduction of cytoplasmic Ca2+ release from cells (Newton 
et al., 1997). Three domains in green aa112-140, aa112-146 and aa155-175 are important for 
NSP4-VP4, Ca2+ and double layer particle binding respectively (Taylor, 1992; Taylor et al., 1993; Au 
et al., 1993; Estes, 2001). Black circle indicates that function does not require glycosylation. Blue 
circle is indicates that function requires glycosylation. 
 
transfection has been studied to try and gain insights into its function. It is well 
established that NSP4 is initially synthesized in the ER but it subsequently moves 
away from the ER to the cytoplasm in which it appears to form vesicular structures 
similar to viroplasms. Recently these structures have been reported to co-localize 
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with the autophagosomal marker LC3 but not to co-localize with ER, ERGIC, Golgi, 
endosomal, or lysosomal markers (Berkova et al., 2006). The colocalization of the 
autophagosomal marker LC3 and viroplasms that has been observed in infected cells 
does suggest a possible new mechanism for the involvement of NSP4 in virus 
replication (Berkova et al., 2006). Putatively glycosylated NSP4 may play a very 
important role in assembling of viroplasms as this has been shown to be a 
calcium-regulated process (Berkova et al., 2006). Although the majority of NSP4 has 
been reported to accumulate in such vesicular structures, a fraction of soluble NSP4 
that is full length and glycosylated has also been observed to co-localize with the 
plasma membrane and to be associated with caveolae (Mir et al., 2007; Storey et al., 
2007). This association has been attributed to the interaction between NSP4 and both 
the N and C-termini of caveolin-1 (Mir et al., 2007; Parr et al., 2006; Storey et al., 
2007). In addition to its interaction with caveolin-1, NSP4 also interacts with the 
microtubule and extracellular matrix proteins laminin-β3 and fibronectin (Boshuizen 
et al., 2004). Its interaction with microtubules may contribute to the blockage of 
ER-to-Golgi trafficking in vivo, while its interaction with laminin-β3 and fibronectin 
which are located at the basal side of infected epithelial cells may signify a new 
mechanism by which rotavirus disease is established (Boshuizen et al., 2004; Xu et 
al., 2000). 
 
1.3 Aims 
The aim of the thesis are to construct glycosylation mutants of NSP4 and to study the 
functional difference between the wild type and the mutant NSP4 by observing their 
intracellular localization and effects on transfected cells; to evaluate the proposed 
function of NSP4 in infected cells; to construct a protein-protein interaction 
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screening system which uses full length NSP4 as bait for the isolation of its cellular 
partners and hence gain a better understanding of the intracellular trafficking and 
pathogenicity of NSP4.
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Chapter 2 
 Materials and Methods 
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2.1 Suppliers 
General chemicals were obtained from BDH Laboratory Supplies, Fisher Scientific 
(Loughborough, Leicestershire), Merck Ltd. (Poole, Dorset) and Sigma-Aldrich 
Company Ltd. (Gillingham, Dorset) and were of analytical or molecular biology 
grade. All water used was double distilled. 
 
Invitrogen Corporation, R & D Systems Ltd. (Abingdon, Oxfordshire) 
TA CloningTM System, restriction and modification enzymes, Taq DNA polymerase, 
1Kbp DNA ladder, LipofectamineTM 2000 Reagent, CellTracker™ Green CMFDA, 
CellTracker™ Red CMTPX, 1,2-bis (o-aminophenoxy) ethane-N,N,N',N'-tetraacetic 
acid/Acetoxymethyl (BAPTA/AM), Dynabeads® mRNA DIRECT™ Kit, Alexa 
Fluor® 594 phalloidin 
 
New England Biolabs (UK) Ltd. (Hitchin, Hertfordshire) 
Restriction and modification enzymes 
 
Qiagen Ltd. (Crawley, West Sussex) 
MinElute Gel Extraction Kit, QIAGEN Plasmid Mini Kit, QIAGEN Plasmid Maxi 
Kit 
 
Sigma-Aldrich Company Ltd. (Gillingham, Dorset) 
Kanamycin, ampicillin, PAC-1 (final concentration is 5 µM), cycloheximide (final 
concentration is 20 µg/ml), SigmaSpinTM Maxiprep kit, Apo-TRACE® Apoptotic 
Cell Staining Kit 
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Promega (Madison, Wisconsin, USA) 
Taq DNA polymerase, reverse transcriptase 
 
MBI Fermentas Life Sciences (Hanover, MD, USA) 
Restriction and modification enzymes, GeneJET™ Plasmid Miniprep Kit 
 
Iwaki Glass Co. Ltd. (Tokyo, Japan) 
35 mm glass based dishes 
 
Vector Laboratories Ltd. (Peterborough, UK) 
VECTASHIELD Mounting Medium 
 
Media Preparation (Department of Biological Sciences, University of Warwick) 
LBroth, LB agar plates with 100 µg/ml ampicillin and/or 25 µg/ml kanamycin, 
GMEM NEAA, DMEM, versene 0.02% in PBS, trypsin 0.25% in Tris saline, 
phosphate buffered saline (PBS), 10X Tris-Borate-EDTA (TBE), G418, penicillin 
and streptomycin sulphate, ampicillin, kanamycin 
 
2.2 Materials 
2.2.1 Bacterial strains 
INVαF' (Invitrogen) 
Genotype: F´ endA1 recA1 hsdR17 (rk-, mk+) supE44 thi-1 gyrA96 relA1 
φ80lacZΔM15Δ(lacZYA-argF)U169 λ- 
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2.2.2 Cell lines 
2.2.2.1 BSR-T7 
Baby hamster kidney (BHK) cells, constitutively expressing bacteriophage T7 RNA 
polymerase (Buchholz et al., 1999). 
Culture medium: GMEM NEAA + 5% FCS (v/v) + 1 mg/ml geneticin (G418) 
sulphate. 
 
2.2.2.2 BSC-1 
African green monkey kidney cells were grown as previously described (McCrae and 
Faulkner-Valle, 1981). 
Culture medium: GMEM NEAA + 5% FCS (v/v). 
 
2.2.2.3 293T 
Human Embryonic Kidney cells, transformed with simian virus 40 (SV-40) T antigen 
(ATCC# CRL-11268). 
Culture medium: DMEM + 10% FCS (v/v). 
 
2.2.3 Viruses 
2.2.3.1 Rotavirus UKtc strain 
The tissue culture adapted Compton (UKtc) strain of group A bovine rotavirus G 
serotype 6 (provided by M.A. McCrae, University of Warwick) 
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2.2.3.2 Vaccinia virus MVA-T7 
An attenuated recombinant vaccinia virus encoding bacteriophage T7 RNA 
polymerase gene (provided by M.A. McCrae, University of Warwick) 
 
2.2.3.3 Reovirus 
Human reovirus serotype 3 Dearing strain (provided by M.A. McCrae, University of 
Warwick) 
 
2.2.4 Plasmids 
pCR2.1 and pcDNA3.1 were obtained from Invitrogen (Oxfordshire). pEYFP-N1 
was obtained from Clontech (Palo Alto, California, USA). YFP1-ERGIC53 and 
YFP2-NCFD2 were obtained from Dr Hans-Gerhard Burgert, University of 
Warwick. 
 
2.2.5 Primers 
All PCR primers were synthesized by and purchased from Invitrogen. Fully 
complementary primer pairs for mutagenesis PCR were designed by SiteFind v4.2 
with additional restriction enzyme sites added for convenient mutant screening. 
 
Table 2.2.1 Oligonucleotide primers used in this study 
Primer Name Primer Sequence Used for 
UKtcsite1F 
GAT GGA AAA GCT TAC AGA 
TCT CGC CTA TAC ATT GAG 
Forward primer for 
mutating glycosylation 
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TG site of NSP4 at amino 
acid 8 
UKtcsite1R 
CAC TCA ATG TAT AGG CGA 
GAT CTG TAA GCT TTT CCA 
TC 
Reverse primer for 
mutating glycosylation 
site of NSP4 at amino 
acid 8 
UKtcsite2F 
GTA ATC ACT CTA ATG GCT 
AGC ACA TTG CAC ACG 
Forward primer for 
mutating glycosylation 
site of NSP4 at amino 
acid 18 
UKtcsite2R 
CGT GTG CAA TGT GCT AGC 
CAT TAG AGT GAT TAC 
Reverse primer for 
mutating glycosylation 
site of NSP4 at amino 
acid 18 
STUENSP4F 
AGT GAC TGC AGC AAT GAG 
GCC TGT TGA GCT GCC GTC 
GAC 
Forward primer for 
making an StuI site at 
the end of NSP4 
STUENSP4R 
GTC GAC GGC AGC TCA ACA 
GGC CTC ATT GCT GCA GTC 
ACT 
Reverse primer for 
making an StuI site at 
the end of NSP4 
STUGFPF 
GCG CGT AGG CCT AGC AAG 
GGC GAG GAA CTG TTC 
Forward primer for the 
amplification of YFP 
to insert into the end of 
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NSP4 
STUGFPR 
GCG CGT AGG CCT TCA TCA 
CTT GTA CAG CTC GTC CA 
Reverse primer for the 
amplification of YFP 
to insert into the end of 
NSP4 
NSP4XhoIF 
GCG CGT CTC GAG AAA AGC 
TTA CCG ACC TCA AC 
Forward primer for the 
amplification of NSP4 
coding sequence with 
XhoI site at 5’-end  
NSP4XhoIR 
GCG CGT CTC GAG TTA CAT 
TGC TGC AGT CAC TTC 
Reverse primer for the 
amplification of NSP4 
coding sequence with 
XhoI site at 3’-end  
VP4XhoIF 
 
GCG CGT CTC GAG CTT CGC 
TCA TAT ACA GAC 
Forward primer for the 
amplification of VP4 
coding sequence with 
XhoI site at 5’-end 
VP4XhoIR 
 
GCG CGT CTC GAG TCA CAA 
TCT ACA TTG CAT GAT C 
Reverse primer for the 
amplification of VP4 
coding sequence with 
XhoI site at 3’-end 
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VP6XhoIF 
 
GCG CGT CTC GAG ATG TCC 
TGT ACT CCT TGT C 
Forward primer for the 
amplification VP6 
coding sequence with 
XhoI site at 5’-end 
VP6XhoIR 
 
GCG CGT CTC GAG TCA TTT 
GAC AAG CAT GCT TC 
Reverse primer for the 
amplification VP6 
coding sequence with 
XhoI sites at 3’-end 
NSP4XhoIF 
3.1 
 
GCG CGT CTC GAG ATG AAC 
AGC ACA TTG CAC ACG 
Forward primer for the 
amplification of NSP4 
to insert into the 
pCDNA3.1 vector 
NSP4XhoIF 
ATG 
 
GCG CGT CTC GAG ATG GAA 
AAG CTT ACCG 
Forward primer for the 
amplification of NSP4 
at the ATG start codon 
with XhoI at 5’-end 
YFP2NSP4Hh
eIF 
GCG CGT GCT AGC ATG GGC 
GGT AGG CGT G 
Forward primer for 
cloning YFP2 into 
pEYFP-N1 vector 
YFP2NSP4No
tIR 
GCG CGT GCG GCC GCT TAC 
ATT GCT GCA GTC ACT TC 
Reverse primer for 
cloning YFP2 into 
pEYFP-N1 vector 
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YFP2PCAseq
uencingF 
ACA ACC ACT ACC TGA GCT 
ACC 
Sequencing forward 
primer to identify gene 
in YFP2-cDNA library 
pEYFPN1seq
uenceR 
TGA AAT TTG TGA TGC TAT 
TGC 
Sequencing reverse 
primer to check the 
end of the gene in 
YFP2-cDNA library 
PCABglII0F 
GGA GGT GGT GGG TCC AGA 
TCT GAA AAG CTT ACC GAC C 
Forward primer for 
making a BglII site at 
the end of the YFP2 
sequence so that the 
downstream insert 
digested by BglII will 
be joined in the correct 
(+1) reading frame. 
PCABglII0R 
 
GGT CGG TAA GCT TTT CAG 
ATC TGG ACC CAC CAC CTC C 
Reverse primer for 
making a BglII site at 
the end of the YFP2 
sequence so that the 
downstream insert 
digested by BglII will 
be joined in the correct 
(+1) reading frame. 
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PCABglII+2F 
 
GGA GGT GGT GGG TCC GCA 
GAT CTA AAG CTT ACC GAC C 
Forward primer for 
making a BglII site at 
the end of the YFP2 
sequence so that the 
downstream insert 
digested by BglII will 
be joined in the correct 
(+2) reading frame. 
PCABglII+2R 
 
GGT CGG TAA GCT TTA GAT 
CTG CGG ACC CAC CAC CTC C 
Reverse primer for 
making a BglII site at 
the end of the YFP2 
sequence so that the 
downstream insert 
digested by BglII will 
be joined in the correct 
(+2) reading frame. 
NotIcDNAdT
R 
GCG GCT GAA GAC GCG GCC 
GCT TTT TTT TTT TTT TTT T 
PolyT tail reverse 
primer for converting 
mRNA into ssDNA 
5XhoBglII3 P-GGC CTC GAG AGA TCT GCC 
Phosphorylated 
adaptor for 
construction of cDNA 
library (see section 
2.3.17.4) 
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5BglIIXho3 P-GGC AGA TCT CTC GAG GCC 
Phosphorylated 
adaptor for 
construction of cDNA 
library (see section 
2.3.17.4) 
 
2.2.6 Antibodies 
2.2.6.1 Polyclonal mono-specific anti-NSP4 antisera 
Produced in rabbit, as described previously in Guzman and McCrae, 2005 and used 
at 1:200 dilution (provided by M.A. McCrae, University of Warwick). 
 
2.2.6.2 Polyclonal anti-group A rotavirus (UKtc) antisera 
Produced in rabbit and used at 1:200 dilution (provided by M.A. McCrae, University 
of Warwick). 
 
2.2.6.3 Monoclonal anti-β-tubulin antibody  
Produced in mouse (Sigma-Aldrich Cat. No. T 5293) and used at 1:500 dilution. 
 
2.2.6.4 Alexa Fluor® 594 goat anti-rabbit IgG (H+L) antibody 
(Invitrogen Cat. No. A-11012) used at 1:1000 dilution. 
 
2.2.6.5 Alexa Fluor® 488 goat anti-mouse IgG (H+L) antibody 
(Invitrogen Cat. No. A-11001) used at 1:3000 dilution. 
 56 
 
2.2.7 Standard Buffers and Solutions 
2.2.7.1 Luria-Bertani Broth (LB 10:5:10): 
1% (w/v) bactotryptone, 1% (w/v) NaCl, 0.5% (w/v) yeast extract. 
2.2.7.2 LB agar: 
LB Broth containing 1.5% (w/v) bacto-agar. 
 
2.2.7.3 Phosphate buffered saline (PBS): 
137 mM NaCl, 2.7 mM Na2HPO4, 1.4 mM KH2PO4. 
2.2.7.4 Tris-Borate-EDTA (TBE): 
90 mM Tris base, 90 mM boric acid, 1 mM EDTA, pH8.0. 
 
2.2.7.5 10X Agarose gel loading buffer: 
50% (v/v) glycerol, 0.01% (w/v) bromophenol blue, 0.01% (w/v) xylene cyanol, 2% 
TBE (v/v). 
 
2.2.7.6 NP40 cell lysis buffer: 
100 mM Tris-HCl pH 8.0, 50 mM NaCl, 10 mM EDTA, 0.5% NP40. 
 
2.2.7.7 Paraformaldehyde cell fixing solution: 
4% paraformaldehyde (v/v) in PBS. 
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2.2.7.8 TfbI: 
10 mM RbCl2, 10 mM CaCl2, 30 mM potassium acetate, 50 mM MnCl2, 15% (v/v) 
glycerol, pH 5.8. 
 
2.2.7.9 TfbII: 
10 mM RbCl2, 75 mM CaCl2, 10 mM 3[N-morpholino] propanesulphonic acid 
(MOPS), 15% (v/v) glycerol, pH 6.5. 
 
2.3 Methods 
2.3.1 General Molecular Biology 
2.3.1.1 Growth of Bacteria 
Bacteria were cultured on LB agar plates containing 100 µg/ml ampicillin and/or 25 
µg/ml kanamycin or in liquid LB medium containing 100 µg/ml ampicillin and/or 25 
µg/ml kanamycin. 
 
2.3.1.2 Small Scale Preparation of Bacterial Plasmids (Mini prep) 
Plasmids were purified and re-suspended in water using the MiniprepKitTM (Qiagen) 
according to the manufacturer’s instructions. 
 
2.3.1.3 Large Scale Preparation of Bacterial Plasmids (Maxi prep) 
Large scale preparation of plasmid was performed using either the Plasmid Maxi Kit 
(Qiagen) or the GenElute™ Plasmid Maxiprep Kit (Sigma) following the 
manufacturer’s instructions. 
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2.3.1.4 Preparation of Plasmids on Cesium Chloride-Ethidium Bromide 
Gradients 
Bacteria (1L) containing plasmids were cultured until the OD590 reached 0.6, then 
chloramphenicol was added to a final concentration of 150 µg/ml and bacterial 
growth cultured overnight in 37 °C shaking incubator. After overnight culture cells 
were centrifuged in 500 ml centrifuge bottles at 6000 rpm for 20 mins at 4 ºC. The 
supernatants were discarded and cell pellets re-suspended in 8.4 ml of 25% sucrose 
containing 50 mM Tris pH 8.0. 1.4 ml of a 10 mg/ml solution of lysozyme in 50 mM 
Tris pH 8.0 was added to the resuspended pellets on ice with gentle swirling for 5 
mins. Then 4.6 ml of 0.25 M EDTA was added again with gentle swirling for 10 
mins. After 10 mins 9.6 ml of lysis mix (500 ml stock made using 50 ml 20% Triton, 
125 ml 0.25 M EDTA, 25 ml 1 M Tris pH 8 and 300 ml H2O) was added slowly with 
swirling. Chromosomal DNA was then pelleted by centrifugation in Oakridge tubes 
for one hour at 16,000 rpm (Beckman JA-20 rotor) at 4°C. Chromosomal DNA was 
hooked out and the remaining supernatants adjusted to 25 ml with H2O followed by 
addition of 25 g CsCl and 1 ml 10mg/ml ethidium bromide. Mixtures were then 
centrifuged in 38 ml Beckman tubes in SW28 rotor and L8 centrifuge at 25,000 rpm 
18 °C for one hour. Floating debris was scooped off and discarded. The supernatants 
were poured into plastic Quick-seal VTi50 tubes, balanced to with 0.1 g and then 
centrifuged in a VTi50 rotor at 45,000 rpm overnight. Plasmid bands were collected 
by side puncture into a syringe and extracted with CsCl saturated isopropanol to 
remove ethidium bromide. Samples were then dialyzed against Tris-EDTA buffer 
(TE). Following dialysis the plasmid DNA was concentrated by ethanol precipitation 
(2X). The final plasmid DNA pellets were washed with 80% ethanol, dried, 
resuspended in ddH2O and stored at -20ºC. 
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2.3.1.5 Precipitation of Nucleic Acids 
Nucleic acids in aqueous solution were precipitated by addition of 1/10 volume of 3 
M sodium acetate pH 5.2 and 2.5 volume of 100% ice-cold ethanol or 0.6 volume of 
isopropanol. After incubation at -20 ºC for 1 hour precipitated nucleic acids were 
concentrated using a tabletop microcentrifuge for 10 minutes at 13,200 rpm. Nucleic 
acid pellets were rinsed in 80% ethanol and air-dried at 37 ºC for 15 minutes. 
 
2.3.1.6 Quantification of Nucleic Acids 
Nucleic acids were quantified using both the NanoDrop Spectrophotometer (Thermo 
Scientific, Wilmington, USA) and agarose electrophoresis. 
 
2.3.1.7 Agarose Electrophoresis 
Fractionation of nucleic acids was performed on 0.8 to 1.5% agarose gels containing 
0.5µg/ml ethidium bromide in 1×TBE buffer. Electrophoresis was carried out at 
100V in 1×TBE buffer. Illumination and digital image capture of nucleic acids was 
performed using the Bio-Rad Gel Doc XR system and analysis done using the 
Bio-Rad Quantity One 4.6.3 software. 
 
2.3.1.8 Agarose Gel Extraction of Nucleic Acids 
Following agarose gel electrophoresis a desired nucleic acid fragment was isolated 
using a sterile scalpel blade under UV light, eluted and cleaned using the Qiagen Gel 
Extraction kit following the manufacturer’s instructions. 
 
 60 
2.3.1.9 Restriction Enzyme Digestion of Plasmid DNA or PCR Products 
Plasmid DNA or PCR Product was incubated with the appropriate enzyme in 
supplied buffer solution using manufacturer’s recommended condition. 
 
2.3.1.10 Polymerase Chain Reaction (PCR) 
2.3.1.10.1 Standard PCR 
Standard PCRs were carried out in a final volume of 25 µl which included 100 ng of 
template plasmid DNA, 0.5 µM of each primer and 2 U Taq DNA polymerase. The 
PCR mixture was subjected to 30-40 cycles of 94 ºC for 1 minute, 55 ºC for 1 minute 
and 72 ºC for 1 minute/kilo-base of amplicon. PCR products were fractionated by 
agarose gel electrophoresis (see section 2.3.1.7). Individual PCR reactions were 
optimized by adjusting the final magnesium concentration used. 
 
2.3.1.10.2 Site-Directed Mutagenesis PCR 
Mutagenesis PCR was performed with Pfx DNA polymerase (2.5 units) to ensure 
higher fidelity. The PCR reaction (25 µl) with 100 ng of template plasmid DNA and 
0.5 µM of each primer was incubated in 94 ºC for 1 minute to fully denature the 
template DNA and this was followed by 18 cycles of 94 ºC for 1 minute, 55 ºC for 1 
minute and 68 ºC for 1 minute/kilo-base of amplicon. Individual PCR reactions were 
optimized by adjusting the final magnesium concentration used. 
 
2.3.1.11 Dephosphorylation of the 5’ Ends of DNA 
Removal of 5’-phosphate groups from DNA was catalyzed using shrimp alkaline 
phosphatase (SAP) (1 units/µg of DNA treated) (Fermentas) in the supplied buffer at 
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37 ºC for 30 minutes or overnight. Catalysis was inactivated by heating at 65 ºC for 
15 minutes.  
 
2.3.1.12 Conversion of 5’ Overhang Restriction Enzyme Ends to Blunt Ends 
5’ Overhangs generated in restriction enzyme digests were filled in using the large 
fragment of DNA polymerase I (1 unit/µg of DNA treated) (Invitrogen) in the 
supplied buffer and 0.5 mM of each dNTP at room temperature for 15 minutes. The 
fill-in reaction was terminated by phenol extraction. 
 
2.3.1.13 DNA Ligation  
T4 DNA ligase (5 units) was used in a final reaction volume of 10 µl containing 
insert DNA fragment (used in a molar ratio of 10:1 to vector DNA) and 
dephosphorylated vector DNA (100 ng) at 16 ºC overnight. 
 
2.3.1.14 Transformation of Competent Bacterial Cells by Heat Shock 
Competent bacterial cells were prepared as follows: 
A single colony of INVαF’ was grown overnight at 37 °C in 2 ml LB overnight. This 
fresh overnight culture was then diluted into 100 ml LB and cultured until the OD600 
reached about 0.39. The culture was then cooled on ice for 10 mins, and bacteria 
concentrated by centrifugation in two 50 ml Falcon tubes (of 3300 × g for 10 mins at 
4 ºC). The bacterial cell pellet was resuspended in 40 ml TfbI solution on ice for 5 
mins. Cells were re-centrifuged as before and resuspended in 4 ml TfbII solution on 
ice for two hours. Cells were then aliquoted (100 µl/tube) and stored at -70 ºC until 
used (max 3 months). 
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Transformation procedure: 
Ligation products (see section 2.3.13) or plasmid DNA (100 ng) was transformed to 
INVαF’ competent cells by heat shock (45 seconds in 42 ºC water bath). After a 1 
hour incubation at 37 ºC in LB the cells were plated on LB agar plates containing the 
appropriate selection antibiotics. 
 
2.3.1.15 Transformation of Competent Bacterial Cells by Electroporation 
Competent bacterial cells were prepared as follows: 
An overnight culture of bacteria was grown in 5 ml of LB. 2 ml of this fresh 
overnight culture was then added to 200 ml LB in a 1 L flask. This was grown at 37 
°C with shaking until the OD590 reached ~ 0.4. Cells were then pelleted and washed 
subsequently in equal, half, quarter volumes, and finally resuspended in 3 ml of 
chilled H2O containing 10% glycerol. The washed resuspended cells were aliquoted 
(100 µl/tube) and stored at -70 °C until used (max 3 months). 
 
Electroporation procedure: 
All procedures were carried out on ice. Pre-cooled 0.2 cm cuvettes containing 
competent cells and DNA (50 µl) were inserted into the cuvette slide of Bio-Rad 
Gene Pulser system that was set with voltage at 2.5 kV, capacitance at 25 µFD, 
capacitance extender at 150 µFD and pulse controller at 200 Ohms resistance. The 
time constant value was used to monitor electroporation, with a reading above 4.6 
being deemed as indicating successful electroporation. Cells were then incubated in 
LB for 1 hour at 37 ºC and then plated on LB agar plates containing appropriate 
selection antibiotics. 
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2.3.1.16 DNA Sequencing 
The Molecular Biology Service (University of Warwick) provided routine DNA 
sequencing by using ABI Prism Genetic Analysers. Sequencing data were opened 
using Chromas Lite 2.0 and analysed using the Clone Manager, SciEd Central, v7.04 
software. 
 
2.3.1.17 Construction of cDNA library 
2.3.1.17.1 Extraction of mRNA Using Dynabeads® mRNA DIRECT™ Kit 
Cellular mRNA was extracted using Dynabeads® mRNA DIRECT™ Kit (Invitrogen) 
following the manufacturer’s instructions. 
 
2.3.1.17.2 Synthesis of The First Strand of DNA from mRNA 
mRNA was re-suspended in 10 µl of water at a final concentration of 1 µg/µl. The 
mRNA was then mixed with 1.5 µl of poly(dT) primer (1 µg/µl) and 1µl of 10 mM 
dNTP. The mixture was placed at 65°C for 5 mins then on ice for 2 mins. Then 4 µl 
of 5X first strand Buffer, 2 µl of 0.1M DTT, 1 µl of RNasin and 1.4 µl of 
SuperScript® II Reverse Transcriptase (RT) were added on ice. The tube was placed 
in a PCR machine and incubated at 25°C for 10 mins, followed by 47°C for 1 hour. 
The final product of first strand DNA (ssDNA) synthesis was analysed using agarose 
gel electrophoresis (see section 2.3.1.7). 
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2.3.1.17.3 Second Strand Synthesis of ssDNA 
DEPC-treated water 93 µl, 5X Second Strand Buffer 30 µl, 10 mM dNTP Mix 3 µl, 
E.coli DNA ligase (10 U/µl) 1 µl, E.coli DNA polymerase I (10 U/µl) 4 µl, E.coli 
RNAaseH (2 U/µl) 1 µl were all added to the first strand DNA product described in 
2.3.17.2 in a final volume of 150 µl on ice. The mixture was then incubated at 16°C 
for 3 hours. After this incubation 2 µl (10 U/µl) of T4 DNA polymerase was added 
and incubation continued for 5 mins. The reaction was stopped by adding 10 µl of 
0.5 M EDTA and the synthesized cDNA ethanol precipitated prior to adaptor 
ligation. 
 
2.3.1.17.4 Adaptor Ligation 
The precipitated cDNA was dissolved in 25 µl of water and 5X T4 DNA Ligase 
Buffer 10 µl, 1 µg/µl phosphorylated adaptor 10 µl, T4 DNA ligase 5 µl were all 
added on ice to give a final reaction volume of 50 µl. This solution was incubated at 
16°C for 16 hours. 
 
2.3.1.17.5 Size Fractionation and Directional Cloning of cDNA into Vector 
The cDNA was analysed using agarose gel electrophoresis (see section 2.3.1.7) and 
fractions separated based on size (0-500bp, 500bp-1Kb, 1Kb-2Kb and above 2Kb). 
Following gel extraction cDNA (see section 2.3.1.8) was digested with either XhoI + 
NotI or BglII + NotI for 2 hours. Finally the digested cDNA was cloned into 
pEYFP-N1 vector digested with either XhoI + NotI or BglII + NotI. 
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2.3.1.18 Protein Concentration Determination 
Protein concentrations were measured in a standard Bradford assay using reagents 
purchased from Invitrogen and used according to the manufacturer’s instruction. 
 
2.3.2 Mammalian Cell Maintenance, Storage, Transfection and Fixation 
2.3.2.1 Maintenance 
Cells were grown in appropriate culture medium (see section 2.2.2) at 37 ºC in a 5% 
CO2 incubator and were split every 3 to 4 days according to their growth condition. 
To split cells, they were washed twice with versene followed by incubation with a 
trypsin/versene (1:5) mixture for 5-10 mins at 37 ºC to detach the adherent cells from 
the flask surface. Cell suspensions were then centrifuged at 1300 rpm for 3 mins to 
pellet the cells. The pelleted cells were resuspended in appropriate medium (see 
section 2.2.2) and re-seeded at the required ratio (1:10 for BSR-T7 cells, 1:4 for 
BSC-1 cells, 1:10 for 293T cells).  
 
2.3.2.2 Long-Term Storage of Cultured Mammalian Cell Lines 
Following routine trypsination of confluent cell monolayers, the cell pellet was 
resuspended at 107 cells/ml in GMEM containing 20% FCS. An equal volume of 
freezing mixture (4 ml FCS, 4.4 ml GMEM and 1.6 ml DMSO making 10 ml master 
mixture) was added and the two solutions gently mixed. Cells were stored at -70 ºC 
for one or two days then moved to liquid nitrogen for long-term storage. 
 
2.3.2.3 Transfection 
Transfection of mammalian cells was carried out using Lipofectamine 2000 
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(Invitrogen). For each well of a 12 well plate, 250 µl of serum free medium was 
mixed with either 3µl of Lipofectamine 2000 or 2µg of DNA and incubated for 10 
mins. The Lipofectamine 2000 and DNA containing solutions were then mixed and 
incubated at room temperature for 20 mins before being added gently to each well 
and incubated at 37 °C for 4 hours. The transfection mixture was then replaced by 
medium containing 5% FCS and incubation at 37 °C continued.  
 
2.3.2.4 Paraformaldehyde Fixation 
Mammalian cells were fixed in 4% paraformaldehyde for 10 to 20 mins before being 
used in downstream applications. 
 
2.3.3 Rotavirus Propagation and Measurement by Plaque Assay 
Cell monolayers were washed twice with serum-free medium and inoculated with 
rotavirus diluted in medium (MOI indicated in the experiments) for 1 hour at 37 °C. 
The inoculum was then removed by aspiration and cells covered with serum free 
media at 37 °C until the time of experiment. 
The cytopathic effect (cpe) reached 80% after 4-6 days and a sterile rubber 
policeman was used to harvest the infected cells. The harvested infected cells were 
then frozen and thawed three times, aliquoted, titrated and stored at -70 °C. 
Virus stocks were titrated by plaque assay in BSC-1 cells. Cells grown in 6 well 
plates were inoculated with serial 10-fold dilutions of rotavirus for 1 hour at 37 °C. 
The inoculum was replaced with serum free GMEM NEAA and cells incubated for 
4-6 days at 37 °C for development of virus plaques. Cell monolayers were fixed with 
formal-saline (30% v/v formaldehyde in PBS) for 1 hour and stained with 0.1% w/v 
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crystal violet to visualize viral plaques. 
 
2.3.4 Immuno-fluorescence 
Cell monolayers grown on coverslips were either infected with virus or transfected 
with the relevant plasmid and incubated at 37 °C. The cell monolayers were then 
washed with serum-free medium twice, fixed in 4% v/v formaldehyde in PBS for 10 
mins, permeabilized with 0.5% v/v Nonidet P-40 in PBS for 10 mins at room 
temperature and finally washed with PBS. Coverslips were blocked with 1% w/v of 
chicken egg albumin in PBS for 1 hour. Primary antibody diluted to the required 
dilutions (see section 2.2.6) in PBS was added to the coverslips and incubated for 1 
hour at room temperature. Coverslips were washed (3X) in PBS before being 
incubated with the fluorescently tagged secondary antibody which had again been 
diluted to the required concentration (see section 2.2.6) in PBS. Finally coverslips 
were incubated with 4', 6-diamidino-2- phenylindole (DAPI) (10 µl/ml) (Sigma) for 
5 mins at room temperature to stain nuclei. The cells were then mounted to glass 
slides with VECTASHIELD® mounting medium and sealed with nail polish. The 
coverslips were examined using Leica SP5 inverted fluorescent confocal microscope 
(Leica Microsystem, Germany). 
 
2.3.5 Apoptosis Assay 
Apoptosis is a process of programmed cell death reported in rotavirus infected cells 
(Martin-Latil et al., 2007). Apoptotic cells in this study were analysed using 
Apo-TraceTM Apoptosis Cell Staining Kit (Sigma) according to manufacturer’s 
instruction. 
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2.3.6 Confocal Microscopy 
Samples were analyzed using the inverted lens of Leica TCS SP5 Confocal 
Microscope System according to the user manual. All images shown are maximum 
projection of z-series unless indicated otherwise. Time-lapse imaging was carried out 
using single dish (35 mm in diameter with 27 mm glass base produced by Iwaki 
Glass Co. Ltd.) for cell culture with the experimental temperature kept for 37 °C. 
 
2.3.7 Flow Cytometry 
Monolayers of cells were washed in PBS (2X) and trypsinized using a 
trypsin/versene (1:5) mixture with incubation for 5-10 mins at 37 ºC to detach the 
adherent cells. Cells were pelleted by centrifugation at 1300 rpm for 3 mins. The cell 
pellet was resuspended in serum free medium (see section 2.2.2) at ~ 4×106 cells per 
30 µl. Cells were analyzed with a FACScan flow cytometer (BD Biosciences) and 
20,000 events were routinely recorded, dot plots and histograms were created and 
analyzed using the software FlowJo version 8.7 (Tree Star, Inc., Ashland, USA). 
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Chapter 3 
Glycosylated NSP4 and Rotavirus Infection 
Stimulated Formation of Cytoplasmic Extrusions 
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3.1 Introduction 
NSP4 is an N-linked non-structural glycoprotein. In virus infected cells an 
unglycosylated NSP4 precursor is synthesized. Subsequent glycosylation of the 
precursor occurs in the ER through two N-linked glycosylation sites positioned in the 
amino terminal half of the protein (Baybutt and McCrae, 1984; Bergmann et al., 
1989). Pulse-chase studies showed that both the unglycosylated NSP4 precursor and 
fully glycosylated NSP4 were detectable in virus infected cells (McCrae and 
McCorquodale, 1982). Furthermore unglycosylated NSP4 was still detectable at the 
end of a 2-hour chase. By contrast, VP7 the structural glycoprotein of rotavirus was 
only detectable in its fully glycosylated form in pulse-chase studies (McCrae and 
McCorquodale, 1982). The fact that two stable forms of NSP4 can be found in virus 
infected cells provides for the possibility that NSP4s with different glycosylation 
status may differ in their functionality. The early functional analysis of NSP4 
showed that it is an intracellular protein located in the ER together with the 
autophagosomal marker LC3 and functions to provide translocation of DLPs (double 
shelled pre-virons) from the viroplasm where they are assembled into the lumen of 
the ER (Au et al., 1989; Bergmann et al., 1989; Berkova et al., 2006). This function 
has been shown to required glycosylation of NSP4 as the presence of tunicamycin, 
an inhibitor of N-linked glycosylation, in the culture medium of infected cells 
resulted in the accumulation of DLPs in the cytoplasm (Sabara et al., 1982). Other 
functional studies appear to show that extracellular secretion is an important feature 
of NSP4 that contributes to its role in pathogenesis (Bugarcic and Taylor, 2006; 
Zhang et al., 2000). Detection of only fully glycosylated NSP4 in its secreted form 
supported the hypothesis that glycosylation is also required for NSP4 to be secreted 
(Bugarcic and Taylor, 2006). Apparently both of these functions require 
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glycosylation of NSP4 but they require distinct fates of NSP4 in terms of widely 
different cellular location. In one case glycosylated NSP4 is an intracellular ER 
membrane protein interacting with DLPs for translocation and the other case it 
appears to be secreted to the extracellular environment to exercise its cytotoxicity. 
Given that NSP4 is found in both glycosylated and unglycosylated form in virus 
infected cells (McCrae and McCorquodale, 1982), it is possible that the two forms of 
NSP4 may play different roles in NSP4 function. Consequently comparison of the 
functioning of unglycosylated and glycosylated NSP4 may reveal whether the 
dichotomy of NSP4 function can be explained by its glycosylation status. To date the 
main experimental approach employed in this type of analysis has been the use of the 
N-linked glycosylation inhibitor tunicamycin. However it has the disadvantage that it 
will also block glycosylation of cellular proteins and this might affect the 
observations. The absence of a convenient reverse genetics system for rotaviruses 
means that analyzing the role of unglycosylated NSP4 in the context of a viral 
infection is currently not possible. However site directed mutagenesis to remove 
N-linked glycosylation sites and subsequent analysis of the functioning of NSP4 
expressed from mutated c-DNA following transfection can be done and this was the 
first strategy used in this study. 
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3.2 Results 
3.2.1 Cloning of NSP4 Glycosylation Defective Mutants 
Gene 10 of rotavirus strain UKtc (provided by M.A. McCrae, University of Warwick) 
was in the PCR 2.1 cloning vector and under the control of the bacteriophage T7 
promoter. Site-directed mutagenesis PCR was used to mutate the two N-linked 
glycosylation sites present in the first of the three hydrophobic domains located in 
the amino terminal half of NSP4. The asparagine residues in each of the N-linked 
glycosylation sites were mutated to alanines by PCR based site-directed mutagenesis 
introducing BglII and NheI restriction enzyme sites for the first and second 
glycosylation sites respectively. Following mutagenesis the complete sequence of 
NSP4 was checked to ensure that no additional mutations had been introduced. 
Figure 3.1 shows that part of the NSP4 cDNA and amino acid sequence where the 
mutations and the sequence changes were introduced. 
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Figure 3.1: Amino terminal region of the NSP4 nucleotide and amino acid sequence covering the 
region where mutations were introduced. 
Glyco+ represents the wild type NSP4 sequence with two N-linked glycosylation sites at amino acid 
positions 8 and 18. GlycoN8A represents a construct with a mutation from N to A at amino acid 
position 8 of NSP4. GlycoN18A represents a construct with a mutation from N to A at amino acid 
position 18 of NSP4. Glyco- represents a construct with mutations from N to A at both amino acid 
position 8 and 18. 
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3.2.2 Different Cellular Distributions and Phenotypes of Glycosylation Variants 
of NSP4 in BSR-T7 Cells 
The first series of experiments were done in BSRT7 cells. This cell line was used as 
it has been engineered to express the bacteriophage T7 RNA polymerase 
endogenously thereby enabling NSP4 expression from the transfected plasmids since 
the NSP4 gene was under the control of the T7 promoter. To more fully characterize 
the intracellular distribution of NSP4, BSRT7 cell monolayers transfected with wild 
type (glyco+), mono- (glycoN8A and glycoN18A) and double- (glyco-) 
glycosylation mutants of NSP4 were examined at 7.5, 23, 30 and 40 hours post 
transfection. A total number of 160 images was taken and analysed. Striking 
differences were observed between cell samples transfected with wild type, mono- 
and double-glycosylation mutants of NSP4 at 7.5-h post transfection. In the case of 
the wild type and mono-glyco mutants intracellular NSP4 containing vesicle-like 
structures in the cytoplasm (frequently seen) and more strikingly long NSP4 
containing ‘pseudopodia-like’ cytoplasmic extrusions were evident in a small 
number of cells (Fig 3.2A-F). However, in the double glycosylation site mutant 
neither of these features was evident (Fig 3.2G and H). At the later time 
post-transfection (23, 30 and 40 hours) cells transfected with both the wild type and 
the glycosylation mutants showed a similar intracellular distribution of NSP4 (Fig 
3.2I-T). 
The striking NSP4 containing cytoplasmic extrusions in cells transfected with wild 
type NSP4 were analysed in greater detail (Fig 3.3). This confirmed the presence of 
vesicle-like structures containing NSP4 at the tips of the extrusion (Fig 3.3). 
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Figure 3.2: Intracellular distribution of wild type (glyco+), mono-glyco mutants (glycoN8A and 
glycoN18A) and glyco- NSP4 mutant expressed in BSR-T7 cells. 
NSP4 was stained with polyclonal rabbit antisera raised against bacterially expressed NSP4 (McCrae 
and McCorquodale, 1987) followed by Alexa-594-conjugated goat-anti-rabbit secondary antibody as 
described in Materials and Methods. Nuclei were stained with DAPI again as described in Materials 
and Methods. (A) Intracellular glyco+ NSP4 containing vesicle-like structure in a cell at 7.5-h post 
transfection. (B) Long glyco+ NSP4 containing cytoplasmic extrusion in a cell at 7.5-h post 
transfection. (C and D) Intracellular glycoN8A NSP4 containing vesicle-like structure and 
cytoplasmic extrusion in cells at 7.5-h post transfection. (E and F) Intracellular glycoN18A NSP4 
containing vesicle-like structure and cytoplasmic extrusion in cells at 7.5-h post transfection. (G and 
H) Glyco- NSP4 expressing cells showing that mutated NSP4 congregates into numerous intracellular 
spots at 7.5-h post transfection. (I, J, L, M, O, P, R and S) All glyco+, mono-glyco mutants and glyco- 
NSP4 distribute in numerous intracellular spots at 23 and 30-h post transfection. (K, N, Q and T) All 
glyco+, mono-glyco mutants and glyco- NSP4 congregate to form larger structures at 40-h post 
transfection. Time post transfection is indicated in the bottom left corner of each image. Arrowheads 
indicate NSP4 containing vesicle-like structures and arrows indicate NSP4 containing 
‘pseudopodia-like’ cytoplasmic extrusions. A magnification bar of 5 µm is shown in the bottom right 
corner of each image.
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Figure 3.3: NSP4 containing cytoplasmic projections in glyco+ NSP4 transfected BSRT7 cells. 
NSP4 was stained with polyclonal rabbit antisera raised against bacterially expressed NSP4 (McCrae 
and McCorquodale, 1987) followed by Alexa-594-conjugated goat-anti-rabbit secondary antibody as 
described in Materials and Methods. Nuclei were stained with DAPI again as described in Materials 
and Methods. (A) Long projection with narrow connection to the cells main body shown in figure 
3.2B, represented here for better comparison. (B) Medium projection. (C) Short projection. Arrows 
indicate the vesicle-like structures at the tips of the cytoplasmic projections. A magnification bar of 5 
µm is shown in the bottom right corner of each image. 
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3.2.3 NSP4 Expression in Simian BSC-1 Cells 
A significant disadvantage of using the fibroblastic BSRT7 cell line was that this line 
was derived from baby hamster kidney (BHK) cells and consequently is not 
permissive for rotavirus infection. This means that the intracellular distribution of the 
NSP4 expressed from transfected cDNA constructs in these cells could not be easily 
compared with that seen for NSP4 expressed during virus infection. To investigate 
whether the striking cytoplasmic extrusions containing NSP4 were also evident in a 
rotavirus permissive cell line, simian BSC-1 cells that do support rotaviral infection 
were transfected with the NSP4 plasmids used in the initial experiments done in 
BSR-T7 cells. However, because these cells do not normally express the 
bacteriophage T7 RNA polymerase, they also had to be infected with a recombinant 
vaccinia virus (T7-MVA) to generate the T7 RNA polymerase necessary to drive the 
expression of NSP4. The infection of cells with T7-MVA was done 4-h after 
transfection. At 7.5-h following the start of NSP4 expression, the transfected BSC-1 
cell monolayers were fixed, stained for NSP4 and observed using confocal 
microscopy. Images showing long cytoplasmic extrusions of the type seen in 
BSR-T7 cells were again seen in more than half of the BSC-1 cells expressing 
glyco+ NSP4 but not with glyco- NSP4 (Fig 3.4). The glycoN8A and glycoN18A 
cDNA constructs were not tested in these experiments as NSP4 glycosylated at only 
one of the two N-linked glycosylation sites is not detected following the natural viral 
infection (McCrae and McCorquodale, 1982). 
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Figure 3.4: Intracellular distribution of glyco+ and glyco- NSP4 expressed in transfected simian 
BSC-1 cells at 7.5-h after the switch on of NSP4 expression using T7-MVA. 
NSP4 was stained with polyclonal rabbit antisera raised against bacterially expressed NSP4 (McCrae 
and McCorquodale, 1987) followed by Alexa-594-conjugated goat-anti-rabbit secondary antibody as 
described in Materials and Methods. Nuclei were stained with DAPI again as described in Materials 
and Methods. (A and B) BSC-1 cells expressing glyco+ NSP4 showing NSP4 containing long 
cytoplasmic extrusions. (C) A BSC-1 cell expressing glyco- NSP4 showing cytoplasmic distribution 
of mutated NSP4 in intracellular spots. Arrows indicate the positions of cytoplasmic projections. A 
magnification bar of 10 µm in panel A and C, 30 µm in panel B is present in the bottom right corner 
of each image. 
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3.2.4 Cellular Distribution of NSP4 in Virus-Infected Cells 
Transfection and expression of glyco+ NSP4 in isolation produced an alteration of 
cellular morphology. However the participation of other viral proteins during a 
normal viral infection may affect the effect of expression of glyco+ NSP4. This led 
us to investigate the relevance of the changes in cell morphology seen when glyco+ 
NSP4 was expressed in isolation to changes that occur following viral infection. To 
do this, monolayers of BSC-1 cells were infected at an MOI of 0.2 and fixed at 
different times post infection. Cells were stained for NSP4 and DAPI before being 
examined by confocal microscopy. NSP4 expression was first detected at 6 hpi, 
viroplasms characteristic of rotavirus infection were visible by 8 hpi. The 
morphology of cells remained smooth at 9 hpi, but significant alterations in cellular 
morphology could be detected at 10 hpi with small cytoplasmic extrusions being 
clearly visible. At 11 hpi cytoplasmic extrusions crossing several cellular diameters 
were clearly evident and cells seemed to lose material from the cytoplasm as less 
cytoplasm was evident compared to images taken earlier time points post infection 
(Fig 3.5). These ‘snapshot’ images showed that the unusual cytoplasmic extrusions 
seen following expression of NSP4 in transfected cells were also evident in 
virus-infected cells. However in the case of virus infected cells their appearance was 
delayed compared to that seen following transfection suggesting that one or more of 
the viral proteins expressed following infection may regulate the kinetics of NSP4 
induced changes in cell morphology.
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Figure 3.5: Time course study of BSC-1 cell morphology changes after rotavirus infection. 
BSC-1 cell monolayers on coverslips were infected with virus at an MOI of 0.2 and observed at 
various times post infection (time indicated on top right corner of every image). NSP4 was stained 
with polyclonal rabbit antisera raised against bacterially expressed NSP4 (McCrae and McCorquodale, 
1987) followed by Alexa-594-conjugated goat-anti-rabbit secondary antibody as described in 
Materials and Methods. Nuclei were stained with DAPI again as described in Materials and Methods. 
(A) NSP4 staining was first evident at 6 hpi. (B and C) At 8 and 9 hpi viroplasms started to be visible 
but the individual cell morphology remained smooth and intact. (D) Cells began to change 
morphology showing short cytoplasmic extrusion at 10 hpi. (E, F and G) Cell morphology changed 
significantly showing long cytoplasmic extrusions at later times after viral infection. Arrowheads 
indicate viroplasms and arrows indicate the positions of cytoplasmic extrusions. A magnification bar 
of 10 µm is present in the bottom right corner of each image. 
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3.3 Conclusions 
The aim of this chapter was to study and compare the intracellular expression pattern 
of wild type NSP4 and its glycosylation defective mutants constructed by 
site-directed mutagenesis. Confocal microscopy of BSR-T7 and BSC-1 cells 
expressing wild type (glyco+) and glycosylation mutants (mono- and 
double-glycosylation sites mutated) showed that the fully glycosylated (glyco+) and 
the single site glyco- mutants of NSP4 were able to both localize in vesicular 
structures in the cytoplasm and to alter cellular morphology as early as 7.5 hours 
after expression. However neither of these phenomena were seen in cells expressing 
the double glycosylation site mutant of NSP4. These results suggested that both fully 
and single glycosylated NSP4 possess the ability to alter cell morphology promoting 
the formation of long cytoplasmic extrusions. Consistent with these observations 
glycosylated NSP4 has been reported to stimulate cellular projections in HEK 293 
cells (a human embryonic kidney cell line) by increasing intracellular calcium levels 
to change the actin filament network. Although unglycosylated NSP4 was not 
analysed in that study (Berkova et al., 2007), nevertheless inhibiting increases in 
intracellular calcium levels either by treatment with tunicamycin or through the use 
of RNAi (RNA interference) silencing of NSP4 indicate that glycosylation of NSP4 
is required for the increase of intracellular calcium concentration in infected cells 
(Ruiz et al., 2005; Zambrano et al., 2008). Unglycosylated NSP4 that did not 
increase intracellular calcium concentrations also did not exhibit the actin network 
changes seen in cells expressing glycosylated NSP4. Taken together these studies 
support the observation that only glycosylated NSP4 was able to change cell 
morphology. Therefore the present study supports the hypothesis that differential 
glycosylation status of NSP4 affects its function. 
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Changes in cellular morphology associated with viral infection were also examined 
to see if there were any similarities to the changes induced by NSP4 expression alone. 
Confocal microscopy of virus-infected cells showed that at 10-hour post infection 
cytoplasmic extrusions similar to those seen in transfected cells expressing wild type 
glyco+ NSP4 were present. The delay in timing (7.5 hours in transfected cells versus 
10 hours in infected cells) of appearance of cytoplasmic extrusions indicated that this 
function of glyco+ NSP4 might be controlled by other viral proteins. However these 
speculations are based on observations using ‘snap-shot’ images made by fixing and 
antibody staining of cells at various times after either transfection or infection and 
require further investigation to validate them. To avoid the drawbacks of only 
examining a ‘frozen’ moment and the possibility of cell fixation destroying fragile 
cellular structure it was decided that real time confocal microscopy should be 
exploited as a means of monitoring the dynamics of the changes in cellular 
morphology in glyco+ NSP4 expressing and virus infected cells. 
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Chapter 4 
Real-time Analysis of NSP4 and Virus Induced 
Cytoplasmic Extrusions 
 90 
4.1 Introduction 
In both fixed cells expressing solely glyco+ NSP4 and fixed virus infected cells 
significant alterations in cellular morphology were evident. In both cases long 
cytoplasmic extrusions were seen. However, to observe the kinetics of these changes 
in cellular morphology and also to avoid the drawbacks of cell fixation and ‘snapshot’ 
imaging of the microscopy in the previous chapter real-time confocal microscopy 
was investigated. Specifically after either glyco+ NSP4 expression following 
transfection or viral infection, real-time fluorescent confocal microscopy was used to 
capture changes in cell morphology highlighted by the presence of either GFP (green 
fluorescent protein) or YFP (yellow fluorescent protein). Despite the additional 
information obtained using this approach, it was quickly realized that long exposure 
of fluorescent molecules to laser light associated with scanning over a longer time 
frame resulted in both photobleaching of fluorescent molecules and phototoxic 
damaging to the living cells being observed. Therefore both transmission light 
confocal microscopy and the use of a resonant scanner were introduced. The 
transmission light monitoring was aimed at minimizing the phototoxic destruction of 
cells and the very high resonant frequency (i.e. 8000 Hz) scanning was used to allow 
high-speed imaging. 
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4.2 Results 
4.2.1 Construction of T7-NSP4-GFP For Real Time Observation Of Glyco+ 
NSP4 Stimulated Cytoplasmic Extrusions 
To facilitate real time monitoring of changes in cell morphology a green fluorescent 
protein (GFP) sequence was fused onto the 3’ end of the NSP4 coding region. To 
allow the fusion construct to be generated, a StuI restriction enzyme site was 
introduced at the 3’ end of the NSP4 open reading franked by site-directed 
mutagenesis PCR. Then a PCR amplicon consisting of the GFP coding sequence 
franked by StuI restriction enzyme sites was ligated to the 3’ end of NSP4 such that 
the GFP open reading frame was joined in frame to the carboxy terminus of NSP4 to 
create a fusion protein (Fig 4.1). Transfection of this plasmid construct into BSR-T7 
cells resulted in colocalization of NSP4 staining and GFP fluorescence (Fig 4.2). 
This indicated that GFP fluorescence could be used to represent the intracellular 
localization of expressed NSP4 to allow real time monitoring of morphologic change 
in NSP4 expressing cells, thereby overcoming the disadvantages seen when 
observing the protein in fixed specimens. However, this construct presented a 
different limitation to that seen in the earlier experiments. An increased incubation 
time following transfection was required for expression of the NSP4-GFP fusion to 
accumulate to the point where it could be clearly detected above background 
fluorescence. This hampered observation of NSP4-GFP positive cells at early times 
after transfection and no cytoplamic extrusions were seen in BSR-T7 cells at the 
earliest time post transfection that the NSP4-GFP could be detected which was 24 
hours post transfection. 
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Figure 4.1: Schematic representation of glyco+ NSP4-GFP fusion protein construct. 
To construct the NSP4-GFP fusion protein a StuI restriction enzyme site was introduced at the 3’ end 
of the NSP4 open reading frame by site-directed mutagenesis PCR. Then a PCR amplicon consisting 
of the GFP coding sequence franked by StuI restriction enzyme sites was ligated to the 3’ end of 
NSP4 such that the GFP open reading frame was joined in frame to the carboxy terminus of NSP4 to 
create the fusion protein. 
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Figure 4.2: Colocalization of NSP4 and GFP after 24 hours of expression of the NSP4-GFP 
fusion protein in BSR-T7 cells. 
NSP4 was stained with polyclonal rabbit antisera raised against bacterially expressed NSP4 (McCrae 
and McCorquodale, 1987) followed by Alexa-594-conjugated goat-anti-rabbit secondary antibody as 
described in Materials and Methods. Nuclei were stained with DAPI again as described in Materials 
and Methods. (A) Localization of NSP4 highlighted by NSP4-antibody staining. (B) GFP signal 
showing intracellular localization of the NSP4-GFP fusion protein. (C) A merged image of panel A 
and B showing colocalization of NSP4 and GFP in yellow spots. Arrows indicate two specific spots of 
NSP4 and GFP colocalization. A magnification bar of 5 µm is present in the bottom right corner of 
each image. 
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4.2.2 Morphological Observation of Glyco+ NSP4-GFP Expressing BSC-1 Cells 
Transfection of the fusion protein plasmid described in 4.2 and subsequent 
expression of the glyco+ NSP4-GFP fusion protein in BSR-T7 cells demonstrated 
that GFP fluorescence could be used to monitor the distribution of NSP4 in cells in 
real time. The fusion protein construct was therefore transfected into rotavirus 
permissive BSC-1 cells and cells monitored 24 hours after expression of NSP4 was 
initiated by infection of the cells with MVA-T7 to drive fusion protein expression. 
This revealed significant changes in cell morphology in all cells positively 
expressing GFP. Notably in these cells cytoplasmic extrusions also were detected 
(Fig 4.3). Subsequent real-time observation for 2 hours did not showed any change 
of these cytoplasmic extrusions. At 48 hours after fusion protein expression was 
initiated a large proportion of GFP fluorescence positive cells had rounded up and 
suspended in the culture medium, possibly due to the cytopathology induced by 
replication of the MVA-T7 vaccinia virus used to drive NSP4 expression. 
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Figure 4.3: Morphologic observation of BSC-1 cells expressing glyco+ NSP4-GFP fusion protein 
at 24 hours post expression. 
BSC-1 cells were transfected with glyco+ NSP4-GFP plasmid and 4 hours later were infected with 
recombinant vaccinia virus MVA-T7 as described in Materials and Methods. Cells were monitored 
using confocal microscopy initiated at 24 hours after NSP4-GFP expression began. Arrow indicates a 
cytoplasmic extrusion. A magnification bar of 5 µm is present in the bottom right corner. 
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4.2.3 Real-Time Morphological Observation of Virus-Infected BSC-1 Cells 
In chapter 3 antibody staining of fixed cells was used to show that viral infection 
changes cellular morphology to stimulate the formation of long cytoplasmic 
extrusions at 10 hpi in BSC-1 cells. However dynamic analysis using real-time 
confocal microscopy was pursued to achieve a better understanding of this novel 
observation. To do this with maximum efficiency, the effects of viral infection were 
examined in BSC-1 cells that had previously been transfected with a CMV-YFP 
plasmid to ‘light-up’ cellular morphology. Twenty-four hours after transfection, cells 
were infected with bovine UKtc rotavirus at an MOI of 10. Subsequent real time 
confocal microscopy of these cells showed that at 14 hours post infection cells began 
to generate long cytoplasmic extrusions which rapidly elongated and lasted for 
approximately 1 hour (Fig 4.4). In some cases these extrusions were more than three 
cellular diameters in length (Fig 4.5). 
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Figure 4.4: Real-time confocal microscopy examination of a virus-infected cell. 
CMV-YFP transfected BSC-1 cells were infected with the bovine UKtc strain of rotavirus at an MOI 
of 10 as described in Materials and Methods. Observation of cells using real-time confocal 
microscopy started at 2 hpi with images being recorded every 20 mins. (A and B) At 14 hpi BSC-1 
cells began showing a significant change in morphology. (C) The cell started to produce cytoplasmic 
extrusions. (D) Cytoplasmic extrusions were clearly evident. (E) Cytoplasmic extrusion elongated 
reaching distant areas and crossing 2 or 3 cellular diameters. (F) Loss of cytoplamic extrusions in the 
observation area. Time post infection is indicated on the top right corner of each image and arrows 
indicate an elongating cytoplasmic extrusion. A magnification bar of 40 µm is shown in the bottom 
right corner of each image. 
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Figure 4.5: Capturing a cell with long cytoplasmic extrusions using real-time confocal 
microscopy. 
CMV-YFP transfected BSC-1 cells were infected with the bovine UKtc strain of rotavirus at an MOI 
of 10 as described in Materials and Methods. The image was taken using real-time confocal 
microscopy at 14 hpi. Arrows indicate long cytoplasmic extrusions. The magnification bar is 15 µm. 
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4.2.4 Monitoring Virus Induced Cytoplasmic Extrusions by Simple 
Transmission Confocal Microscopy 
In section 4.2.3 real time fluorescent confocal microscopy showed that significant 
changes in cellular morphology with the generation of cytoplasmic extrusions were 
seen in BSC-1 cells infected with rotavirus beginning at 14 hours post infection. To 
observe the phenomenon in detail more frequent scanning was required. However 
when cells are being imaged with fluorescent confocal microscopy long exposure of 
cells to laser excitation leads to reduced GFP fluorescence as a result of 
photobleaching and also photo-induced cytotoxicity. Therefore to minimize 
photo-toxicity and allow closer monitoring of the dynamics of the formation of the 
cytoplasmic extrusions simple transmission confocal microscopy was employed. In 
addition a resonant scanner operating at very high scanning frequency was also used 
to minimize the duration of each scan. BSC-1 cells infected with virus at an MOI of 
10 were observed beginning at 12 hpi. Dynamic growth of the cytoplasmic 
extrusions was recorded, with measurement of the cellular extrusion showing that the 
extrusion was 32 µm in length when it was initially found (Fig 4.6A). Subsequent 
active elongation of this extrusion showed that at its maximum the extrusion was 62 
µm long and 10 µm wide (Fig 4.6B-F). Its growth speed was about 2 µm/min as it 
elongated from 32 µm to 62 µm in 15 mins. These simple transmission confocal 
microscopic observations of cellular extrusion stimulated from virus-infected cells 
again confirmed the observations made using fluorescent confocal microscopy. It 
also raised the possibility that these cytoplasmic extrusions might support a novel 
mechanism to transfer viral material from cell to cell. 
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Figure 4.6: Real time transmission confocal microscopic examination of virus-infected cells. 
BSC-1 cells were infected with the bovine UKtc strain of rotavirus at an MOI of 10 as described in 
Materials and Methods. Real-time transmission confocal microscopy of the infected cells was started 
at 12 hpi. (A) A cellular extrusion was initially captured being extruded from a virus-infected cell. (B) 
The cellular extrusion elongated and reached edge of viewing area. (C, D and E) As the cellular 
extrusion elongated, the viewing area was moved to fit it in the observation area. (F) Measurement of 
its maximum length showed that extrusion reached 62 µm. 
Images were recorded using a resonant scanner with highest scan speed and took less than one second 
to collect and single step scan images were taken. The time of recording is indicated on the bottom 
left of each image and arrows indicate the elongating cytoplasmic extrusion. A 10 µm magnification 
bar is shown in the bottom right corner of each image. 
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4.2.5 Apoptosis and the Induction of Cellular Extrusions 
It is possible that the unusual cytoplasmic extrusions seen in rotavirus-infected cells 
reflected a general response of cells undergoing viral infection or apoptotic cell death. 
To test this possibility BSC-1 cells were infected with a different virus (reovirus) or 
treated with the apoptosis inducing chemical PAC-1 (triggers apoptosis through 
activating procaspase-3 into caspase-3) and observed with confocal microscopy. 
Reovirus was chosen to challenge BSC-1 cells as it falls in the same virus family 
(Reoviridae) as rotaviruses and thus shares some similarity in its replication cycle. 
Monolayers of BSC-1 cells were infected with reovirus type 3 at an MOI of 10 and 
observed from 12 hpi using real time with transmission confocal microscopy. There 
were no obvious morphologic changes in the cells and certainly no appearance of 
long cytoplamic extrusions in the subsequent 4 hours of observation (Fig 4.7). In the 
case of treatment of PAC-1, which selectively induces caspase-3 dependent 
apoptosis, on BSC-1 cells Monolayers of BSC-1 cells were challenged by treatment 
of PAC-1 and observed using transmission confocal microscopy beginning at 1 hour 
after treatment. Real time observation revealed that during the first 8 hours post 
treatment cells started to shrink and round up. Additionally the cytoplasm appeared 
dense and some cytoplasmic fronts making contact with the surface of culture vessel 
were visible (Fig 4.8A-D). These cytoplasmic fronts were residual from retreat of 
cytoplasm during apoptosis and lacked progressive growth that differentiated them 
from cytoplasmic extrusions seen in rotavirus infected cells. In the subsequent 2 
hours the membranes of cells showed irregular buds known as blebs and some 
cytoplasmic vesicles called apoptotic bodies broke apart from cell main body (Fig 
4.8E and F). Finally cells burst showing a membranous structure that connected to a 
fraction of cell debris (Fig 4.8G and H). However at no stage were any of the long 
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cytoplasmic extrusions seen in rotavirus-infected cells observed. 
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Figure 4.7: Reovirus infection in BSC-1 cells. 
BSC-1 cells were incubated in the culture medium containing reovirus at an MOI of 10 until the time 
of observation. Observation using transmission confocal microscopy was started at 12 hpi. (A) Initial 
morphology and location of cells at 12 hpi. (B, C and D) Alteration in cellular morphology could be 
noticed but no appearance of cytoplasmic extrusions seen in rotavirus infected cells. The cellular 
morphology of a cell in the middle of the images is marked by dashed line indicating continuous 
change of the cell shape. The time of observation is indicated in the bottom left corner of each image. 
Single slice images were taken in this experiment. A magnification bar of 20 µm is present in the 
bottom right corner of each image. 
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Figure 4.8: Apoptosis stimulated by treatment of PAC-1 in BSC-1 cells. 
BSC-1 cells were challenged by adding PAC-1 to the culture medium described in Materials and 
Methods. Observation using transmission confocal microscopy was carried out one hour after the 
addition of PAC-1. (A) Initial morphology and location of cells after one hour treatment of PAC-1. 
Two target cells to be followed through the subsequent images are marked in number 1 and 2 in the 
image. (B, C and D) Cells appeared to shrink and round up and the cytoplasm appeared dense. (E) 
Cellular membrane appeared to show irregular buds known as blebs. (F) Cell 1 shows that the 
cytoplasmic vesicles called apoptotic bodies have broken apart from cell main body whilst cell 2 
continued to show blebs on the cell membrane. (G and H) Both cell 1 and 2 burst and show a 
membranous structure connecting to a fraction of cell debris. Single slice images were taken in this 
experiment. The time of observation is indicated in the bottom left corner of each image. A 
magnification bar of 25 µm is present in the bottom right corner of each image. 
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4.3 Conclusions 
The aim of the experiments described in this chapter was to capture a real-time 
record of the changes in cell morphology seen when NSP4 was expressed in isolation 
and how such changes relate to those seen for virus-infected cells. Real-time 
monitoring of BSC-1 cells expressing an NSP4-GFP fusion protein confirmed the 
capacity of NSP4 to change cell morphology after 24 hours of expression. However 
observations at earlier times after the start of expression were not possible because of 
the weak GFP signal which meant that it could not be clearly differentiated from 
background fluorescence. The relevance of the changes in cellular morphology seen 
in cells expressing NSP4 in isolation to those seen in rotavirus-infected cells was 
examined using a combination of real-time fluorescent and transmission confocal 
microscopy to allow capture of the dynamic changes seen in cell morphology. 
Fluorescence based confocal microscopy showed that virus-infected cells shrank, 
rounded up and interestingly generated cytoplasmic extrusions not dissimilar to those 
seen at early expression times in cells transfected with NSP4 expression plasmid. 
These cytoplasmic extrusions, that reached several diameters of cell in length, 
appeared at 14 hpi in the late period of viral infection and disappeared after 
approximately 1 hour. Subsequent observation using transmission confocal 
microscopy and a resonant scanner revealed the dynamic growth of the cytoplasmic 
extrusion in detail and showed their speed of growth was 2 µm/min. 
The cytoplasmic extrusions seen in virus-infected cells were novel and to investigate 
the possibility that they were not linked specifically to rotavirus infection, controls 
including only uninfected cells, reovirus-infected cells and PAC-1 treated cells were 
all monitored using real-time transmission confocal microscopy. None of these 
controls showed any evidence of similar types of cytoplasmic extrusion to those seen 
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in rotavirus-infected and NSP4 expressing transfected cells. Taken together these 
observations confirmed the changes in cell morphology seen in the earlier 
experiments on fixed cells and revealed a novel phenomenon of changes in cell 
morphology in rotavirus-infected cells. In viral infection the appearance of such 
cytoplasmic extrusions was delayed until 14 hpi whereas they were seen at 7.5 hours 
post transfection in cells transfected with glyco+ NSP4 construct and infected with 
MVA-T7. This suggests the possibility that other viral proteins might regulate the 
function of NSP4 to delay timing in NSP4 induced cytoplasmic extrusion that 
provided sufficient time for virus replication. 
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Chapter 5 
Functional Investigation of Virus Stimulated 
Cytoplasmic Extrusions 
 112 
5.1 Introduction 
Study of the changes in cell morphology induced by rotavirus infection showed that 
cells produced cytoplasmic extrusions at late times in the virus replication cycle that 
usually finishes within 16 hours with gradual cell lysis form 10 hpi in BSC-1 cells. 
The next objective was to investigate the potential functions of these cytoplasmic 
extrusions. Building on the initial observations it was hypothesized that they may be 
responsible for disseminating NSP4 to bystander uninfected cells where the protein 
could exhibit its cyto-toxicity. To test this hypothesis green and red Cell Tracker 
dyes were employed. The purpose of using Cell Trackers was to allow separate 
staining of virus-infected and uninfected cells in mixed populations, thereby 
allowing them to be discriminated from each other. The hope was that by observing 
such mixed and separately tagged populations the transfer of cellular material from 
infected to uninfected cells could be monitored. Cell Tracker dyes are 
non-fluorescent probes prior to entering cells, which when added to the culture 
medium are able to pass freely through the cell membrane. However once inside the 
cell they react with intracellular thiols and transform into fluorescent and 
cell-impermeable reaction products. Consequently they will not transfer to adjacent 
cells in a culture even if released by cell lysis. 
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5.2 Results 
5.2.1 Spread of NSP4 Cytotoxicity Through Virus Induced Cytoplasmic 
Extrusions 
To investigate possible transfer of cellular material between cells through rotavirus 
induced cytoplasmic extrusions, populations of BSC-1 cells were split into two 
populations and separately stained with green or red fluorescent Cell Tracker dyes. 
In control experiments it was found that the pattern of cell staining with these two 
dyes differed, with the green Cell Tracker staining the whole cytoplasm whereas 
staining with the red Cell Tracker was focused near the nuclei of cells (Fig 5.1). A 
fraction of each of the stained cell populations (i.e. either green or red) was then 
infected with the UKtc strain of bovine rotavirus at an MOI of 10. Virus-infected 
cells labeled with one Cell Tracker were then mixed with uninfected cells stained 
with the other Cell Tracker at a ratio of 2:5. Examination of these cell mixtures 
started at 14 hours post infection and in both cases cytoplasmic extrusions were seen 
(Fig 5.2 and 5.3). In the case of the mixture containing green infected and red 
uninfected cells, cytoplasmic extrusions protruding outward from green infected cells 
were clearly observed (Fig 5.2C, D and E). Direct contact of these extrusions with 
bystander cells was not seen in these real time experiments, but rather the 
cytoplasmic extrusions broke apart into small and mobile membranous vesicles (Fig 
5.2F). However in the case of the mixture of red infected cells and green uninfected 
cells, the cytoplasmic extrusions from the red infected cells were seen to make direct 
contact with uninfected green cells (Fig 5.3A, B and C). In addition obvious red 
cytoplasmic material was seen in those green cells having direct contact but not in 
other bystander green cells indicative of a transfer of cytoplasmic material from an 
infected red cell into an uninfected green cell (Fig 5.3A, B and C). Extending the real 
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time observation of this mixture showed that the cytoplasmic extrusions also 
scattered into small vesicles (Fig 5.3D and E) in this case, one red vesicle from a 
virus-infected cell was clearly evident on the surface of an uninfected green cell (Fig 
5.3F). 
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Figure 5.1: Cell Trackers staining of Mock infected BSC-1 cells. 
BSC-1 cells were divided into separate wells of a culture dish and stained with either green or red Cell 
Tracker. After one hour of incubation cells were washed extensively, mixed, and incubated at 37 ºC 
for 24 hours. Subsequent observations were made using these live i.e. unfixed cells. (A) BSC-1 cells 
fluorescing in the green channel demonstrated that green Cell Tracker stained the whole cytoplasm of 
cells. (B) BSC-1 cells fluorescing in the red channel demonstrated that red Cell Tracker stained an 
area surrounding nuclei. (C) A merged image of panel A and B that showing that the Cell Trackers 
were distinguishable from each other. A magnification bar of 20 µm is present in the bottom right 
corner of each image. 
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Figure 5.2: Detection of cytoplasmic extrusions in cells stained with green Cell Tracker after 
virus infection. 
BSC-1 cells were divided into separated wells of a culture dish and stained with either green or red 
Cell Tracker dye. The cell population stained with green Cell Tracker was then infected with bovine 
UKtc rotavirus at an MOI of 10. After 1-hour incubation the cell populations were washed extensively, 
mixed and cultured for 14-hour at 37 ºC before confocal microscopic examination was started. (A) 
Overview of mixed cells in fluorescent channel with a specific green virus-infected target cell marked 
with red square. (B) Overview of mixed cells in transmission light channel showing the same green 
target cell labeled with a red square. (C, D and E) After cytoplasmic extrusions had been detected in 
the target cell, observation at higher magnification revealed the dynamics of extrusion formation in 
real-time. (F) The cytoplasmic extrusions broke into small vesicles. Time of recording is showed in 
the bottom left of image B-F. Arrows indicate cytoplasmic extrusion and arrowhead indicates a 
scattered vesicle. Fluorescent image and transmission record were taken a single step scan image by 
scan crossing the middle of cells. A magnification bar of 10 µm is present in the bottom right corner 
of each image. 
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Figure 5.3: Observation of cytoplasmic extrusion in red Cell Tracker staining cell after viral 
infection. 
BSC-1 cells were divided into separate wells and stained with either green or red Cell Tracker. Cells 
stained with red Cell Tracker cells were also infected with bovine UKtc rotavirus at an MOI of 10. 
Following one hour of incubation at 37 ºC cells were washed extensively, mixed, and cultured for a 
further 14-hour at 37 ºC before real time confocal microscopy was started. (A) Overview of mixed 
cells in fluorescent channel showing a red infected cell (marked by green square) already showing 
cytoplasmic extrusions, one of which has established contact with a green uninfected cell (surrounded 
by red circle). (B) Overview of mixed cells showing only red fluorescence with red Cell Tracker 
present in the green target cell (red circle) indicating transfer of material from the red cell (green 
square) to the green cell (red circle). For comparison there was no detectable red Cell Tracker present 
in two other nearby uninfected green cells (surrounded by white circles in panel A and B). (C) 
Overview of mixed cells using transmission light microscopy indicating the position of the target cells 
highlighted in A and B. (D and E) Real time observation revealed that the cytoplasmic extrusion 
making contact with the green cell (red circle) broke apart and also that other cytoplasmic extrusions 
broke into small vesicles. (F) Fluorescent detection using stacked images to show a physical contact 
between a red vesicle and the cytoplasmic membrane surface of the green cell and its intracellular red 
Cell Tracker at the end of recording. Time of recording is in the bottom left of image C-E. Green 
square indicates the red target cell having cytoplasmic extrusion. Arrow indicates cytoplasmic 
extrusion and arrowhead indicates a scattered vesicle. Fluorescent images (A-E) were taken a single 
step scan crossing the middle of cells. A magnification bar of 10 µm in image A-E and 5 µm in image 
F is indicated in the bottom right corner. 
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Further detailed examination of scattered small vesicles generated by infected cell 
populations carried out at 16 hours post infection revealed in the case of green 
virus-infected and red uninfected cell mixtures the presence of scattered green 
vesicular structures surrounding red cells (Fig 5.4). Internalization of such vesicles 
was however much more clearly seen on mixing virus-infected red cells with 
uninfected green cells (Fig 5.5). 
The observation of fluorescent Cell Tracker transferred from infected cells to 
uninfected cells implied that NSP4 had also been transferred. To investigate this 
more definitively infected BSC-1 cells with no staining were mixed with 
green-staining virus non-permissive cells (BSR-T7). The use of BSR-T7 cells as 
recipient was to mimic the non-permissive cells below the top of the villi in vivo to 
acquire NSP4 transferred from virus infected cells at the tip of the villi. Subsequent 
staining with NSP4 antibody revealed the dissemination of NSP4-containing 
structures from infected BSC-1 cells on the cytoplasmic membrane surface of green 
BSR-T7 cells at 16 hours post infection (Fig 5.6). Attempts to address whether the 
scattered NSP4 had entered green BSR-T7 cells were not conclusive. This was 
because simple interpretation of the experiment was confounded by the observation 
that the exposure of BSR-T7 cells to high titre rotavirus resulted in a few cells in the 
population becoming infected. Thus on staining cells using specific antibody against 
NSP4 it was not possible to definitely distinguish between internalized NSP4 and the 
NSP4 that may have been expressed in the cells following their infection by 
exogenous virus released from the virus-infected cells. However our observations 
support a new model for the spread of NSP4 cytotoxicity through virus induced 
cytoplasmic extrusions to produce membranous vesicles that deliver NSP4 from 
virus-infected cells to surrounding uninfected cells.
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Figure 5.4: Dissemination of material from virus-infected cell to uninfected cell. 
BSC-1 cells were divided into separated wells of a culture dish and stained with either green or red 
Cell Tracker dye. The cell population stained with green Cell Tracker was then infected with bovine 
UKtc rotavirus at an MOI of 10. After 1-hour incubation the cell populations were washed extensively, 
mixed and cultured for 14-hour at 37 ºC before confocal microscopic examination was started. The 
image shows a uninfected cell stained with red fluorescent Cell Tracker acting as recipient of 
vesicular structures from virus-infected cell stained with green Cell Tracker. Arrows indicate 
vesicular structures from the green virus-infected cell. A magnification bar of 10 µm is present in the 
bottom right corner.
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Figure 5.5: Internalization of material from a virus-infected cell to a uninfected cell. 
BSC-1 cells were divided into separate wells and stained with either green or red Cell Tracker. Cells 
stained with red Cell Tracker cells were also infected with bovine UKtc rotavirus at an MOI of 10. 
Following one hour of incubation at 37 ºC cells were washed extensively, mixed, and cultured for a 
further 14-hour at 37 ºC before real time confocal microscopy was started. Panel A shows already 
internalized vesicular structures from a infected red cell into an uninfected cell marked with green 
Cell Tracker. Panel B shows intracellular location of a vesicular structure with vertical view (panel C) 
on its top and horizontal view (panel D) on its right. Panels B, C and D are single slice images 
crossing the cell. A magnification bar of 5 µm is present in the bottom right corner of panel A. 
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Figure 5.6: Dissemination of NSP4 from virus-infected cell to uninfected cell. 
BSC-1 cells, infected with bovine UKtc rotavirus at an MOI of 10 for 1 hour, were mixed with 
BSR-T7 cell stained with green Cell Tracker. Following 16 hours of incubation at 37 ºC cells were 
fixed, stained with polyclonal rabbit antisera raised against bacterially expressed NSP4 (McCrae and 
McCorquodale, 1987) followed by Alexa-594-conjugated goat-anti-rabbit secondary antibody (red 
staining) as described in Materials and Methods. (A) A max projection of z-stack image shows that 
NSP4-containing vesicular structures were disseminated from infected non-fluorescent BSC-1 cells on 
the surface of a group of green Cell Tracker stained BSR-T7 cells. (B-D) Single slice images crossing 
the cells from top (B) to bottom (D) show that the NSP4-containing vesicular structures are closely 
associated with the cytoplasmic membrane of a group of green Cell Tracker stained BSR-T7 cells. 
Arrows indicate NSP4 containing vesicular structures. A magnification bar of 10 µm is present in the 
bottom right corner of each image.
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5.3 Conclusions 
The aim of the experiments described in this chapter was to study the potential 
function of the cytoplasmic extrusions seen in virus-infected cells. Through the use 
of impermeable Cell Tracker dyes for imaging of virus-infected cells such 
cytoplasmic extrusions were seen to scatter into small vesicles that disseminated onto 
the surface of and were internalized into bystander cells. Subsequent detection of 
NSP4 containing vesicular structures on the plasma membrane of BSR-T7 cells 
implied that NSP4 could also be disseminated in a similar manner. These 
observations allow a new hypothesis to be proposed covering the mechanism by 
which rotavirus might spread its cytotoxicity through a population of cells. It is 
proposed that this involves cytoplasmic extrusions mediating a direct cell-to-cell 
transfer of cytoplasm from virus-infected cells to these surrounding uninfected cells 
thereby delivering sufficient cyto-toxin (NSP4) to surrounding cells to kill them over 
a large area. The advantage of this hypothesis compared to that involving NSP4 
being secreted from infected cells might be that NSP4 could still anchor on 
membrane derived from the ER to exercise its paracrine-like secretion. This provides 
an explanation of how an ER resident protein such as NSP4 can be transported to 
cellular environments other than those in which it was synthesized. 
Taken together the observations in this chapter support the hypothesis that 
dissemination of NSP4 from infected cells to bystander cells is possible through 
membranous vesicles released from virus induced cytoplasmic extrusions. 
The changes in cell morphology seen in these experiments imply that the 
cyto-skeleton has undergone radical reorganization in cells expressing NSP4 or 
infected with virus. Therefore analysis of the cyto-skeletal network was undertaken 
to achieve a better understanding of the processes underpinning the formation of 
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cytoplasmic extrusions. 
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Chapter 6 
Analysis of Cytoskeletal changes in Transfected Cells 
Expressing NSP4 or Cells Infected with Rotavirus 
 129 
6.1 Introduction 
Eukaryotic cells have a cytoplasmic skeleton composed of actin filaments, 
intermediate filaments and microtubules to maintain their cell morphology and 
support special structures such as flagella, cilia and lamellipodia. The alterations 
seen in the cytoplasmic morphology of either NSP4 expressing or rotavirus-infected 
cells implied that the cyto-skeleton of such cells had been affected. Calcium 
dependent rearrangement of the actin network leading to generation of cellular 
projections has been reported following NSP4 expression in both HEK 293T cells 
(human embryonic kidney cell line) and MA104 cells (rhesus monkey kidney cell 
line) (Berkova et al., 2007). Virus infection of MA104 cells has also been reported as 
leading to modification of actin filaments (Berkova et al., 2007). Furthermore in 
infected polarized Caco-2 cells (human colorectal carcinoma cell line) both actin and 
microtubules were changed in a calcium dependent manner (Brunet et al., 2000a; 
Brunet et al., 2000b). By contrast a disorganization of vimentin, a member of the 
intermediate filament family of proteins, has only been detected in undifferentiated 
(i.e. non-polarized) Caco-2 cells and CV-1 cells (cercopithecusaethiops monkey 
kidney cell line) (Brunet et al., 2000a; Brunet et al., 2000b; Weclewicz et al., 1994). 
These observations on cyto-skeleton albeit done primarily in cell lines other than 
those employed in this study give further support to the hypothesis that 
disorganization of the cyto-skeleton contributed to the cytoplasmic extrusions seen in 
NSP4 expressing or virus-infected BSC-1 cells used in the present study. The effect 
of NSP4 expression on actin filaments has already been investigated (Berkova et al., 
2007). Therefore in this study the analysis focused on cellular microtubules and the 
effects of glycosylation of expressed NSP4 and virus infection of BSC-1 cells on 
these components and more generally the cytoskeleton using confocal microscopy. 
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6.2 Results 
6.2.1 Microtubule Disruption and Re-assembly in BSC-1 Cells Expressing 
Glyco+ or Glyco- NSP4 
The alteration of cellular morphology seen earlier in this study in cells expressing 
glyco+ NSP4 indicated that NSP4 was potentially capable of changing the cellular 
skeletal network. Changes in F-actin have been studied and proposed to be linked to 
changes in intracellular calcium concentration and cofilin-1 (Berkova et al., 2007). 
However the effects of NSP4 expression on the microtubule network have not been 
studied previously. To avoid any side effects from the infection of cells with the use 
of MVA-T7 to drive NSP4 expression, both glyco+ and glyco- NSP4 cDNAs were 
cloned into the pcDNA3.1 cloning vector that employs the immediate early promoter 
of cytomegalovirus (CMV) to drive protein expression. To study the effect of NSP4 
expression on microtubules, BSC-1 cells were separately transfected with the two 
plasmids and cells were fixed and stained with NSP4 and β-tubulin antibodies at 
24-h and 48-h post transfection. Confocal microscopy showed that expression of 
both glyco+ and glyco- NSP4 leads to the disassembly of microtubules at 24-h post 
transfection (Fig 6.1A and B). This disassembly appeared to initiate primarily from 
the centre of the cell. Interestingly prior to complete destruction of the microtubular 
network, a reforming of microtubules was evident at the periphery of cells 
independent of the centrosome (Fig 6.1C and D). In this experiment even though 
different expression levels of NSP4 were observed in cells at different stages of the 
microtubular disassembly (Fig 6.1B and C). It was impracticable to interpret from 
fixed sample that cell-cell transfer of NSP4 resulted in the difference of NSP4 
expression levels. At 48-h post transfection a greater proportion of cells expressing 
NSP4 showed complete disruption of the microtubule network compared to that seen 
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at 24-h post transfection (data not shown). 
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Figure 6.1: Examination of the microtubule network after glyco+ and glyco- NSP4 expression in 
BSC-1 cells. 
NSP4 was stained with polyclonal rabbit antisera against NSP4 followed by Alexa-594-conjugated 
goat-anti-rabbit antibody as described in Materials and Methods. Microtubules were stained by 
polyclonal mouse anti-β-tubulin antibody followed by Alexa-488-conjugated goat-anti-mouse 
antibody as described in Materials and Methods, finally nuclei were stained with DAPI as described in 
Materials and Methods. (A and B) Microtubules were completely destroyed in cells expressing either 
glyco+ or glyco- NSP4 but remained intact in other bystander cells indicated by arrow. (C and D) 
Prior to complete destruction of the microtubule network in cells expressing either glyco+ or glyco- 
NSP4 disassembly of the microtubule started from centre of the cytoplasm and re-polymerization of 
the microtubules appeared to form a ring structure at the cell periphery. NSP4 stained in red and 
β-tubulin stained in green.
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The NSP4 mediated destructive effect on the microtubule network was studied 
further by examining the effect of manipulating intracellular calcium concentrations 
and also the functionality of the centrosome. The reason to investigate the effect of 
intracellular calcium levels was that actin breakdown in NSP4 expressing cells and 
both actin and microtubule network damage in virus-infected cells have been 
reported to be dependent on intracellular calcium levels (Berkova et al., 2007; Brunet 
et al., 2000a; Brunet et al., 2000b). To investigate whether elevation of intracellular 
calcium was a factor contributing to the NSP4 driven breakdown of the microtubule 
network in our study EGTA and BAPTA/AM, both calcium chelator, were added 
together to the culture medium of transfected BSC-1 cells. Confocal microscopy 
showed that treatment with both compounds did not prevent the destruction of the 
microtubule network in NSP4 expressing cells at 24-hour post transfection 
suggesting that NSP4 driven elevation of intracellular calcium was not involved in 
the microtubule disassembly (Fig 6.2). 
In healthy mammalian cells the microtubule network grows from a cellular organelle 
localized near the nucleus called the centrosome. However following NSP4 
expression polymerization of microtubules at the periphery of cell occurred and this 
appeared to lack a starting centre. This implied that some functionality of the 
centrosome had been disrupted by NSP4 expression. To further investigate the 
possible role of centrosomal functionality nocodazole that prevents microtubule 
re-polymerization by binding to free tubulin subunits was added to BSC-1 cells 
expressing either glyco+ or glyco- NSP4 at 24 or 48 hours post transfection. 
Subsequent removal of medium containing nocodazole and washing of the cells 
allowed centrosome dependent reformation of the microtubule network in 
untransfected cells within 10 mins but not in transfected cells expressing NSP4. In 
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this latter case the microtubule network re-polymerized independently of the 
centrosome and again distributed in a ring surrounding the centre of the cell (Fig 6.3). 
This suggested that NSP4 expression resulted in either inhibition of the centrosome 
functioning as a microtubule polymerization centre or microtubular 
de-polymerization was occurring faster than its polymerization from the centrosome 
in the centre of cells. It also suggested that expression of NSP4 caused microtubule 
polymerization in a centrosome-independent manner at the cell periphery.
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Figure 6.2: The microtubule network in cells expressing glyco+ NSP4 after treatment of EGTA 
and BAPTA/AM. 
BSC-1 cells were transfected with a glyco+ NSP4 construct for 4 hours and subsequently incubated 
with culture medium containing EGTA (3mM) and BAPTA/AM (75 µM) for 24 hours prior to 
fixation. NSP4 was stained with polyclonal rabbit antisera against NSP4 followed by 
Alexa-594-conjugated goat-anti-rabbit antibody (red staining) as described in Materials and Methods. 
Microtubules were stained by polyclonal mouse anti-β-tubulin antibody followed by 
Alexa-488-conjugated goat-anti-mouse antibody (green staining) as described in Materials and 
Methods, finally nuclei were stained with DAPI as described in Materials and Methods. (A and B) 
EGTA and BAPTA/AM treatment did not prevent disassembly of the microtubule and 
re-polymerization of the microtubule at the periphery of the cell expressing NSP4. Arrows indicate 
the re-polymerized microtubule at the periphery of a NSP4 expressing cell. A magnification bar of 10 
µm is present in the bottom right corner of each image.
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Figure 6.3: Recovery of microtubules in a glyco+ NSP4 expressing BSC-1 cells after treatment 
of nocodazole. 
BSC-1 cells were transfected with a glyco+ NSP4 construct for as described in Materials and Methods. 
24 hours after transfection cells were treated for one hour with nocodazole (15 mg/ml final 
concentration). Following washes (5X) to remove the nocodazole and 10 mins incubation in 
nocodazole free medium to allow polymerization of microtubules, cells were fixed, stained and 
examined by confocal immunofluorescent microscopy. NSP4 was stained with polyclonal rabbit 
antisera against NSP4 followed by Alexa-594-conjugated goat-anti-rabbit antibody. Microtubules 
were stained by polyclonal mouse anti-β-tubulin antibody followed by Alexa-488-conjugated 
goat-anti-mouse antibody; finally nuclei were stained with DAPI all as described in Materials and 
Methods. (A) Recovery of microtubule polymerization appeared to occur independent of centrosome 
and form ring-like structure in the cytoplasm in a NSP4 expressing cell. (B) Green fluorescent channel 
showing the ring-like structure of microtubule formed in the NSP4 expressing cell, by contrast a cell 
indicated by arrow shows normal microtubular network recovery with a microtubules oriented centre. 
(C) Red fluorescent channel shows expression of NSP4 in the cell with re-arranged microtubules in 
ring-structure. (D) Control image showing disassembly of the microtubule caused by treatment of 
Nocodazole prior to washing out the drug. A magnification bar of 10 µm is indicated in the bottom 
right of each image. 
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6.2.2 NSP4 Expression Did Not Induce Apoptosis And Necrosis 
The pattern of destruction of the microtubule network starting with disassembly from 
the centre of the cytoplasm and re-polymerization at the periphery of the cell has 
been proposed as one of the cellular defense mechanisms seen in apoptotic cells 
(Moss et al., 2009; Sanchez-Alcazar et al., 2007). Furthermore induction of Bax 
dependent apoptosis through the mitochondrial pathway has been reported to occur 
following rotavirus infection (Martin-Latil, Mousson et al. 2007). This lead us to 
investigate whether an NSP4 induced pro-apoptotic signaling might be responsible 
for the pattern of changes seen in the microtubules in transfected cells. To do this 
expression plasmids carrying either glyco+ or glyco- NSP4 were transfected into 
HEK 293T cells. Subsequent FACS (fluorescence activated cell sorting) analysis of 
NSP4 expressing cells using an apoptotic cell staining kit (Apo-TRACE) at 24 and 
48 hours post transfection did not appear to show any apparent induction of either 
apoptosis or necrosis when compared with controls transfected with the empty 
pcDNA3.1 plasmid used for the NSP4 constructions. By contrast treatment of cells 
with PAC-1, a recognized apoptosis inducer, showed a significant induction of both 
apoptosis and necrosis (Fig 6.4). 
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Figure 6.4: Induction of apoptosis in PAC-1 treated but not in glyco+ and glyco- NSP4 
expressing 293T cells. 
293T cells were transfected with the indicated plasmid or treated with medium containing PAC-1 at a 
final concentration of 5 µM. Cells were stained using Apo-Trace and analysed by FACS (as described 
in Materials and Methods) at 24 and 48 hours post transfection or treatment. Cell only: Cells without 
treatment showing their apoptotic status after culture for the indicated times. pcDNA3.1: Cells 
transfected with pcDNA3.1 cloning vector used in constructing both glyco+ and glyco- NSP4 
expression plasmids. Glyco+: Cells transfected with glyco+ NSP4 construct. Glyco-: Cells transfected 
with glyco- NSP4 construct. PAC-1: Cells treated with PAC-1 at the start of the experiment. 
Examination of apoptosis and necrosis at 24 hours in A and 48 hours in B after transfection or 
chemical treatment. Significant induction of apoptosis and necrosis only seen in cells treated with 
PAC-1 but not in cells transfected with either glyco+ or glyco- NSP4. A total number of 20,000 cells 
were analysed in each sample. Transfection controls were included in this experiment: 1. Cells were 
transfected with pEGFP-N1 and examined at 24 hours post transfection using UV-light microscopy to 
confirm transfection efficiency above 70% by looking at GFP fluorescence on the cell monolayer. 2. 
Cells were transfected with either glyco+ or glyco- NSP4 construct, fixed and stained with anti-NSP4 
sera at 24 hours post transfection. Specific antibody staining against NSP4 in these cells confirmed 
positive expression of NSP4 in more than 70% of the cell population. 
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6.2.3 Disruption of The Microtubular Network In Virus-Infected Cells 
Expression of NSP4 in isolation led to the disassembly of the microtubular network 
in transfected cells and re-polymerization of microtubules into a ring-like structure at 
the periphery of the cells apparently independent of centrosome function. To 
examine whether these changes in the microtubular network also occurred during 
viral infection, BSC-1 cells were infected with rotavirus and fixed and stained for 
NSP4 and β-tubulin at 15 hpi. Confocal microscopy showed virus replication in cells 
also resulted in complete destruction of the microtubular network (Fig 6.5). Notably 
in some virus-infected cells re-polymerization of microtubules into a ring-like 
structure at the cell periphery (Fig 6.5) similar to that seen in cells expressing only 
NSP4 was also observed. This similarity of microtubular modification between cells 
transfected with NSP4 and those infected with virus suggested that the viral NSP4 
protein might also function to disrupt microtubular network following viral infection. 
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Figure 6.5: Destruction of microtubular network in virus infected BSC-1 cells. 
BSC-1 cells were infected with rotavirus at an MOI of 1 and fixed using paraformaldehyde at 15 hpi 
as described in Materials and Methods. NSP4 was stained with a polyclonal rabbit antisera against 
NSP4 followed by Alexa-594-conjugated goat-anti-rabbit antibody, microtubules were stained by a 
polyclonal mouse anti-β-tubulin antibody followed by Alexa-488-conjugated goat-anti-mouse 
antibody, finally nuclei were stained with DAPI all as described in Materials and Methods. (A) Green 
fluorescent channel showing the microtubular network of a cell monolayer infected with virus. (B) 
Red fluorescent channel showing staining of NSP4 to distinguish infected and uninfected cells. (C) 
Merge of Panels A and B showing both microtubular network and NSP4 staining pattern in cells. 
The white square area in panel C was enlarged to produce panels D, E and F. (D) Green fluorescent 
channel showing complete destruction of the microtubular network in the cell labeled 1 and the 
destruction of the network from the centre of the cytoplasm and re-polymerization forming a ring-like 
structure at the cell periphery in the cell labeled 2. (E) Red fluorescent channel showing staining of 
NSP4 to indicate infected cells. (F) Merge of Panels D and E to show both microtubular network and 
NSP4 staining pattern in cells. A magnification bar of 10 µm is indicated in the bottom right corner of 
each image.
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6.2.4 Detection of β-Tubulin and F-Actin in Virus Induced Cytoplasmic 
Extrusions 
Analysis of cells expressing NSP4 both in isolation and following viral infection 
revealed similarities in the disruption of the microtubular network. However no 
obvious cytoplasmic extrusions were observed in these experiments. This may have 
been due to the fragility of these cytoplasmic extrusions resulting in their destruction 
during the two cycles of antibody staining (first cycle for NSP4 antibody staining 
and second cycle for β-tubulin antibody staining). To overcome this difficulty and 
allow observation of the cellular components in the extrusions induced by viral 
infection, BSC-1 cells infected with virus were fixed for one hour at 14 hpi and only 
stained using β-tubulin antibody. Staining of F-actin was carried out by covering the 
cells with PBS containing Alexa-594-conjugated phalloidin. These treatments 
minimized the number of washes used, as it was the washing procedures that were 
suspected of disrupting the fragile cellular extrusions induced by viral infection. 
Confocal microscopy of samples prepared using this gentler procedure revealed that 
β-tubulin and F-actin were reorganised and concentrated in the cytoplasmic 
extrusions (Fig 6.6). This suggested that β-tubulin and F-actin might be acting to 
provide a vesicle transport track and cytoskeleton to allow the radial transport of 
NSP4 containing vesicles seen at the tips of the cytoplasmic extrusions in earlier 
experiments. 
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Figure 6.6: Detection of tubulin and actin in cytoplasmic extrusions induced by virus infection 
of BSC-1 cells. 
BSC-1 cells, were infected with rotavirus at an MOI of 10, and fixed at 14 hpi as described in 
Materials and Methods β-tubulin and F-actin were stained using polyclonal mouse anti-β-tubulin 
antibody followed by Alexa-488-conjugated goat-anti-mouse antibody and Alexa-594-conjugated 
phalloidin respectively. Finally nuclei were stained with DAPI all as described in Materials and 
Methods. (A) Green fluorescent channel showing the staining of concentrated β-tubulin in 
cytoplasmic extrusions. (B) Red fluorescent channel showing the presence of concentrated F-actin 
also in cytoplasmic extrusions. (C) Merge of Panels A and B showing an overlay of both β-tubulin 
and F-actin in cytoplasmic extrusions. Arrow indicates a cytoplasmic extrusion containing clear 
staining of both β-tubulin and F-actin. A magnification bar of 10 µm is shown in the bottom right 
corner of each image. 
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6.2.5 Effect of Cytoskeleton Disrupting Chemical on The Cytoskeleton Network 
in Virus-Infected Cells 
The importance β-tubulin functionality in supporting cytoplasmic extrusions was 
studied by using nocodazole and colchicine. Interestingly in the presence of 
nocodazole or colchicine the β-tubulin in virus-infected cells could still 
re-polymerize into long tubular structures in the cytoplasm of infected cells (Fig 
6.7E). Furthermore staining of such cells with anti-viral antibodies showed that viral 
protein did localize with these tubular structures but use of mono-specific anti-NSP4 
sera showed that NSP4 did not specifically localize to these structures (Fig 6.8). 
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Figure 6.7: Virus induced microtubule re-polymerization in the presence of nocodazole. 
BSC-1 cells, with or without viral infection at an MOI of 10, were treated with nocodazole from 0 hpi. 
At 10 hpi cells were fixed and stained using polyclonal mouse anti-β-tubulin antibody followed by 
Alexa-488-conjugated goat-anti-mouse antibody and nuclei were stained with DAPI all as described 
in Materials and Methods. (A) Overview of an intact microtubular network in a control cell monolayer 
without viral infection or nocodazole treatment. The white square in panel A marks a region that is 
enlarged in panel B. (C) Complete destruction of the microtubular network following nocodazole 
treatment in uninfected cells. The white square in panel C marks a region that is enlarged in panel D. 
(E) Reformation of de-polymerized microtubules into long tube structures in the cytoplasm of the cell 
following viral infection and in the continuing presence of nocodazole. Arrow indicates a reformed 
microtubular tube. A magnification bar of 10 µm is present in the bottom right of each image. 
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Figure 6.8: Colocalization of reformed tubular structure with viral proteins but not NSP4 in 
cells treated with nocodazole and infected with virus at 10 hpi. 
BSC-1 cells, were infected with virus at an MOI of 10, and overlaid with medium containing 
nocodazole and cultured at 37ºC for 10 hours before being fixed as described in Materials and 
Methods. Cells were stained with either a polyclonal rabbit antisera against viral structural proteins or 
a polyclonal mono-specific NSP4 sera followed by Alexa-594-conjugated goat-anti-rabbit antibody as 
described in Materials and Methods. Microtubules were stained with a polyclonal mouse 
anti-β-tubulin antibody followed by Alexa-488-conjugated goat-anti-mouse antibody, finally nuclei 
were stained with DAPI all as described in Materials and Methods. (A) Green fluorescent channel 
showing reformed microtubular bundles in virus-infected cells in the continued presence of 
nocodazole. (B) Red fluorescent channel showing the localization of viral proteins to tubular 
structures. (C) Merge of Panels A and B showing colocalization of microtubular bundles and viral 
proteins in yellow. (D) Green fluorescent channel also showing reformed microtubular bundles in 
virus-infected cells in the continued presence of nocodazole. (E) Red fluorescent channel showing 
NSP4 staining in virus-infected cells. (F) Merge of Panels D and E showing the absence of 
colocalization of microtubular bundles and NSP4. Arrow indicates a bundle containing both tubulin 
and viral protein. A magnification bar of 10 µm is indicated in the bottom right corner of each image.
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6.2.6 Kinetics of Nocodazole Induced Microtubular Tubes In Virus-Infected 
Cells 
The observation on reformed microtubule tubes after treatment with nocodazole or 
colchicine in infected cells indicated that accumulation of viral proteins following 
viral replication led to the aggregation of microtubules into tubular structures even in 
the presence of microtubule inhibitors. Thus to further support the hypothesis that 
aggregation of microtubules was a result of accumulation of viral proteins following 
viral replication, studies on these re-assembled microtubules were conducted. To do 
this BSC-1 cells infected with virus were fixed at different times post infection and 
examined by confocal microscopy. This showed that short tubes containing both 
β-tubulin and viral proteins could first be detected in about 1% of infected cells at 6 
hpi (Fig 6.9A-F). At 8 hpi more tubes of medium length were seen in the cytoplasm 
of about 5% of infected cells (Fig 6.9G-I). A large number of long tubes were 
evident in the cytoplasm of about 40% of infected cells at 10 hpi (Fig 6.9J-L). These 
observations demonstrated that the formation of the tubulin containing tubes in 
virus-infected cells treated with nocodazole was a gradual process associated with 
the accumulation of viral proteins. It also showed the ability of viral proteins to cause 
aggregation of free tubulin generated in cells expressing NSP4 even when treated 
with nocodazole. 
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Figure 6.9: Kinetics of formation of microtubule and viral proteins containing bundles in 
virus-infected BSC-1 cells. 
BSC-1 cells, were infected with rotavirus at an MOI of 10, and treated with nocodazole from 0 hpi. 
Virus-infected cell monolayers were fixed at different times post infection as described in Materials 
and Methods. Viral proteins were stained with a polyclonal rabbit antisera against viral structural 
proteins followed by Alexa-594-conjugated goat-anti-rabbit antibody as described in Materials and 
Methods. Microtubules were stained with a polyclonal mouse anti-β-tubulin antibody followed by 
Alexa-488-conjugated goat-anti-mouse antibody. Finally nuclei were stained with DAPI all as 
described in Materials and Methods. Panels A, B and C show no detectable microtubules or viral 
protein containing tubes at 4 hpi. Panels D, E and F show very short tubes indicated by arrows could 
be detected in about 1% of infected cells at 6 hpi. Panels G, H and I show medium length tubes were 
clearly seen in about 5% of infected cells at 8 hpi. Panels J, K and L show longer tubes were evident 
in about 40% of infected cells at 10 hpi. A magnification bar of 10 µm is indicated in the bottom right 
corner of each image.
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6.2.7 Effect of Cycloheximide and Tunicamycin Treatment On The Formation 
of Tubulin Containing Tubes Seen in Virus-infected Cells Treated With 
Nocodazole 
The association of viral proteins with tubulin containing tubes in virus-infected cells 
treated with nocodazole implies that they have an important role in the re-formation 
of microtubular tubes. The involvement of glycosylation in the process of forming 
these tubes was also studied, even though no colocalization of NSP4 with the tubes 
had been detected. To do this virus-infected BSC-1 cells were overlaid with medium 
containing nocodazole. Medium containing either cycloheximide, an inhibitor of 
protein synthesis, or tunicamycin was then added to cell monolayers at different 
times post infection. Cell monolayers were fixed, stained with anti-virus antibody 
and β-tubulin antibody, and examined by confocal microscopy. The use of 
cycloheximide showed that formation of tubes containing viral structural proteins 
was blocked when it was added before 8 hpi (Fig 6.10B). This indicated that viral 
protein synthesis was important for tubes containing re-polymerized β-tubulin. 
Treatment with the glycosylation inhibitor tunicamycin at any time post infection 
completely inhibited formation of the reassembled microtubular tubes (Fig 6.11). 
This suggested inhibition of glycosylation could affect the formation of microtubular 
tubes in virus-infected cells treated with nocodazole (Fig 6.11D) but did not 
significantly affect the formation of virus structural proteins containing tubes (Fig 
6.11E). This result is reminiscent of that seen in NSP4 transfected cells, where 
glycosylation was found to be dispensable for disruption and re-polymerization of 
microtubules. However the difference here was that the virus-infected cells were 
treated with tunicamycin which not only affected glycosylation of NSP4 but also 
glycosylation of cellular and other viral proteins. Thus there was no clear correlation 
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between observations done in cells transfected with constructs encoding different 
glycosylation version of NSP4 and virus-infected cells treated with nocodazole and 
tunicamycin. 
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Figure 6.10: Inhibition of the assembly of viral proteins containing tubes in virus-infected 
BSC-1 cells treated with both nocodazole and cycloheximide. 
BSC-1 cells were infected with rotavirus at an MOI of 10 and treated with nocodazole. Culture media 
were replaced by cycloheximide (20 µg/ml) containing media at 6, 8 and 9 hpi. At 10 hpi cells were 
fixed and viral proteins were stained with a polyclonal rabbit antisera against viral structural proteins 
followed by Alexa-594-conjugated goat-anti-rabbit antibody (red staining) as described in Materials 
and Methods. Nuclei were stained with DAPI all as described in Materials and Methods. Panel A 
shows a complete inhibition of the formation of viral proteins containing tubes in a virus infected and 
nocodazole-treated cell with treatment of cycloheximide at 6 hpi. Panel B shows that block of viral 
protein synthesis resulted in formation of short viral proteins containing tubes in a virus infected and 
nocodazole-treated cells with cycloheximide treatment at 8 hpi. Panel C shows a great number of long 
viral proteins containing tubes were observed in a virus infected and nocodazole-treated cell with 
treatment of cycloheximide at 9 hpi. Arrowhead indicates a short viral proteins containing tube. 
Arrow indicates a long viral proteins containing tube. A magnification bar of 5 µm is present in the 
bottom right corner of each image. 
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Figure 6.11: Inhibition of the assembly of microtubular tubes in virus-infected BSC-1 cells 
treated with both nocodazole and tunicamycin. 
BSC-1 cells infected with rotavirus at an MOI of 10 and treated with nocodazole were cultured in 
media with or without tunicamycin at 0 hpi. At 10 hpi cells were fixed and viral proteins were stained 
with a polyclonal rabbit antisera against viral structural proteins followed by Alexa-594-conjugated 
goat-anti-rabbit antibody as described in Materials and Methods. Microtubules were stained with a 
polyclonal mouse anti-β-tubulin antibody followed by Alexa-488-conjugated goat-anti-mouse 
antibody. Finally nuclei were stained with DAPI all as described in Materials and Methods. Panel A 
shows the formation of microtubular tubes in cells infected with virus and treated with nocodazole. 
Panel B shows the formation of viral proteins containing tubes in virus-infected cells and treated with 
nocodazole. (C) Merge of Panels A and B showing colocalization of both microtubules and viral 
proteins in tube structures. Panel D shows inhibition of the formation of microtubular tubes in 
virus-infected cells treated with both nocodazole and tunicamycin. Panel E shows the formation of 
viral proteins containing tubes could still be detected in virus-infected cells treated with both 
nocodazole and tunicamycin. (F) Merge of Panels D and E showing only the formation of viral 
proteins containing tubes could be detected in virus-infected cells treated with both nocodazole and 
tunicamycin. A magnification bar of 10 µm is present in the bottom right corner of each image.
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6.3 Conclusions 
The experiments reported in this chapter focused on analyzing the cellular skeleton 
(primarily microtubular network) in cells expressing NSP4 in isolation and in 
virus-infected cells. BSC-1 cells transfected with either glyco+ or glyco- NSP4 
displayed disassembly of the microtubular network from the centre of the cytoplasm 
and its re-polymerization into ring-like structures at the cell periphery. This function 
of NSP4 was shown to be independent of both glycosylation of the protein and 
increases of intracellular calcium levels stimulated by expression of NSP4. In 
contrast other studies using polarized caco-2 cells showed that intracellular calcium 
levels were important for destruction of the microtubular network in infected cells 
(Brunet et al., 2000b). Our study used a different cell line (i.e. BSC-1 cells) for 
transfection and infection which might account for the differences seen. Further 
studies analyzing the role of the centrosome in cells expressing NSP4 following 
recovery from treatment with the inhibitor of centrosome function, nocodazole, 
showed that the microtubular network could not reform from a microtubular 
polymerization centre (i.e. centrosome) suggesting that either the functional 
disruption of centrosome or that the speed of microtubular polymerization from the 
centrosome was slower than its de-polymerization caused by the expression of NSP4. 
A similar pattern of redistribution of the microtubular network has been seen in 
apoptotic cells (Moss et al., 2009; Sanchez-Alcazar et al., 2007), however neither 
apoptosis nor necrosis were detected in 293T cells expressing NSP4 for 48 hours. 
This implied that expression of NSP4 was sufficient to trigger de-polymerization of 
the microtubular network and might employ a different mechanism to that found 
initially in apoptotic cells. A recent study focusing on microtubular disruption by 
viral infection revealed a role of NSP2 in sequestrating tubulin molecules which lead 
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to de-polymerization of microtubules throughout the cytoplasm, but this did not start 
from the centre of cells (Martin et al., 2010). The pattern of disrupted microtubular 
network seen in NSP4 transfected cells was very similar to that seen in virus infected 
cells i.e. they both initiated microtubular de-polymerization from the centre of cell 
and induced re-polymerization at cell periphery, suggesting that NSP4 alone might 
act as the main factor in de-polymerizing the microtubular network whilst NSP2 
possibly enhanced the effect of de-polymerization by sequestrating tubulin molecules 
in infected cells. 
In our study the relevance of the NSP4 induced microtubular network destruction 
seen in transfected cells to the situation in virus infection was also examined. 
Virus-infected cells consistently showed a pattern of microtubular modification 
involving both disassembly of microtubules from the centre of the cell and 
re-polymerization at the cell periphery. 
In addition to using antibodies to detect the cytoskeleton in infected cells, attempts 
were made to detect the cytoskeleton in cytoplasmic extrusions found in both NSP4 
transfected and virus-infected cells. Using double antibody staining no convincing 
evidence of cytoplasmic extrusions were seen in virus-infected cells, but it was 
suspected that this may have seen due to the fragility of these extrusions. Consistent 
with this, when single antibody staining of microtubular network and chemical 
staining of actin filament was used, cytoplasmic extrusions containing microtubules 
and actin filaments were clearly seen in virus-infected cells. Subsequent inhibitor 
experiments using either nocodazole or colchicine for β-tubulin or CytoD for F-actin 
blocked the generation of cytoplasmic extrusion in virus-infected cells. This further 
supported the hypothesis that the virus employs microtubules and actin filaments to 
provide trafficking of molecules and physical support of the cytoplasmic extrusions. 
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Interestingly when tubulin inhibitors were used, de-polymerized microtubules were 
rearranged to form long tubes in the cytoplasm of virus-infected cells. Colocalization 
of viral proteins excluding NSP4 with these long microtubular tubes was also 
demonstrated, indicating their participation in the formation of these tubes. 
Consistent with this, inhibition of viral protein synthesis using cycloheximide before 
8 hpi completely blocked the formation of both viral proteins and microtubules 
containing tubes. A tunicamycin block was also used in these nocodazole 
experiments to investigate the role of glycosylation in the formation of these tubes. 
This treatment of cells inhibited the formation of microtubular tubes but appearance 
of tubes containing viral proteins was still evident at 10 hpi. The inhibition of 
microtubular tubes by treatment of tunicamycin suggested the potential involvement 
of glycosylation of NSP4 in the formation of microtubular tubes. 
Taken together our studies on the cytoskeletal network suggested that after viral 
infection, expression of NSP4 in infected cells leads to the destruction of both the 
microtubular (in this study) and actin networks (Berkova et al., 2007). The 
destruction of microtubular network by NSP4 is independent of its glycosylation and 
its ability to raise intracellular calcium levels. This break down process can be 
greatly enhanced by viral proteins through their promoting aggregation of free 
tubulin. This microtubular disruption appears to be irreversible and eventually 
contributes to overall viral pathology. 
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Chapter 7 
Yellow Fluorescent Protein Complementarity Assay 
For Capturing Intracellular Partners For NSP4 
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7.1 Introduction 
The observation of morphological changes associated with the expression of 
glycosylated NSP4 in transfected cells matching those seen following virus infection 
suggested that glycosylated NSP4 was able to interact with cellular metabolic 
processes. These changes were not seen with non-glycosylated NSP4 and this 
prompted an investigation of possible interactions between glycosylated NSP4 and 
cellular proteins. To do this use was made of a two hybrid type assay based on 
yellow fluorescent protein complementation (YFP-PCA). YFP-PCA involves 
splitting YFP into two fragments (i.e. N-terminal half and C-terminal half of YFP) 
that can spontaneously fold to generate functional YFP if the two fragments form a 
complex. Interaction of two proteins under study each fused to one of the YFP 
fragments is essential to bring these two YFP fragments together to generate 
fluorescence (Nyfeler et al., 2005). In this study, NSP4 was fused to fragment 1 of 
YFP (i.e. N-terminal half) as the ‘bait’ fusion protein and a cDNA library was fused 
to fragment 2 of YFP as ‘prey’. Following transfection of these two plasmids into 
cells yellow fluorescence positive cells were sorted by FACS analysis. cDNAs that 
putatively encoded cellular proteins interacting with NSP4 were recovered and 
analysed in a cyclic panning process (Fig 7.1). 
The advantage of the YFP-PCA assay in screening for cellular proteins interacting 
with full length NSP4 is that it allows the search to be done in live cells following 
detection of protein-protein interactions in a natural cellular environment. This 
approach was not practicable in our previous studies because screens based on 
traditional two-hybrid assays required growth of cell populations showing positive 
interaction before isolation of the cellular cDNA could be undertaken. 
Expression of full length NSP4 is a potent toxin for mammalian, yeast and bacterial 
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cells. To avoid this problem a truncated NSP4 has usually been employed in this type 
of experiment (Boshuizen et al., 2004). However the YFP PCA assay enables clear 
detection of interaction indicated by YFP fluorescence in individual cells at only 
24-hour post transfection allowing isolation of the cells and extraction of plasmid 
DNAs that encode interacting proteins. This assay has also been reported to enhance 
the intensity of fluorescence from positive interactions by trapping and accumulating 
the YFP complex (Nyfeler et al., 2005). This latter property should allow the assay 
to be used for screening of transient and weak interactions between NSP4 and 
cellular proteins. 
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Figure 7.1: Strategy of the YFP-PCA assay system for screening interactions of NSP4 with 
cellular partners. 
Panel A: Schematic representation of the YFP-PCA assay. The interaction of two test proteins brings 
two non-fluorescent fragments of YFP fused to those proteins into close proximity to reconstitute 
functional YFP. To study interactions of NSP4 with cellular proteins, YFP1 was fused to NSP4 as bait 
and YFP2 was fused to a cDNA library constructed from BSC-1 cellular mRNA as prey. 
Panel B: The YFP1-NSP4 was constructed using the ampicillin resistant pcDNA3 cloning vector. The 
YFP2-cDNA was expressed using the kanamycin resistant pEYFP-N1 cloning vector. 
Panel C: Optimized flow chart of YFP-PCA based screening of a cDNA library for cellular interaction 
partners of NSP4. 
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7.2 Results 
7.2.1 Construction of YFP-PCA System for Studying Interaction of NSP4 
The YFP-PCA system was established using the pcDNA3 cloning vector with YFP 
fragment 1 (YFP1, amino acids 1–158) and fragment 2 (YFP2; amino acids 159 –239) 
engineered into two separate plasmid constructs. An ER translocation signal 
sequence from calreticulin (SScal) was fused to the N terminus of each YFP fragment. 
A linker sequence encoding 10 amino acids (GGGGS)2 was also fused to the C 
terminus of each YFP fragment. Downstream of these linker sequence cDNAs 
encoding ERGIC-53 (endoplasmic reticulum Golgi intermediate compartment) and 
MCFD2 (multi-coagulation factor deficiency protein) were inserted to generate 
positive controls for the assay (Nyfeler et al., 2005). Subsequently the 
YFP2-MCFD2 construct was sub-cloned into the pEYFP-N1 cloning vector 
replacing the EYFP from the vector to allow exploitation of kanamycin resistance 
based selection. In this study the ERGIC-53 and MCFD2 sequences were initially 
replaced by the coding sequences of NSP4, rotavirus VP4 and rotavirus VP6. In 
addition a cDNA library generated from rotavirus permissive BSC-1 cells was 
cloned downstream of the C terminus of YFP fragment 2 in three different reading 
frames to ensure expression of proteins from inserts present in the cDNA library (Fig 
7.2). 
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Figure 7.2: Schematic representation of the fusion constructs used in the YFP-PCA assay. 
SScal is the signal sequence of calreticulin to ensure more efficient translocation of the fusion protein 
in the ER. Linker is a 10 amino acid sequence (GGGGS)2. The YFP1 fragment was in the pcDNA3 
cloning vector with ampicillin resistance and the YFP2 fragment was in the pEYFP-N1 cloning vector 
with kanamycin resistance. The cDNA library as cloned into three different reading frames in relation 
to the YFP2 linker sequences. All the cloning experiments to generate these constructs were carried 
out as described in Materials and Methods. 
 172 
7.2.2 Interaction of YFP-PCA Constructs for Studying NSP4 
The plasmid constructs described in the previous section were co-transfected into 
293T cells. After 24 hours of incubation cells were first examined by UV-light 
microscopy and then subjected FACS analysis. To test the utility of the assay for 
examining NSP4’s interactions a control experiment in which NSP4 was fused to 
both YFP1 and YFP2 was examined both by optical observation and FACS analysis. 
This showed that YFP1-NSP4 was able to interact with YFP2-NSP4 to produce an 
intense YFP fluorescence in both rotavirus non-permissive cells (293T cells) and 
permissive cells (BSC-1 cells) (Fig 7.3, 7.4, 7.5 and 7.6). By contrast positive 
interactions were not seen between YFP1-NSP4 and YFP2-VP4 or YFP2-VP6 (data 
not shown). The failure to see positive interactions between YFP1-NSP4 and 
YFP2-VP4 or YFP2-VP6 may reflect the fact that the original interactions reported 
between these two rotavirus structural proteins and the C terminal half of NSP4 
occurred in the cytoplasm and not in the ER lumen where YFP fragment 1 was 
presented. Having shown that the YFP-PCA assay can be used to study NSP4 
interaction with itself the requirement of glycosylation in such interactions was 
examined. For this the N-linked glycosylation inhibitor tunicamycin was added to the 
culture medium after co-transfection of YFP1-NSP4 and YFP2-NSP4. Subsequent 
analysis using UV-light microscopy and FACS analysis showed that this inhibitor 
dramatically reduced the intensity of fluorescence suggestive of an important role for 
glycosylation in the NSP4-NSP4 interaction (Fig 7.3E, 7.4E and 7.6). However the 
use of tunicamycin, a broad-spectrum glycosylation inhibitor, did not in itself 
provide definitive support for the involvement of glycosylated NSP4 in the 
interaction. Therefore manipulation of the mutated NSP4 lacking the N-linked 
glycosylation sites generated for experiments reported in Chapter 3 into the YFP 
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vectors should be an early future experimental priority to definitively substantiate the 
results obtained in this study. 
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Figure 7.3: Interaction between YFP1-NSP4 and YFP2-NSP4 in non-permissive 293T cells. 
Cells were transfected with plasmids as described in Materials and Methods. At 24-hour post 
transfection cells were observed with UV-light microscopy as described in Materials and Methods. (A) 
Cells transfected with YFP1-NSP4 alone. (B) Cells transfected with YFP2-NSP4 alone in B. (C) Cells 
transfected with YFP1-NSP4 and YFP2. (D) Cells transfected with YFP1 and YFP2-NSP4. Panel E 
shows cells transfected with both YFP1-NSP4 and YFP2-NSP4 with the positive fluorescence 
indicating the interaction of NSP4 with itself. Panel F shows cells transfected with YFP1-NSP4 and 
YFP2-NSP4 and then treated with tunicamycin (5µg/ml), the reduced fluorescence compared to that 
seen in the absence of tunicamycin treatment being evident. Images were obtained at magnification of 
40×.
 175 
 
 
 
 
 
 
 176 
 
 
 
 
 
 
 
Figure 7.4: Interaction between YFP1-NSP4 and YFP2-NSP4 in rotavirus permissive BSC-1 
cells. 
Cells were transfected with plasmids as described in Materials and Methods. At 24 hours post 
transfection culture cells were observed with UV-light microscopy as described in Materials and 
Methods. (A) Cells transfected with YFP1-NSP4 alone. (B) Cells transfected with YFP2-NSP4 alone. 
(C) Cells transfected with YFP1-NSP4 and YFP2. (D) Cells transfected with YFP1 and YFP2-NSP4. 
Panel E shows cells transfected with both YFP1-NSP4 and YFP2-NSP4 with the positive fluorescence 
indicating the interaction of NSP4 with itself. Panel F shows cells transfected with YFP1-NSP4 and 
YFP2-NSP4 and then treated with tunicamycin (5µg/ml), the reduced fluorescence compared to that 
seen in the absence of tunicamycin treatment being evident. Images were obtained at magnification of 
40×. 
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Figure 7.5: Confocal examination of the interaction between YFP1-NSP4 and YFP2-NSP4 in 
BSC-1 cells. 
Cells were co-transfected with YFP1-NSP4 and YFP2-NSP4 as described in Materials and Methods. 
At 24 hours post transfection culture cells were fixed, nuclei stained with DAPI and cells examined by 
confocal microscopy as described in Materials and Methods. Panel A low magnification of cells 
expressing YFP1-NSP4 and YFP2-NSP4 showing that the interaction resulted in fluorescence in spots 
distributing in the cytoplasm. Panel B A higher magnification image of a cell showing the NSP4 
self-interaction. A magnification bar of 10 µm is indicated in the bottom right corner of each image.
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Figure 7.6: Disruption of the self-interaction of NSP4 by treatment of 293T cells with 
tunicamycin. 
Cells were transfected with the indicated plasmid constructs and incubated in the presence or absence 
of tunicamycin as described in Materials and Methods. Subsequent FACS analysis was used to 
measure the mean value of fluorescence intensity in each sample as described in Materials and 
Methods. The mean value of fluorescence intensity in cells transfected with YFP1-NSP4+YFP2-NSP4 
was set at 100%. Addition of tunicamycin to the culture medium of cells transfected with YFP1-NSP4 
and YFP2-NSP4 decreased the mean value of fluorescence intensity by ~80%.
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7.2.3 Optimization of Interactions Between YFP1-NSP4 and YFP2-cDNAs 
To test the interaction between NSP4 and the cDNA library, 293T cells were 
co-transfected with 2 µg of the YFP1-NSP4 construct and 2 µg of the YFP2-cDNA 
library construct. FACS analysis at 24 hours post transfection showed that 1%-5% of 
the 20,000 cells analysed were positively fluorescing. By contrast only a few cells 
were detected in negative controls i.e. cells transfected with either YFP1-NSP4 alone, 
YFP2-cDNA alone or YFP1-NSP4 and YFP2. This preliminary experiment showed 
that detection of the fluorescence signal from interactions between YFP1-NSP4 and 
clones in the YFP2-cDNA library using FACS analysis could be distinguished from 
background fluorescence noise. 
To optimize transfection conditions in the screen different concentrations of 
YFP2-cDNA (2µg, 1.5µg, 1µg, 0.8µg, 0.5µg, 0.2µg and 0.1µg) were co-transfected 
with 2 µg of YFP1-NSP4. This optimization was necessary as transfection of large 
amounts of DNA increased the possibility that each transfected cell receiving a 
positive cDNA construct would also receive a larger number of irrelevant constructs 
leading to more rounds of screening being required to isolate/purify a positive cDNA 
construct. This optimization experiment showed that only 1µg of YFP2-cDNA for 
each transfection produced equal numbers of fluorescent cells to that of 2µg of 
YFP2-cDNA. When the amount of YFP2-cDNA used was less than 1 µg, the number 
of fluorescent cells reduced with the clearest detection of positively fluorescent cells 
above background fluorescent noise being achieved at 0.2µg of YFP2-cDNA for 
each transfection. Therefore 0.2µg of YFP2-cDNA plasmid i.e. 1/10 of that for 
YFP1-NSP4 was used in all future screening assays. This lowered the percentage of 
fluorescence-positive cells to 0.1%-0.5% and minimized the number of plasmid 
copies in individual transfected cells to favor subsequent recovery of the plasmids 
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generating positive interaction (Fig 7.7). Following co-transfection of 2µg of 
YFP1-NSP4 and 0.2µg of YFP2-cDNA pools with insert of either 1-2kb or over 2kb 
into 293T cells in a 12-well plate, cells in 4 wells of each pool were used to isolate 
1000 positively fluorescing cells using flow cytometry in the actual screen. 
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Figure 7.7: FACS analysis of 293T cells transfected with YFP1-NSP4 and YFP2-cDNA. 
Cells were transfected with indicated bait and prey DNA constructs and analysed using FACS at 24 
hours post transfection as described in Materials and Methods. Panel A Control i.e.: non-transfected 
cells showing only showed 0.035% (i.e. 7 cells) in the gated area. Panel B Cells transfected with 
YFP1-NSP4 and YFP2 showing 0.05% (i.e. 10 cells) in gated area. Panel C Cells transfected with 
YFP1-NSP4 and YFP2-cDNA pool with inserts ranging from 1 kb to 2 kb showing 0.22% (i.e. 45 
cells) in the gated area. Panel D Cells transfected with YFP1-NSP4 and YFP2-cDNA pool with inserts 
over 2 kb showing 0.4% (i.e. 80 cells) in the gated area. 
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7.2.4 Recovery of c-DNA Containing Plasmids from Screen 
1000 sorted fluorescent cells were isolated from each positive transfection sample 
and the cells lysed, the plasmid DNA extracted and amplified by transformation back 
into E. coli. To maximize the number of bacterial colonies harvested per 1000 cells 
three different plasmid extraction methods were tested. In the first, heat was used to 
boil the transfected cells for 5 mins followed by ethanol precipitation of total cellular 
DNA. This procedure failed to yield any colonies on antibiotic selective plates. The 
second method used Hirt extraction (Grillner and Blomberg, 1984), which is known 
to extract low molecular weight DNA from eukaryotic cells. This method produced 
hundreds of bacterial colonies on selective plates. However it was less efficient than 
the final method used which was the standard mini-prep kit (Qiagen) normally 
employed for isolating plasmid DNA from bacterial cells which gave approximately 
twice as many bacterial colonies from each extraction as the Hirt extraction. 
Therefore the mini-prep kit and ethanol precipitation were used to extract plasmid 
DNA from 293T cell in this study. It is also important to note that the YFP-cDNA 
library was based on the use of pEYFP-N1 as the cloning vector. This was done to 
favour recovery of YFP2-cDNA from transfected cell extracts as it allowed 
differentiation from the YFP1-NSP4 that was cloned into the pcDNA3 vector which 
carries an ampicillin resistance marker. This allowed the recovery of 220 kanamycin 
resistant bacterial colonies from the plasmid DNA extracted from 1000 fluorescing 
cells in the actual screen. 
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7.2.5 Use of YFP2-NSP4 to Examine the Sensitivity of the YFP-PCA Screen 
The sensitivity of the YFP-PCA screen was studied following optimization of each 
step in the screen. For this the YFP2-NSP4 construct was mixed with YFP2 construct 
in a ratio of 1/105 (i.e. 1 ng of YFP2-NSP4 construct mixed with 100 µg of YFP2 
construct). The reason for the use of the dilution was because that ~106 bacterial 
colonies were collected in our construction of the YFP2-cDNA library. If 10 colonies 
harbored the correct cDNA inserts for positive hits, these positive hits in the library 
then accounted for 1/105. Co-transfection of 200 ng of the mixed plasmids (i.e. YFP2 
and YFP2-NSP4 constructs) with 2 µg of the YFP1-NSP4 in 293T cells resulted in 
0.1%-0.5% of fluorescent cells similar to that seen in cells transfected with 
YFP2-cDNA and YFP1-NSP4. 1000 cells were then collected and extracted for 
plasmids following isolation of fluorescing cells. After electroporation of the 
plasmids into bacterial cells, 100 colonies were isolated. Re-transfection of these 100 
plasmids with the YFP1-NSP4 in 24-well plates for 24-hour showed two out of 100 
gave positive signals. Sequencing of these two clones identified that they were 
YFP2-NSP4. This control experiment (Fig 7.8) provided some evaluation of the 
functionality and sensitivity of the YFP-PCA assay established in this study. 
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Figure 7.8: Examination of the sensitivity of the YFP-PCA screen. 
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7.2.6 Re-screening of Positive c-DNA and Final Identification of Cloned Inserts 
Purification and re-transfection of the 220 plasmids (see section 7.2.4) into 293T 
cells with YFP1-NSP4 using a 96-well plate format showed 18 of them gave positive 
fluorescence and 39 of them gave weak fluorescence. However when re-transfection 
of the 57 fluorescent positive plasmids with YFP1-NSP4 in 24-well plates was 
carried out, only the 18 positives showed clearly positive fluorescence. Sequencing 
of these 18 plasmids showed that two of them encoded proteins (sterol regulatory 
element (SRE) binding protein and lysine specific demethylase 5C) and the other 16 
plasmids only encoded short peptides downstream of YFP fragment 2. To investigate 
the possibility that the two proteins identified in this screen were actually interacting 
with the YFP fragment 1 region of the fusion protein rather than the NSP4 region, 
these two plasmid constructs were re-transfected with YFP1 construct. Figure 7.9 
shows that this gave positive fluorescence in both cases showing that the 
identification of these two proteins represented false positives in the assay. 
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Figure 7.9: Interactions between YFP1 and two cDNA identified in the YFP-PCA screen. 
Cells transfected with the indicated plasmid DNA constructs were examined using UV-light 
microscopy at 24 hours post transfection as described in Materials and Methods. Panel A Cells 
transfected with YFP1-NSP4 and YFP2-SRE binding protein showed positive fluorescence indicative 
of protein-protein interaction. Panel B Co-transfection of YFP1 and YFP2-SRE binding protein also 
showed positive fluorescence suggesting that the interaction occurred between YFP1 and SRE binding 
protein rather than NSP4 and SRE binding protein. Panel C Co-expression of YFP1-NSP4 and 
YFP2-lysine specific demethylase 5C resulted in positive detection of fluorescence. Panel D 
Co-transfection of YFP1 and YFP2-lysine specific demethylase 5C demonstrated that the interaction 
also occurred between YFP1 and lysine specific demethylase 5C rather than NSP4 and lysine specific 
demethylase 5C. Images were taken at magnification of 40×.
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7.3 Conclusions 
The experiments described in this chapter were aimed at identifying interactions 
between cellular proteins and rotavirus NSP4. To achieve this an YFP-PCA assay 
was exploited. This assay had the advantage that it allowed screening of interactions 
using full length NSP4 in live cells to identify protein-protein interactions. To 
establish the assay YFP2 in pcDNA3 was cloned into a kanamycin resistant cloning 
vector pEYFP-N1. And a full-length c-DNA for NSP4 the UKtc strain of rotavirus 
was fused in frame to the C-terminus of YFP1 and YFP2. Subsequent co-expression 
of YFP1-NSP4 and YFP2-NSP4 led to detection of positive yellow fluorescence in 
both 293T and BSC-1 cells. 
The capability of the YFP-PCA assay to study involvement of glycosylation in the 
self-interaction of NSP4 was examined. To do this tunicamycin was added to the 
culture medium of cells transfected with YFP1-NSP4 and YFP2-NSP4. This 
treatment dramatically decreased the intensity of fluorescence by ~80%, suggesting 
that glycosylation is important for self-interaction of NSP4. Confirmation of this 
suggestion could be achieved through the manipulation of the glyco- mutants 
constructed in Chapter 3 into the YFP-PCA assay and this should be an important 
priority as work on NSP4 function moves forward. 
To construct the YFP2-cDNA library mRNA from BSC-1 cells was extracted and 
converted into dsDNA (double-stranded DNA). The dsDNA was fused to YFP 
fragment 2 in three different reading frames to increase the chance of correct 
expression of all the c-DNAs present in the c-DNA library. Co-expression of 
YFP1-NSP4 and YFP2-cDNA was carried out in 293T cells and resulted in the 
detection of 1%-5% of fluorescent cells. In the screen carried out to identify 
interaction partners the amount of YFP2-cDNA was reduced to a ratio of 1/10 of that 
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of YFP1-NSP4 to minimize the number of copies of YFP2-cDNA in each cells. 
Although this also reduced the detection of fluorescent cells to 0.1%-0.5%, it 
increased the number of plasmid DNAs harboring truly positive interaction 
candidates for NSP4 following plasmid recovery on kanamycin plates. Following 
FACS-based cell isolation of 1000 fluorescence-positive cells, and extraction of 
plasmid DNA and its electroporation into E .coli, 220 kanamycin resistant colonies 
were obtained. Co-transfection of these ‘rescued’ YFP2-cDNA plasmids with 
YFP1-NSP4 showed that 18 out of 220 plasmids demonstrated clear positive 
fluorescence indicating positive interactions. However following sequence analysis 
only two out of 18 plasmids encoded proteins. Unfortunately these two proteins were 
subsequently shown to interact with YFP1 rather than NSP4. Despite isolation of 
false positive clones in the screen, the control experiment analyzing the sensitivity of 
the assay indicated the existing possibility to identify cellular partners of NSP4. For 
further screening, given weak fluorescence could be generated from false-positive 
clones, a threshold of fluorescent intensity could be set to distinguish real 
interactions (Nyfeler et al., 2008). Because the assay also identified cellular proteins 
interacting with YFP fragment 1 it is critical to test the interaction of the YFP 
fragment 1 and the isolated positive candidates. 
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Chapter 8 
Discussion 
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8.1 Introduction 
Rotavirus infection is a common cause of diarrhoea in young infants and children 
worldwide (Parashar et al., 2006). Studies of viral pathogenesis have shown that the 
virus primarily infects the tips of the villi in the small intestine of the gastrointestinal 
track. However it has been noted that early in the infection even when only a few 
epithelial cells are infected, the villi in a large area of the gut have become blunted 
and damaged prior to wide-spread distribution of the infection (Estes, 2001). An 
explanation for this observation was forthcoming following the identification of 
NSP4 as an enterotoxin (Bugarcic and Taylor, 2006; Zhang et al., 2000). The 
currently accepted mode for NSP4 action as an enterotoxin is that following 
synthesis, it is released from virus-infected cells. This secreted NSP4 is then 
postulated to bind to cellular receptors on surrounding uninfected cells and induce 
cytotoxic destruction of these cells (Seo et al., 2008). 
 
8.2 Intracellular Expression of Wild Type and Glycosylation Mutants of NSP4 
The early studies using pulse-chase analysis revealed that both unglycosylated NSP4 
precursor and fully glycosylated NSP4 could be detected in virus-infected cells 
(McCrae and McCorquodale, 1982). Furthermore following a 2-hour chase of 
pulse-labeled samples, most of the unglycosylated NSP4 remained unmodified. By 
contrast the unglycosylated precursor of VP7 could only be detected if N-linked 
glycosylation was specifically blocked (McCrae and McCorquodale, 1982). The 
observation of two stable forms of NSP4 in infected cells raises the possibility that 
these different forms of the protein may differ in terms of their functionality. 
A number of investigations have demonstrated that glycosylation is an important 
modification of NSP4. When expressed intracellularly, fully glycosylated NSP4 is 
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able to increase intracellular calcium levels (Tian et al., 1995; Tian et al., 1994). 
These elevated calcium levels have been shown to participate in a number of 
important events (formation of viroplasms, disruption of actin and microtubular 
networks, mediating DLP translocation from viroplasm into the ER lumen, 
distribution of other viral proteins and increased cytoplasmic membrane permeability) 
during the viral replication cycle (Berkova et al., 2007; Berkova et al., 2006; Diaz et 
al., 2008; Estes, 2001; Ruiz et al., 2005; Sen et al., 2007). Glycosylation has also 
been implicated as a requirement for secretion because only fully glycosylated NSP4 
is detectable in the culture medium of infected polarized caco-2 cells (Bugarcic and 
Taylor, 2006). Given the importance of glycosylation of NSP4 in viral replication a 
number of studies have been done regarding its importance for NSP4 function. 
However they have almost all focused on the use of the broad-spectrum N-linked 
glycosylation inhibitor tunicamycin. The disadvantage of using tunicamycin is that 
N-linked glycosylation of cellular proteins is also blocked. This side effect may 
change the function of these cellular proteins requiring N-linked glycosylation and 
hence cause misleading results. 
To avoid using tunicamycin for studying the functions of different forms of NSP4 we 
carried out PCR based site-directed mutagenesis to manipulate the coding sequence 
of NSP4, mutating two asparagines to alanines such that the mutated version of 
NSP4 would not be glycosylated. Comparison of the native and mutated version of 
NSP4 was carried out following expression from transfected plasmids in mammalian 
cells. The results showed that glycosylated NSP4 appeared to alter the cellular 
morphology of the transfected cells showing cytoplasmic extrusions at as early as 7.5 
hours post transfection in BSR-T7 cells. By contrast this alteration in cellular 
morphology was not seen in cells transfected with a plasmid expressing 
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unglycosylated NSP4, although observation at later time post-transfection did not 
show any evidence of these cytoplasmic extrusions in cells expressing either 
glycosylated or unglycosylated NSP4. In order to examine whether these changes in 
cellular morphology were a feature of expression of glycosylated NSP4 in a rotavirus 
permissive cell line, BSC-1 cells were transfected and monitored using confocal 
microscopy which showed that glycosylated NSP4 stimulated changes in cellular 
morphology at 24 hours post transfection. Furthermore as with BSR-T7 cells no 
change in cellular morphology was seen in BSC-1 cells transfected with 
unglycosylated NSP4. These observations suggested that fully glycosylated NSP4 
could modify cellular morphology promoting the formation of long cytoplasmic 
extrusions. Consistently long cytoplasmic projections have also been reported in 
fully confluent HEK 293 cells transfected with NSP4 constructs (Berkova et al., 
2007). Berkova et al. also showed that actin participates in the formation of the 
cytoplasmic projections in a calcium dependent manner, demonstrated by changes in 
the actin network being inhibited following normalization of calcium levels (Berkova 
et al., 2007). Although this study did not examine the effect of expression of 
unglycosylated NSP4 in cells (Berkova et al., 2007), nevertheless prevention of 
increases in intracellular calcium levels either by the use of tunicamycin or through 
the use of RNAi (RNA interference) silencing of NSP4 suggested that increases in 
the intracellular calcium concentrations required glycosylation of NSP4 in infected 
cells (Ruiz et al., 2005; Zambrano et al., 2008). Based on these reported experiments 
unglycosylated NSP4 can be speculated as not being able to increase intracellular 
calcium levels. Assuming this to be the case the unglycosylated NSP4 would not be 
expected to show the alteration in actin network found in cells expressing 
glycosylated NSP4. The data presented here show that only glycosylated NSP4 could 
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alter cellular morphology and hence supports the hypothesis that differential 
glycosylation of NSP4 influences its function. Our study also revealed that the 
changes in cellular morphology seen in transfected cells expressing glyco+ NSP4 
were found in virus-infected cells where cytoplasmic extrusions were seen at 10 hpi. 
This observation suggested that glyco+ NSP4 is responsible for the alteration in 
cellular morphology in infected cells. 
 
8.2.1 Future Work 
To validate the results obtained to-date, the glycosylation status of the NSP4 used in 
the study needs to be confirmed using sodium dodecyl sulphate polyacrylamide gel 
(SDS-PAGE). Furthermore our speculation that unglycosylated NSP4 cannot trigger 
increases in intracellular calcium levels will require validation. To do this, 
intracellular calcium indicators need to be employed to monitor calcium levels in 
cells transfected with an unglycosylated NSP4-GFP fusion protein. If these 
additional studies confirm the inability of unglycosylated NSP4-GFP to stimulate 
increases of intracellular calcium levels, then a dichotomy of function for the 
different forms of NSP4 will be established. 
 
8.3 Analyzing the Formation of Cytoplasmic Extrusions in Virus-Infected Cells 
Following the recognition of the cytoplasmic extrusions in ‘snapshot’ images of 
fixed samples, real time recording was employed to study the dynamics of their 
formation. To facilitate this an NSP4-GFP fusion protein was constructed and 
transfected into both BSR-T7 and BSC-1 cells. In BSR-T7 cells NSP4 specific 
antibody staining demonstrated that the GFP signal could be used to monitor 
intracellular localization of NSP4-GFP fusion protein. However cytoplasmic 
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extrusions were not observed in these experiments probably because visualization of 
the GFP signal required protein expression for 24 hours which was well beyond the 
7.5 hours post transfection time that cytoplasmic extrusions were seen in fixed cells. 
By contrast, in BSC-1 cells real time observation did confirm the presence of 
cytoplasmic extrusions at 24 hours post transfection. 
To observe cytoplasmic extrusions in virus-infected cells, cells were first transfected 
with a CMV-YFP construct which expressed YFP to allow the cell morphology of 
transfected cells to be monitored in real time. Using fluorescent confocal microscopy 
on these cells following their infection with virus, we were able to show the dynamic 
process of cytoplasmic extrusions projecting out from the infected cells at 14 hpi. 
However, photobleaching of the fluorescent protein and photo toxicity prevented 
YFP fluorescence being used for continuous monitoring of the extrusion process. 
Therefore transmission light confocal microscopy was employed to record the 
cytoplasmic extrusions. This minimized photo toxicity caused by the scanning laser 
and showed a clear dynamic growth of cytoplasmic extrusions with a growth speed 
of 2 µm/min being estimated. To exclude the possibility that these observations were 
not rotavirus specific or seen solely in apoptotic cells, control assays employing 
reovirus and PAC-1 were used. The results showed that cells treated with either 
reovirus or PAC-1 did not display the cytoplasmic extrusions found in 
rotavirus-infected cells. 
 
8.3.1 Future Work 
An important priority for future experiments is quantitation of the changes observed, 
that is measurement of the percentage of cells showing cytoplasmic extrusions at 
different times post infection. To do this, several selected viewing fields containing 
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20-30 virus-infected BSC-1 cells can be monitored using confocal microscopy. 
However in addition to doing these studies in BSC-1 cells they should also be 
performed in differentiated caco-2 cells. The latter are preferable because when fully 
differentiated they more closely resemble the cells that rotaviruses infect in vivo. 
 
8.4 Functioning of the Cytoplasmic Extrusion in Viral Infection 
The observation of cytoplasmic extrusions in infected cells led us to speculate that 
they may function to deliver material from infected cells to uninfected cells. To 
investigate this possibility, mixtures of virus-infected and uninfected cells separately 
tagged with Cell Tracker dyes were employed to follow the flow of cellular material 
from infected cells. No transfer of Cell Tracker dyes among uninfected cells was 
detected. However, the Cell Tracker dyes from virus-infected cells were found in 
vesicular structures scattered on the surface of uninfected cells following destruction 
of the cytoplasmic extrusions and these vesicles were subsequently internalized into 
uninfected cells. These experiments using Cell Tracker dyes provided support for the 
possibility that NSP4 was also transferred between cells through the cytoplasmic 
extrusions. Direct experimental evidence in support of this possibility was obtained 
using NSP4 specific antibody to stain NSP4 in the scattered vesicle structures on 
uninfected cells. These results have begun the process of unraveling a new 
mechanism for the spread of NSP4 cytotoxicity from virus-infected cells to 
surrounding uninfected cells. 
 
8.4.1 Future Work 
Future studies are clearly required to both confirm the observations made thus far 
and also extend analysis of the process. A start on this could involve using the 
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recently developed reverse genetic technology for rotaviruses (Troupin et al., 2010) 
to construct a recombinant virus which is able to express fluorescently tagged NSP4. 
The spread of NSP4 through cytoplasmic extrusions could then be monitored in 
virus-infected cells using real-time fluorescent confocal microscopy. The efficiency 
of the cytoplasmic extrusions in spreading NSP4 could also be determined using 
quantitative imaging (Piston et al., 1999). 
 
8.5 Microtubular Network in Cells Expressing NSP4 or Infected with Virus 
The cytoplasmic extrusions seen in infected cells implied that the cellular skeleton 
must be undergoing re-arrangement. The actin network in cells expressing NSP4 has 
already been studied (Berkova et al., 2007) and therefore we focused on analyzing 
the effect of expression of NSP4 on the microtubular network. Following expression 
of NSP4 in BSC-1 cells changes to the microtubular network were clearly evident at 
24 hours post transfection. The changes seen were glycosylation independent with 
the glycosylation mutant of NSP4 displaying the same pattern of disassembly of the 
microtubular network seen in wild type NSP4 transfected cells. Further analysis 
showed that the disassembly started from the centre of the cell, with a 
re-polymerization of microtubules occurring to produce a ring like feature at the 
periphery of the cell. This pattern of disassembly/reassembly was similar to that seen 
in virus infected cells suggesting that NSP4 functions to alter the microtubular 
network during the viral replication cycle. It has been reported that NSP2 induces 
microtubular de-polymerization through sequestration of free tubulin molecules to 
tubulin granules (Martin et al., 2010). However it is possible to speculate that it is 
actually NSP4 mediates the major changes in microtubular polymerization with 
NSP2 merely enhancing the effect by its binding to tubulin. Cells undergoing 
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apoptosis have also been reported to display disassembly of the microtubular 
network and polymerization of microtubules at the cell periphery (Sanchez-Alcazar 
et al., 2007) similar to that seen in our study. We therefore speculated that NSP4 
induced apoptosis might actually be the trigger for the observed changes in the 
microtubular network. However study of apoptosis and necrosis following 
expression of NSP4 showed that NSP4 did not trigger either apoptosis or necrosis, 
suggesting that apoptosis was not the pathway used by NSP4 to mediate changes in 
the microtubular network. 
Detection of β-tubulin and F-actin in the cytoplasmic extrusions suggested that these 
two proteins were involved in forming these extrusions. In support of this suggestion, 
the formation of cytoplasmic extrusions was inhibited following addition of chemical 
inhibitors of either tubulin or actin polymerization. Interestingly when the 
microtubule network was de-polymerized using nocodazole, the released 
microtubules were able to form striking long tubes in the cytoplasm of infected cells. 
Formation of these long microtubular tubes was inhibited by blocking the synthesis 
of viral proteins suggesting that they caused this phenomenon and thus were 
potentially capable of accumulating tubulin to enhance the effect of 
de-polymerization of microtubular network in infected cells. 
 
8.5.1 Future Work 
An important next step is to determine whether NSP4 is the only viral protein 
responsible for microtubular de-polymerization in infected cells. To achieve this, the 
effect of RNAi specific silencing of NSP4 on the integrity of the microtubular 
network can be examined. 
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8.6 Screening for Cellular Interaction Partners of NSP4 
The YFP-PCA assay described in the final results chapter established a system for 
screening cellular partners interacting with full length NSP4. The advantage of this 
screening assay was that it preserved both of the glycosylation sites in the N-terminal 
domain of NSP4 and many of the functional domains reported in C-terminal of NSP4. 
This contrasts with the truncated version of NSP4 with reduced cytotoxicity used in a 
previous report designed to capture cellular partners of NSP4 (Boshuizen et al., 
2004). Using a construct in which YFP1 was fused to the N-terminus of NSP4 we 
attempted to identify cellular proteins involved in the glycosylation of NSP4 or its 
intracellular trafficking. In the preliminary control experiments NSP4, VP4 and VP6 
were all cloned into constructs for use in YFP-PCA assays. Co-transfections of 
NSP4-NSP4, NSP4-VP4 and NSP4-VP6 demonstrated that only NSP4-NSP4 
interaction was seen in the assay. NSP4’s ability to interact with itself to form 
oligomers has been shown previously using SDS-PAGE (Maass and Atkinson, 1990), 
providing some validation of our use of the YFP-PCA assay approach. Following the 
screening procedure two proteins (sterol regulatory element (SRE) binding protein 
and lysine specific demethylase 5C) were isolated as interacting with the 
YFP1-NSP4 fusion protein. However in the validation step they were identified as 
false positive clones as they also interacted with YFP1 fragment. Despite the failure 
to identify cellular partner of NSP4 in the first attempt, the feasibility of the 
YFP-PCA assay was demonstrated in a control experiment that aimed at examining 
the sensitivity of the assay. In this control, it was found that the YFP-PCA assay 
using in our study was sufficient to isolate one target plasmid from a pool containing 
over 100,000 off-target plasmids. 
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8.6.1 Future Work 
The immediate future work would be to repeat the YFP-PCA screen to further 
optimize it for identifying cellular partners of NSP4. Furthermore, our YFP1-NSP4 
construct was designed to isolate cellular partners interacting with N-terminal tail of 
NSP4 in the ER. To isolation cellular partners in the cytosol of cells YFP fragment 1 
can be fused to the C-terminus of YFP1-NSP4 to construct an YFP1-NSP4-YFP1 
fusion protein as bait for screening. Such YFP1-NSP4-YFP1 fusion protein presents 
YFP fragment 1 both in the ER and the cytosol of cells so that cellular partners fused 
with YFP fragment 2 and interacting with different domains of NSP4 would be 
revealed from subsequent screening. 
 
8.7 Future Work on NSP4 
8.7.1 Understanding of NSP4 Induced Changes in Calcium Homeostasis and 
Intracellular Trafficking of NSP4 
The Ca2+ homeostasis changes in rotavirus-infected cells have been shown to be 
primarily associated with NSP4 rather than the other viral glycoprotein VP7 using 
RNAi technology (Diaz et al., 2008; Zambrano et al., 2008). This disturbance of 
Ca2+ has an important role throughout the viral replication cycle (Ruiz et al., 2000; 
Zambrano et al., 2008). However the precise mechanism of this function of NSP4 
remains unclear. To gain an understanding of the homeostasis of Ca2+ in NSP4 
expressing cells, the YFP-PCA assay provides a practicable approach that is able to 
identify cellular partners of NSP4. By knowing these proteins and their roles in the 
cellular metabolism, the mechanism used by NSP4 to affect homeostasis of Ca2+ can 
then be proposed. The secretion pathway of NSP4 is also worthy of investigation. 
One approach would be to focus on possible interactions of NSP4 with cellular 
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proteins identified by the YFP-PCA assay and known to be involved in the pathway. 
 
8.7.2 Study of NSP4-Caveolin Interaction 
Recently NSP4 has been shown to interact with both the N- and C- termini of 
caveolin (Mir et al., 2007; Parr et al., 2006). These interactions lead to the 
observation of an NSP4-caveolae association on the plasma membrane which is 
believed to be the final cellular destination of secreted NSP4 (Storey et al., 2007). 
The possible involvement of caveolin and caveolae in the putative secretion of NSP4 
provides a new approach to study intracellular trafficking of NSP4 probably by 
studying trafficking pathway of caveolin using confocal microscopy and markers of 
cellular structures. In addition, the importance of this caveolin-NSP4 interaction in 
different functionalities of NSP4 can be studied by over-expression of 
dominant-negative version of caveolin in cells (Sieczkarski and Whittaker, 2002) 
prior to expression of NSP4. Furthermore, infection on the caveolin knockout mice 
(Sieczkarski and Whittaker, 2002) with rotavirus would provide an approach to study 
the relevance of the caveolin-NSP4 interaction to viral pathology. 
 
8.7.3 Entero-toxic Mechanism of Exogenous NSP4 
It is known that exogenous addition of NSP4 to cells promotes intracellular calcium 
increases through a mechanism that is different from that of endogenously expressed 
NSP4 (Tian et al., 1995). To date, studies of exogenous NSP4 have been shown that 
NSP4 initially binds to cellular receptors (integrins α1β1 and α2β1) and stimulates a 
PLC-IP3 dependent pathway (Dong et al., 1997; Seo et al., 2008). These actions of 
NSP4 are currently thought to be responsible for inducing diarrhoea seen in rotaviral 
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disease (Dong et al., 1997; Seo et al., 2008). However this conclusion does require 
additional evidence to substantiate it and the possible involvement of other cellular 
receptors and pathways have not been excluded. One approach to progress this area 
could be to exploit the recently developed reverse genetics technology for rotavirus 
(Troupin et al., 2010) using segment 10 (encodes NSP4) mutants carrying introduced 
point mutations or deletions for the entero-toxic function of NSP4. The pathology of 
the recombinant virus can be examined and compared to the wild type virus using 
both tissue culture and experimental animal approaches. 
 
8.8 Remaining questions about NSP4 
Many important questions of NSP4 remained to be addressed in the future: 
 What is the story of age-dependent diarrhoea induced by NSP4? 
 What is/are the cellular signaling pathway(s) that NSP4 participates in? 
 Does unglycosylated NSP4 play a role different from glycosylated NSP4 in 
infected cells? 
 Does the secreted NSP4 function similarly both in vitro and in vivo situation? 
 How is the enteric nervous system involved in the pathogenesis of NSP4? 
 What are the mechanisms used by endogenously and/or exogenously 
expressed NSP4 to stimulate cell death? 
The occurrence of diarrhoea is a multi-component process involving secretory 
mediators, water and electrolytes and the responses of different cell types in the 
intestinal track. The enterotoxin found as being NSP4 shed the light on 
understanding the basic pathogenesis of rotavirus-induced illness. Knowledge of 
functionalities of NSP4 is still extending, in the future the story of NSP4 will be 
better understood by using novel technologies. 
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